Name,Term,ES,NES,NOM p-val,FDR q-val,FWER p-val,Tag %,Gene %,Lead_genes
prerank,phosphatidylinositol metabolic process (GO:0046488),0.7193450667110414,1.7835635019321407,0.0,0.3389270320459308,0.245,5/18,10.91%,CDS1;CMD1;INP51;SFH5;PIS1
prerank,glycerophospholipid metabolic process (GO:0006650),0.7618489144717758,1.7790395905015564,0.009900990099009901,0.18082695878835375,0.262,4/13,11.68%,CDS1;SFH5;UPS2;YPK1
prerank,inner mitochondrial membrane organization (GO:0007007),0.6708738329656485,1.7640470586638133,0.0,0.1521713205104179,0.324,13/24,14.05%,MIC60;TIM12;MGR2;ATP20;AFG3;ATP14;TIM13;TIM54;MIC19;UPS2;MBA1;TIM22;YTA12
prerank,mRNA polyadenylation (GO:0006378),0.7024498535533694,1.7400144503796096,0.0,0.1605703869022267,0.417,4/18,3.29%,RNA14;PCF11;FIP1;CLP1
prerank,cristae formation (GO:0042407),0.8193612860959427,1.729152860982014,0.00966183574879227,0.14999744450312624,0.47,8/11,17.59%,MIC60;ATP20;AFG3;ATP14;MIC19;UPS2;YTA12;MIC10
prerank,mRNA cleavage involved in mRNA processing (GO:0098787),0.7518592594909926,1.7213849555281295,0.012121212121212121,0.1404785025924096,0.505,4/14,3.29%,RNA14;PCF11;FIP1;CLP1
prerank,proteasome regulatory particle assembly (GO:0070682),0.8245490309144643,1.7097535007341933,0.00851063829787234,0.13989033267701684,0.558,6/10,16.16%,RPT2;RPT5;RPT3;NAS2;RPT1;RPN14
prerank,pre-mRNA cleavage required for polyadenylation (GO:0098789),0.7587871436620042,1.704970574134423,0.00558659217877095,0.1321617799887558,0.589,4/13,3.29%,RNA14;PCF11;FIP1;CLP1
prerank,positive regulation of RNA polymerase II transcriptional preinitiation complex assembly (GO:0045899),0.7875495198437078,1.67093347702002,0.014218009478672985,0.18236404283391353,0.742,5/11,13.76%,RPT2;RPT5;RPT3;SGF73;RPT1
prerank,regulation of RNA polymerase II transcriptional preinitiation complex assembly (GO:0045898),0.7516714619765699,1.6342572375315065,0.016129032258064516,0.2707463754536007,0.881,5/12,13.76%,RPT2;RPT5;RPT3;SGF73;RPT1
prerank,"energy coupled proton transport, down electrochemical gradient (GO:0015985)",0.8181625883617294,1.6207419751760124,0.014563106796116505,0.27025231272467076,0.922,6/10,10.58%,ATP20;ATP14;ATP16;ATP19;ATP15;ATP7
prerank,ATP biosynthetic process (GO:0006754),0.8181625883617294,1.6207419751760124,0.014563106796116505,0.27025231272467076,0.922,6/10,10.58%,ATP20;ATP14;ATP16;ATP19;ATP15;ATP7
prerank,regulation of chromatin silencing at telomere (GO:0031938),0.6179295493969482,1.6146653418525687,0.010638297872340425,0.2693782017427178,0.938,14/22,27.41%,ORC5;CDC7;WTM2;BDF1;PAF1;SIF2;RPD3;YRB2;CDC45;GSP1;YAP5;MCM5;WTM1;CDC6
prerank,"DNA replication, Okazaki fragment processing (GO:0033567)",0.8076065796715395,1.5690926956668265,0.028037383177570093,0.42503510765943264,0.991,3/9,6.14%,RNH203;MGS1;CDC9
prerank,membrane lipid metabolic process (GO:0006643),0.8377434205093788,1.5651290862464489,0.028268551236749116,0.4152761924232357,0.993,2/7,5.38%,KES1;HFD1
prerank,regulation of translation in response to stress (GO:0043555),0.9353109007964923,1.5597536349280483,0.0029239766081871343,0.415321481506721,0.995,1/5,0.47%,SBP1
prerank,lagging strand elongation (GO:0006273),0.8119619135662257,1.5590723660741885,0.01968503937007874,0.3925764319050277,0.995,3/8,6.14%,MGS1;POL30;CDC9
prerank,protein-cofactor linkage (GO:0018065),0.7998963694227559,1.5512436027119962,0.05363984674329502,0.4044177915585313,0.998,2/8,4.48%,SDH5;LIP5
prerank,mRNA 5'-splice site recognition (GO:0000395),0.8807567948686534,1.513633344810924,0.022598870056497175,0.5656238147202,1.0,3/5,9.88%,PRP42;PRP9;PRP28
prerank,centromere complex assembly (GO:0034508),0.7545590873319518,1.5116366355278124,0.06477732793522267,0.5472238785627886,1.0,4/9,6.77%,HST4;SKP1;SCM3;ARP4
prerank,mRNA cleavage (GO:0006379),0.875370940087425,1.508352447381859,0.05172413793103448,0.5386695353133161,1.0,3/6,3.29%,RNA14;PCF11;CLP1
prerank,rRNA export from nucleus (GO:0006407),-0.8356186804404485,-1.496449000671184,0.0011641443538998836,0.8532105183742336,0.73,3/17,3.70%,RPS5;RPS15;RNA1
prerank,rRNA transport (GO:0051029),-0.8356186804404485,-1.496449000671184,0.0011641443538998836,0.8532105183742336,0.73,3/17,3.70%,RPS5;RPS15;RNA1
prerank,phosphatidylserine metabolic process (GO:0006658),0.8768292936896349,1.4961719807759382,0.03142857142857143,0.5757178235839837,1.0,1/5,0.18%,CDS1
prerank,protein complex assembly (GO:0006461),0.7367782422360636,1.483308828401059,0.06666666666666667,0.6188243084788423,1.0,5/9,14.05%,ATP20;AFG3;CDC123;ATP19;YTA12
prerank,establishment of protein localization to mitochondrial membrane (GO:0090151),0.6083309524365743,1.4819459222482132,0.06896551724137931,0.6011508254254903,1.0,8/18,12.64%,SAM35;TIM12;MGR2;TIM13;TIM54;SAM50;TIM22;DJP1
prerank,cellular response to water deprivation (GO:0042631),0.8111749303976569,1.4733971535047474,0.076158940397351,0.6223214133601377,1.0,5/7,18.40%,TPS1;STF2;YJL144W;ATH1;YNL190W
prerank,neutral amino acid transport (GO:0015804),-0.980019579445043,-1.4729950041272764,0.0,1.0,0.942,2/5,1.39%,AVT1;YCT1
prerank,RNA phosphodiester bond hydrolysis (GO:0090501),0.7749416057545432,1.4693364673530944,0.061224489795918366,0.6207328116625014,1.0,4/8,8.20%,RNA14;PCF11;CLP1;NOP10
prerank,nucleic acid-templated transcription (GO:0097659),-0.9148040799241283,-1.4685434131811308,0.004026845637583893,0.9582943535296727,0.954,3/8,7.37%,GAT3;TEA1;BRE2
prerank,protein import into mitochondrial outer membrane (GO:0045040),0.7329580606931716,1.4600715070159638,0.0942622950819672,0.6481737031168858,1.0,3/9,12.64%,SAM35;SAM50;DJP1
prerank,vacuole organization (GO:0007033),-0.7839226369423292,-1.4562266978299527,0.008791208791208791,1.0,0.985,10/24,14.16%,VPS9;NEO1;VPS41;CLA4;VAC8;MYO2;VPS16;ENV9;PEP7;ATG16
prerank,regulation of DNA biosynthetic process (GO:2000278),0.8810777172588296,1.455338293204929,0.01892744479495268,0.6494101669834672,1.0,1/5,3.20%,TGS1
prerank,regulation of Ras protein signal transduction (GO:0046578),-0.8915335754170868,-1.4547679534273104,0.011936339522546418,0.9130673409448735,0.988,2/9,3.00%,YLR179C;IRA1
prerank,transcription-dependent tethering of RNA polymerase II gene DNA at nuclear periphery (GO:0000972),-0.8115465283609617,-1.4512075969412972,0.006936416184971098,0.8542853615568667,0.991,6/18,7.87%,NUP60;NUP120;NUP145;NUP100;RRP6;NUP170
prerank,cellular response to topologically incorrect protein (GO:0035967),-0.845501550123088,-1.4455412068846558,0.010126582278481013,0.8601074287961299,0.995,6/12,12.82%,SSQ1;TMC1;SSA3;SSA2;SSA1;SSZ1
prerank,regulation of mitotic metaphase/anaphase transition (GO:0030071),0.8783462494020218,1.440909911890225,0.0375,0.7086563197437687,1.0,1/5,1.10%,APC11
prerank,acetate metabolic process (GO:0006083),-0.9388392110658588,-1.4398812547198279,0.010057471264367816,0.8815784165943971,0.996,2/6,5.47%,IAH1;TDA9
prerank,regulation of transcription from RNA polymerase II promoter in response to stress (GO:0043618),-0.7910564282617883,-1.4343574891330286,0.007927519818799546,0.9044733725646198,0.998,7/22,12.39%,MGA1;RAD26;PDR8;ZAP1;SFL1;SUB1;RRD1
prerank,'de novo' posttranslational protein folding (GO:0051084),-0.8420712732177685,-1.4340964538898613,0.011335012594458438,0.7583257507517805,0.998,5/12,12.82%,SSQ1;SSA3;SSA2;SSA1;SSZ1
prerank,chaperone mediated protein folding requiring cofactor (GO:0051085),-0.8420712732177685,-1.4340964538898613,0.011335012594458438,0.7583257507517805,0.998,5/12,12.82%,SSQ1;SSA3;SSA2;SSA1;SSZ1
prerank,transcription-coupled nucleotide-excision repair (GO:0006283),-0.890612981876555,-1.4331865487810005,0.013404825737265416,0.7172015156487248,0.998,2/8,2.94%,THO2;RAD26
prerank,positive regulation of reproductive process (GO:2000243),-0.9584093626469147,-1.4326146350716604,0.004552352048558422,0.6750731749058246,0.999,1/5,1.41%,SWI1
prerank,late endosome to vacuole transport (GO:0045324),-0.7643628484567864,-1.4320012732427267,0.004333694474539545,0.6402339245460739,0.999,8/26,15.62%,VPS9;PKH1;ENT5;STP22;VPS16;MUK1;SNF7;VPS8
prerank,intra-S DNA damage checkpoint (GO:0031573),-0.8754837229800989,-1.4279816747209901,0.01349527665317139,0.6571501648354161,0.999,3/9,9.77%,FAR11;POL2;SGS1
prerank,"DNA replication, removal of RNA primer (GO:0043137)",0.7533562239620457,1.425870373831244,0.09615384615384616,0.7727799830769319,1.0,1/7,0.56%,RNH203
prerank,posttranscriptional tethering of RNA polymerase II gene DNA at nuclear periphery (GO:0000973),-0.8100543239190253,-1.4195238426521275,0.009512485136741973,0.7497347329214398,1.0,5/15,7.19%,NUP60;NUP120;NUP145;NUP100;RRP6
prerank,regulation of cytoplasmic mRNA processing body assembly (GO:0010603),-0.8845955069040712,-1.4188468645734729,0.013071895424836602,0.7175573469245708,1.0,2/9,4.08%,PKH1;PKC1
prerank,cellular response to glucose starvation (GO:0042149),-0.8413856006948183,-1.418681104815845,0.013480392156862746,0.6820087419684999,1.0,1/12,0.63%,YAK1
prerank,"regulation of transposition, RNA-mediated (GO:0010525)",-0.8558405185841332,-1.4182781690692576,0.015151515151515152,0.6536264706016837,1.0,4/10,11.81%,RTT103;RTT107;RTT101;STE4
prerank,monocarboxylic acid transport (GO:0015718),0.7619625622418659,1.4157268831819747,0.09486166007905138,0.8093385000167619,1.0,2/7,3.03%,ADY2;OAC1
prerank,nuclear envelope organization (GO:0006998),0.7694891588304411,1.4148904118345553,0.11419753086419752,0.7884314786104912,1.0,3/7,5.80%,SHP1;MPS3;BRL1
prerank,mitochondrial outer membrane translocase complex assembly (GO:0070096),0.7355205222946329,1.4148679539450681,0.1,0.7648390475792217,1.0,1/8,0.09%,SAM35
prerank,RNA transport (GO:0050658),-0.8521412508072914,-1.4143298844825634,0.02295918367346939,0.6770556634426814,1.0,5/11,7.87%,NSP1;NUP145;RNA1;NUP100;NUP170
prerank,rRNA-containing ribonucleoprotein complex export from nucleus (GO:0071428),-0.75589089849136,-1.4107585431098821,0.015350877192982455,0.6952541699349014,1.0,3/25,3.70%,RPS5;RPS15;RNA1
prerank,mitotic DNA damage checkpoint (GO:0044773),-0.809889717114301,-1.4092956586166936,0.019656019656019656,0.6857001027202068,1.0,4/14,9.77%,FAR11;POL2;DPB11;SGS1
prerank,L-serine metabolic process (GO:0006563),0.7826939466699208,1.4068614996283677,0.09352517985611511,0.7861409892679153,1.0,2/6,11.47%,LPD1;SER2
prerank,endosome transport via multivesicular body sorting pathway (GO:0032509),-0.768146546950426,-1.4063234781294198,0.017084282460136675,0.6992213184089838,1.0,6/21,15.62%,VPS9;PKH1;ENT5;SNA2;MUK1;VPS8
prerank,cellular response to unfolded protein (GO:0034620),-0.8613055205163844,-1.4056654231087304,0.02168021680216802,0.6806021682372899,1.0,5/9,12.82%,SSQ1;SSA3;SSA2;SSA1;SSZ1
prerank,positive regulation of cellular process (GO:0048522),-0.7922210867815014,-1.405112344796602,0.02127659574468085,0.6609844611888479,1.0,9/15,12.15%,CLB1;NSE4;CLN2;KOG1;PDR1;CLB3;CLB2;CLB6;CRZ1
prerank,RNA export from nucleus (GO:0006405),-0.7163423382599103,-1.4042969249193327,0.002036659877800407,0.6466097350694271,1.0,13/58,11.30%,RPS5;NUP120;UTP8;THO2;RPS15;NSP1;NUP145;RNA1;GFD1;NUP100;NUP170;SOL2;IST3
prerank,Golgi to endosome transport (GO:0006895),-0.8156241692719314,-1.4001741315273795,0.022946859903381644,0.678011079605022,1.0,6/13,12.46%,VPS9;ENT5;GGA1;VPS16;MUK1;PEP7
prerank,telomere tethering at nuclear periphery (GO:0034398),-0.8179711680492201,-1.3998734796920496,0.02743142144638404,0.637190924069019,1.0,7/13,7.87%,NUP60;MLP1;NUP120;NUP145;NUP100;SIR3;NUP170
prerank,telomere localization (GO:0034397),-0.8179711680492201,-1.3998734796920496,0.02743142144638404,0.637190924069019,1.0,7/13,7.87%,NUP60;MLP1;NUP120;NUP145;NUP100;SIR3;NUP170
prerank,C4-dicarboxylate transport (GO:0015740),0.820461817635055,1.399291720682293,0.09495548961424333,0.8062256771458263,1.0,2/5,10.04%,OAC1;ODC1
prerank,positive regulation of protein localization to nucleus (GO:1900182),-0.9383320014921853,-1.3977294977465526,0.01195814648729447,0.6432693741534586,1.0,1/5,3.16%,CLA4
prerank,intracellular lipid transport (GO:0032365),0.7460278308918232,1.3949493301220337,0.13333333333333333,0.8074631866478128,1.0,1/7,0.85%,KES1
prerank,carbon catabolite regulation of transcription from RNA polymerase II promoter (GO:0000429),-0.8247116700815651,-1.3947377257528926,0.025220680958385876,0.6601283761539622,1.0,4/11,9.57%,SWI1;GSM1;USV1;HAP4
prerank,late endosome to vacuole transport via multivesicular body sorting pathway (GO:0032511),-0.7348764793411724,-1.3928814879187223,0.02145922746781116,0.663471382734493,1.0,5/29,5.51%,VPS9;PKH1;TRE1;ENT5;GGA1
prerank,poly(A)+ mRNA export from nucleus (GO:0016973),-0.7313733438959928,-1.3922559425936114,0.010460251046025104,0.6528091682757519,1.0,8/35,8.31%,NUP60;MLP1;NSP1;NUP145;MTR4;GBP2;NEW1;SPN1
prerank,"nuclear-transcribed mRNA catabolic process, exonucleolytic, 3'-5' (GO:0034427)",0.6449336604950235,1.3903690369354667,0.11797752808988764,0.7889921747995727,1.0,5/13,12.28%,RRP45;RRP43;SKI6;SKI8;UPF3
prerank,"nuclear-transcribed mRNA catabolic process, 3'-5' exonucleolytic nonsense-mediated decay (GO:0070478)",0.6449336604950235,1.3903690369354667,0.11797752808988764,0.7889921747995727,1.0,5/13,12.28%,RRP45;RRP43;SKI6;SKI8;UPF3
prerank,ribonucleoprotein complex disassembly (GO:0032988),-0.8108910340613166,-1.3896060867314644,0.03233830845771144,0.6663167857779729,1.0,4/13,11.23%,DOM34;PRP43;HBS1;SSA1
prerank,protein acetylation (GO:0006473),-0.8473674690752179,-1.3890552187712597,0.030343007915567283,0.6548302949662327,1.0,1/9,0.72%,HPA3
prerank,mitochondrial membrane organization (GO:0007006),-0.8250754379773153,-1.38451201632137,0.027379400260756193,0.6928497254885095,1.0,1/10,1.59%,SAR1
prerank,NAD metabolic process (GO:0019674),-0.8714218526984938,-1.3812511000462304,0.03342245989304813,0.714216323651614,1.0,1/8,0.34%,QNS1
prerank,nuclear export (GO:0051168),-0.7871715743840872,-1.3810862768786532,0.019562715765247412,0.6986554180666744,1.0,6/17,7.87%,NUP60;NUP120;NSP1;NUP145;NUP100;NUP170
prerank,positive regulation of phosphatase activity (GO:0010922),0.8336779734922577,1.3806098666284452,0.08641975308641975,0.8222977367908114,1.0,1/5,0.85%,KES1
prerank,heterocycle biosynthetic process (GO:0018130),0.5774129236210721,1.3801480607516399,0.10714285714285714,0.8044082321072626,1.0,8/18,14.57%,HIS3;BNA3;LIP5;YHR033W;BIO3;ISA2;PRO3;ACP1
prerank,positive regulation of gene expression (GO:0010628),-0.7657072397865967,-1.38013657709338,0.02593010146561443,0.6920986909187345,1.0,5/21,6.14%,DOM34;NUP120;NUP145;HBS1;NUP100
prerank,protein complex localization (GO:0031503),0.6357597531778618,1.3766594117508377,0.0972972972972973,0.8040208146259189,1.0,4/12,9.52%,RPT2;CDC7;WTM2;ARL1
prerank,aldehyde biosynthetic process (GO:0046184),-0.8756649139846113,-1.374339419504363,0.03537414965986395,0.7295080107551817,1.0,1/7,3.12%,SNO3
prerank,pyridoxal phosphate metabolic process (GO:0042822),-0.8756649139846113,-1.374339419504363,0.03537414965986395,0.7295080107551817,1.0,1/7,3.12%,SNO3
prerank,nuclear retention of pre-mRNA at the site of transcription (GO:0071033),-0.8634137860739293,-1.3736234215756196,0.032432432432432434,0.7218980099272359,1.0,3/8,7.19%,MLP1;MTR4;RRP6
prerank,nucleoside phosphate biosynthetic process (GO:1901293),0.7691816011502361,1.372316169493183,0.11610486891385768,0.80621626642718,1.0,2/7,4.59%,YNK1;APA1
prerank,pyridoxal phosphate biosynthetic process (GO:0042823),-0.8560677414574689,-1.371947150736719,0.0426098535286285,0.7248709852672761,1.0,2/8,8.20%,SNO3;PDX3
prerank,positive regulation of ribosomal protein gene transcription from RNA polymerase II promoter (GO:0060963),-0.8607058752267744,-1.37149505054126,0.04076086956521739,0.7139347273090295,1.0,2/8,7.60%,IFH1;FHL1
prerank,intracellular mRNA localization (GO:0008298),-0.7725545338716827,-1.3709972889847601,0.02662037037037037,0.7036920429512408,1.0,4/18,7.98%,NUP60;LOC1;RRP6;SCP160
prerank,amino acid transmembrane transport (GO:0003333),-0.875448625775319,-1.3675694263194256,0.034334763948497854,0.7290821390828192,1.0,2/7,8.09%,AVT1;AVT2
prerank,carboxylic acid transmembrane transport (GO:1905039),-0.825781583492784,-1.3674817430271404,0.03969270166453265,0.7151051121078966,1.0,2/10,8.09%,AVT1;AVT2
prerank,positive regulation of protein kinase activity (GO:0045860),-0.7715382371325463,-1.3649323961773234,0.022326674500587545,0.7303815341036073,1.0,8/17,18.60%,PKH1;CLA4;KOG1;SKG3;CDC15;RPP2B;MKK2;SSK2
prerank,ribosome disassembly (GO:0032790),-0.8946164202199077,-1.3646010476905734,0.04093567251461988,0.719285057818137,1.0,2/6,5.29%,DOM34;HBS1
prerank,cellular response to amino acid starvation (GO:0034198),-0.9253504906066952,-1.3643531851878907,0.024922118380062305,0.7078172538225131,1.0,1/5,1.41%,SWI1
prerank,translation reinitiation (GO:0002188),-0.9151762698661612,-1.3640249273460614,0.03129890453834116,0.6980637949815327,1.0,2/5,3.61%,TMA20;TIF35
prerank,sister chromatid segregation (GO:0000819),-0.715798073777215,-1.363564197966061,0.019230769230769232,0.6908551176364879,1.0,11/34,13.72%,HIR2;TUB2;MPS1;KIP1;SMC4;CIN8;SGS1;ESP1;RTS1;CIK1;SPC72
prerank,positive regulation of cellular protein metabolic process (GO:0032270),-0.8775722147602574,-1.3600895918270786,0.0364656381486676,0.7166470476365632,1.0,2/7,5.29%,DOM34;HBS1
prerank,early endosome to Golgi transport (GO:0034498),-0.8279389917979305,-1.358500350843351,0.03773584905660377,0.7216015077317391,1.0,3/10,4.89%,ENT5;YPT32;TRS120
prerank,gene expression (GO:0010467),-0.6875825519089667,-1.3578244905648935,0.0,0.7171353714528705,1.0,17/75,14.32%,RPS5;SSQ1;DOM34;NUP120;GAT3;THO2;TEA1;GFD1;HBS1;NUP100;RPS4A;BRE2;IST3;HSP60;RPS14A;TOS4;YME1
prerank,positive regulation of protein catabolic process (GO:0045732),0.7513469269831099,1.357744952833809,0.14028776978417265,0.862932260315194,1.0,2/6,13.76%,RPT2;RPT1
prerank,amino acid catabolic process via Ehrlich pathway (GO:0000955),-0.8767022967621916,-1.3563795087314905,0.043923865300146414,0.7205170418169446,1.0,2/6,6.81%,ADH4;ADH1
prerank,primary alcohol metabolic process (GO:0034308),-0.821349964483532,-1.3561214607639183,0.04846938775510204,0.7111384877649377,1.0,2/10,6.81%,FMP30;ADH1
prerank,regulation of cell cycle process (GO:0010564),-0.7100755457004396,-1.355134266052433,0.017222820236813777,0.7097292768453031,1.0,14/30,16.00%,CLB1;MPS1;CLN2;CLB3;SLI15;DBF2;RTT101;VRP1;CLB2;ECM27;CLB6;NIS1;KEL1;CLN1
prerank,positive regulation of autophagy (GO:0010508),-0.7613720737608983,-1.354197823282285,0.06168446026097272,0.7081496824460569,1.0,4/15,8.29%,GCN2;FAR11;PCL1;SFL1
prerank,response to amino acid (GO:0043200),-0.8545715217350562,-1.3521419366447938,0.048034934497816595,0.7186930130486865,1.0,1/7,6.59%,KOG1
prerank,DNA replication-independent nucleosome organization (GO:0034724),-0.8364206758037842,-1.3515717743567515,0.058423913043478264,0.7134277403454649,1.0,2/9,5.18%,HIR2;HIR3
prerank,vacuole inheritance (GO:0000011),-0.7678452484230648,-1.351327796518725,0.05771495877502945,0.704778655753265,1.0,5/15,12.46%,VPS9;CLA4;VAC8;MYO2;PEP7
prerank,protein stabilization (GO:0050821),-0.8429686774341414,-1.3511212817476475,0.050870147255689425,0.6958042127908626,1.0,4/8,13.81%,ZIM17;HSP60;OCT1;HSP78
prerank,rRNA methylation (GO:0031167),0.6811101746870579,1.3499066756875833,0.12345679012345678,0.8843273699910325,1.0,2/9,7.58%,BMT6;EMG1
prerank,tRNA pseudouridine synthesis (GO:0031119),-0.8558290594184488,-1.3487683973831663,0.055873925501432664,0.7102718087297174,1.0,1/7,0.13%,DEG1
prerank,positive regulation of cell cycle (GO:0045787),-0.7654689188311327,-1.3483937939450574,0.04659498207885305,0.7037204599734607,1.0,6/14,16.00%,CLB1;CLN2;CLB3;CLB2;CLB6;CLN1
prerank,positive regulation of cell proliferation (GO:0008284),-0.8172750741336242,-1.348005889809087,0.05312084993359894,0.6870798055165331,1.0,6/9,16.00%,CLB1;CLN2;CLB3;CLB2;CLB6;CLN1
prerank,regulation of cell proliferation (GO:0042127),-0.8172750741336242,-1.348005889809087,0.05312084993359894,0.6870798055165331,1.0,6/9,16.00%,CLB1;CLN2;CLB3;CLB2;CLB6;CLN1
prerank,double-strand break repair via synthesis-dependent strand annealing (GO:0045003),-0.8089952560958268,-1.3440953459056213,0.04068241469816273,0.7175258458844358,1.0,2/10,2.60%,RAD54;RAD55
prerank,outer mitochondrial membrane organization (GO:0007008),0.6266655385632649,1.343587845840021,0.15706806282722513,0.8975253325458618,1.0,3/12,12.64%,SAM35;SAM50;DJP1
prerank,activation of protein kinase activity (GO:0032147),-0.8041538849199799,-1.3408560377113823,0.05432098765432099,0.7415844710471672,1.0,6/11,18.60%,CLA4;SSK1;SKG3;CDC15;MKK2;SSK2
prerank,regulation of protein localization to nucleus (GO:1900180),0.7314914869832299,1.3407068494861198,0.12542372881355932,0.892191364494593,1.0,1/7,0.61%,SLT2
prerank,ubiquitin-dependent endocytosis (GO:0070086),-0.8327122116342857,-1.3400334807816592,0.0625,0.7399422317731945,1.0,3/8,7.75%,LDB19;RIM8;CSR2
prerank,amino acid catabolic process to alcohol via Ehrlich pathway (GO:0000947),-0.8143466550446249,-1.3398087481393433,0.0560625814863103,0.7316855634251829,1.0,2/9,6.81%,ADH4;ADH1
prerank,polyamine transport (GO:0015846),-0.8228599982568618,-1.3397090555464524,0.049531459170013385,0.7224457838894419,1.0,4/9,11.95%,SAM3;TPO5;PTK2;TPO4
prerank,negative regulation of small GTPase mediated signal transduction (GO:0051058),-0.9131548299317731,-1.3384198732417276,0.0380517503805175,0.7264700455795229,1.0,1/5,3.00%,IRA1
prerank,regulation of chromatin organization (GO:1902275),-0.8508454700209317,-1.337157210637238,0.061079545454545456,0.7297984572685331,1.0,2/7,2.51%,HIR2;CHD1
prerank,mRNA export from nucleus (GO:0006406),-0.6813715423090317,-1.3363762397774601,0.011144883485309016,0.7288417336946018,1.0,12/59,8.31%,NUP60;MLP1;NUP120;THO2;NSP1;NUP145;GFD1;MTR4;NUP100;GBP2;NEW1;SPN1
prerank,positive regulation of cellular amide metabolic process (GO:0034250),-0.8826736937841864,-1.3355827186361187,0.057692307692307696,0.7270499855375234,1.0,2/6,5.29%,DOM34;HBS1
prerank,fermentation (GO:0006113),-0.8969872359150911,-1.3352930912885317,0.04538341158059468,0.7210213429593136,1.0,1/5,3.50%,ADH4
prerank,proteasomal ubiquitin-independent protein catabolic process (GO:0010499),0.6324959747365587,1.3349344999000512,0.13901345291479822,0.9024949261606396,1.0,6/12,20.87%,PRE5;PRE10;PRE9;PRE1;PUP3;PUP2
prerank,positive regulation of GTPase activity (GO:0043547),-0.7393270875834946,-1.3344065328352646,0.0518018018018018,0.7207834889892002,1.0,7/20,15.44%,ROM1;IRA1;GYP7;BUB2;ROM2;SED4;GYP6
prerank,valine metabolic process (GO:0006573),0.775792041137732,1.3324967269036396,0.18618618618618618,0.8944388128865189,1.0,4/5,22.03%,LPD1;CBS2;PAN6;ILV5
prerank,positive regulation of protein serine/threonine kinase activity (GO:0071902),-0.8247265456357814,-1.3272266002429296,0.07005494505494506,0.7863230271189696,1.0,3/8,10.65%,PKH1;KOG1;CLB2
prerank,regulation of nuclear-transcribed mRNA poly(A) tail shortening (GO:0060211),-0.8889810989295192,-1.3265805019589827,0.06515151515151515,0.7832908635382004,1.0,2/5,4.08%,PKH1;PKC1
prerank,organic cyclic compound biosynthetic process (GO:1901362),0.5111500477347976,1.3254222431924307,0.11764705882352941,0.9111928329264819,1.0,8/22,14.57%,HIS3;BNA3;LIP5;YHR033W;BIO3;ISA2;PRO3;ACP1
prerank,mitotic spindle organization (GO:0007052),-0.6990019384470376,-1.3253054647608058,0.05450733752620545,0.7873916659222558,1.0,14/31,18.20%,CLB1;BIK1;KIP1;CNM67;STU2;CIN8;RRD1;CIK1;SPC72;RRD2;SPC97;SLK19;ASE1;MIF2
prerank,positive regulation of transcription from RNA polymerase II promoter in response to heat stress (GO:0061408),-0.7592803006725719,-1.3248296656299905,0.05826397146254459,0.7831143396372559,1.0,3/15,8.29%,YAK1;MGA1;SFL1
prerank,mitotic recombination (GO:0006312),-0.7105954080230069,-1.323242421545006,0.04643628509719223,0.7906665878470106,1.0,8/25,16.09%,RAD54;IRC8;IES3;SGS1;MSH2;IES5;PIF1;RAD51
prerank,"regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay (GO:1900151)",-0.7751265148432602,-1.3231986746972721,0.0880503144654088,0.7818957269743468,1.0,3/11,10.69%,PKH1;PKC1;EDC3
prerank,mRNA pseudouridine synthesis (GO:1990481),-0.856217626405159,-1.3223721786155551,0.07761194029850746,0.7817509441762849,1.0,1/6,0.13%,DEG1
prerank,cellular response to organonitrogen compound (GO:0071417),-0.8590982075460938,-1.3222354840936972,0.07480916030534351,0.7655912563863072,1.0,1/6,6.59%,KOG1
prerank,cellular response to amino acid stimulus (GO:0071230),-0.8590982075460938,-1.3222354840936972,0.07480916030534351,0.7655912563863072,1.0,1/6,6.59%,KOG1
prerank,negative regulation of supramolecular fiber organization (GO:1902904),-0.8824285466748683,-1.3216811432484619,0.05223880597014925,0.7624108257841029,1.0,1/5,0.83%,BIK1
prerank,histone deubiquitination (GO:0016578),0.7851361291703782,1.3214165991687898,0.16666666666666666,0.9120002725863332,1.0,4/5,21.38%,SGF73;SGF11;SEM1;SUS1
prerank,coenzyme transport (GO:0051182),-0.8734351058586276,-1.3212951986654151,0.06321839080459771,0.7578854631369687,1.0,3/6,5.45%,SAM3;FLC2;FLC1
prerank,meiosis I (GO:0007127),-0.7872896512700529,-1.3209833667162718,0.06551297898640297,0.7528642612468623,1.0,2/12,7.89%,TUB2;RIM9
prerank,regulation of glycolytic process by positive regulation of transcription from RNA polymerase II promoter (GO:0072363),0.7872814284261079,1.320741510350225,0.18181818181818182,0.8801917540013183,1.0,1/5,1.03%,RAP1
prerank,regulation of glycolytic process by regulation of transcription from RNA polymerase II promoter (GO:0072361),0.7872814284261079,1.320741510350225,0.18181818181818182,0.8801917540013183,1.0,1/5,1.03%,RAP1
prerank,regulation of DNA-templated transcription in response to stress (GO:0043620),-0.7839640359215557,-1.3203279207617995,0.08111533586818757,0.7512452861921736,1.0,4/11,12.39%,MGA1;SFL1;SUB1;RRD1
prerank,carbohydrate derivative biosynthetic process (GO:1901137),-0.8480212658976031,-1.3202677090425747,0.06591865357643759,0.7437067277226113,1.0,2/7,5.38%,RNR2;GUT1
prerank,intronic snoRNA processing (GO:0031070),0.7150332179129548,1.3196596192023173,0.13666666666666666,0.8528071659918262,1.0,3/7,17.37%,POP7;POP1;RPR2
prerank,intronic box C/D snoRNA processing (GO:0034965),0.7150332179129548,1.3196596192023173,0.13666666666666666,0.8528071659918262,1.0,3/7,17.37%,POP7;POP1;RPR2
prerank,positive regulation of transcription from RNA polymerase II promoter in response to stress (GO:0036003),-0.6950281679370733,-1.3195165283753532,0.05,0.7432548230909868,1.0,8/33,12.15%,YAK1;SWI1;MGA1;PDR8;ARR1;ZAP1;SFL1;CRZ1
prerank,"negative regulation of transposition, RNA-mediated (GO:0010526)",-0.8875277446811195,-1.3180302094889218,0.0654490106544901,0.7424524069171432,1.0,3/5,9.91%,RTT103;RTT107;RTT101
prerank,negative regulation of transposition (GO:0010529),-0.8875277446811195,-1.3180302094889218,0.0654490106544901,0.7424524069171432,1.0,3/5,9.91%,RTT103;RTT107;RTT101
prerank,tRNA transport (GO:0051031),-0.7556507092475855,-1.3171894463162512,0.04367816091954023,0.7428237541558856,1.0,7/17,11.32%,UTP8;NSP1;NUP145;RNA1;SOL2;SSA2;YDJ1
prerank,protein depolymerization (GO:0051261),-0.851304214181899,-1.3161193742975623,0.07927677329624479,0.7453167360413391,1.0,4/7,9.46%,KIP1;TWF1;CIN8;DOA4
prerank,leucine metabolic process (GO:0006551),0.7897383150093107,1.314829473467024,0.14326647564469913,0.858555261458306,1.0,3/5,16.67%,LPD1;LEU1;LEU4
prerank,positive regulation of transcription from RNA polymerase II promoter involved in cellular response to chemical stimulus (GO:1901522),-0.738356642077219,-1.3143193724168687,0.07019562715765247,0.7558253832269277,1.0,6/18,12.15%,SWI1;ARR1;USV1;HAP4;SUB1;CRZ1
prerank,regulation of protein catabolic process (GO:0042176),0.7378830711547206,1.3142191828847265,0.16721311475409836,0.8461177134874257,1.0,2/6,13.76%,RPT2;RPT1
prerank,chronological cell aging (GO:0001300),-0.7226030593005032,-1.31394470936536,0.09027777777777778,0.7519588574459428,1.0,4/19,11.27%,ALT1;GCN2;MDH1;GIS1
prerank,recombinational repair (GO:0000725),-0.6974453117442313,-1.3126007425905002,0.05194805194805195,0.7573267023414321,1.0,5/28,10.33%,MGM101;DPB11;SMC6;SGS1;RSC2
prerank,thiamine-containing compound biosynthetic process (GO:0042724),-0.8462743579011522,-1.3123260706304671,0.07736389684813753,0.7449588525183929,1.0,2/7,3.12%,THI12;SNO3
prerank,thiamine biosynthetic process (GO:0009228),-0.8462743579011522,-1.3123260706304671,0.07736389684813753,0.7449588525183929,1.0,2/7,3.12%,THI12;SNO3
prerank,negative regulation of growth of unicellular organism as a thread of attached cells (GO:0070785),0.7657477830298027,1.31194353653229,0.16716417910447762,0.8265328722081197,1.0,3/5,21.72%,NRG2;SLZ1;IME4
prerank,negative regulation of cell growth (GO:0030308),0.7657477830298027,1.31194353653229,0.16716417910447762,0.8265328722081197,1.0,3/5,21.72%,NRG2;SLZ1;IME4
prerank,beta-glucan biosynthetic process (GO:0051274),-0.8122598693704897,-1.3115105233429434,0.06587615283267458,0.7454065031642843,1.0,2/9,4.44%,GSC2;SKN1
prerank,rRNA base methylation (GO:0070475),0.7255704672907648,1.3110644611286244,0.18322981366459629,0.8158399225207998,1.0,2/6,7.58%,BMT6;EMG1
prerank,organelle disassembly (GO:1903008),-0.7365616926280553,-1.3105761261333888,0.0908004778972521,0.7469156932330278,1.0,6/15,19.81%,DOM34;HBS1;RTS1;SSA1;ATG11;ATG8
prerank,energy reserve metabolic process (GO:0006112),0.6047711748683164,1.3095235714247762,0.17326732673267325,0.8092088749566986,1.0,2/12,2.76%,GLC7;SHP1
prerank,carbon catabolite activation of transcription (GO:0045991),-0.8053715645560876,-1.3090352388850888,0.07942708333333333,0.7541221449714823,1.0,3/9,9.57%,SWI1;USV1;HAP4
prerank,double-strand break repair (GO:0006302),-0.6688954981946326,-1.3089676472890683,0.023445463812436288,0.7476930626824986,1.0,18/58,19.99%,NUP60;NUP120;NUP145;RTT107;PSO2;POL2;SIR3;SMC6;SGS1;RSC2;SUB1;RAD5;SRS2;PDS5;RSC1;RFA3;TDP1;NUP133
prerank,metal ion homeostasis (GO:0055065),-0.8552649136126944,-1.3078005097145577,0.10028248587570622,0.7517678803708259,1.0,3/6,14.05%,FLC2;FRE8;PCA1
prerank,septin cytoskeleton organization (GO:0032185),-0.7686530665852813,-1.3074849527270178,0.1,0.747641195946394,1.0,3/11,7.69%,BUD4;CLA4;PCL1
prerank,nicotinamide nucleotide biosynthetic process (GO:0019359),-0.796402961315592,-1.3055458970278333,0.08740359897172237,0.7584275894290845,1.0,2/10,6.36%,QNS1;UTR1
prerank,RNA biosynthetic process (GO:0032774),0.6282832067447924,1.3052635559344528,0.18468468468468469,0.8145069552804804,1.0,3/11,10.06%,GRS1;SUP45;PAF1
prerank,regulation of hydrolase activity (GO:0051336),-0.8475653502604473,-1.3047551091859797,0.09447674418604651,0.7582557084182576,1.0,1/6,4.89%,TRS120
prerank,spindle assembly checkpoint (GO:0071173),-0.7126923281708342,-1.3046853481687462,0.0771889400921659,0.7454300633756394,1.0,4/18,3.88%,MLP1;MPS1;IBD2;PPH22
prerank,mitotic spindle assembly checkpoint (GO:0007094),-0.7126923281708342,-1.3046853481687462,0.0771889400921659,0.7454300633756394,1.0,4/18,3.88%,MLP1;MPS1;IBD2;PPH22
prerank,activation of GTPase activity (GO:0090630),-0.7854142667134612,-1.3034748136904666,0.08461538461538462,0.7501110574454453,1.0,5/10,15.44%,ROM1;GYP7;BUB2;ROM2;GYP6
prerank,DNA replication-independent nucleosome assembly (GO:0006336),-0.85080259819448,-1.3025439766412878,0.08529411764705883,0.7518232091208069,1.0,2/6,5.18%,HIR2;HIR3
prerank,glycerol metabolic process (GO:0006071),-0.8126419911391347,-1.3016982777708208,0.09299191374663072,0.7526410245858539,1.0,4/8,13.69%,GUT1;GUT2;DAK1;GUP1
prerank,regulation of transcription initiation from RNA polymerase II promoter (GO:0060260),-0.7780419067541116,-1.3007002358441833,0.09753086419753086,0.7549196308884104,1.0,3/11,12.12%,CHD1;XRN1;SUB1
prerank,establishment of protein localization to vacuole (GO:0072666),-0.6596822059316654,-1.300551713899671,0.02672147995889003,0.7497802414031505,1.0,9/54,10.78%,VPS9;BSD2;TRE1;VPS41;STP22;GGA1;APM3;VPS16;PEP1
prerank,RNA polyadenylation (GO:0043631),0.5004210372305464,1.3003824085889517,0.13157894736842105,0.8207497553043047,1.0,5/22,5.54%,RNA14;PCF11;FIP1;CLP1;AIR2
prerank,alditol metabolic process (GO:0019400),-0.8627227048607109,-1.2974507575206138,0.08722741433021806,0.7705993358784371,1.0,2/5,6.12%,GUT1;GUT2
prerank,positive regulation of catabolic process (GO:0009896),0.7718458991816942,1.2956388654487763,0.17405063291139242,0.8139683459120569,1.0,2/5,13.76%,RPT2;RPT1
prerank,positive regulation of protein metabolic process (GO:0051247),0.7718458991816942,1.2956388654487763,0.17405063291139242,0.8139683459120569,1.0,2/5,13.76%,RPT2;RPT1
prerank,regulation of phosphoprotein phosphatase activity (GO:0043666),-0.8693297888804703,-1.2950971557398774,0.09214501510574018,0.7850356038402155,1.0,2/5,10.24%,GIP1;ESP1
prerank,peptidyl-serine dephosphorylation (GO:0070262),-0.8604087675042291,-1.294014661063192,0.1095890410958904,0.7887453920205684,1.0,2/5,8.34%,PPH22;PTC5
prerank,positive regulation of cellular biosynthetic process (GO:0031328),-0.7282698350580253,-1.2927682756462113,0.09684947491248541,0.7933975509717011,1.0,5/17,12.84%,DOM34;GSM1;HBS1;CLB6;RRI1
prerank,mitotic sister chromatid segregation (GO:0000070),-0.6636798089407235,-1.2924903370411294,0.029804727646454265,0.7896141736413591,1.0,18/55,17.26%,HIR2;BIK1;TUB2;TOP3;KIP1;SMC4;POL2;SMC3;CIN8;SGS1;ESP1;RAD61;CIK1;DCC1;SPC72;PDS5;ASE1;IRR1
prerank,flavin-containing compound biosynthetic process (GO:0042727),0.7429379694072771,1.2924733196729656,0.22818791946308725,0.8142305792066427,1.0,3/6,10.85%,FMN1;RIB1;RIB3
prerank,cellular response to UV (GO:0034644),-0.8097533243584261,-1.2922726170507395,0.11650485436893204,0.7854792174333347,1.0,3/7,10.33%,RAD26;SGS1;RSC2
prerank,galactose metabolic process (GO:0006012),-0.8623951079659559,-1.2919205778528962,0.12575757575757576,0.7825259644357874,1.0,1/5,6.75%,PGM1
prerank,aromatic amino acid family metabolic process (GO:0009072),-0.8233253268048354,-1.2918898815320046,0.10584958217270195,0.7765861421545156,1.0,3/7,15.80%,ARO80;ARO9;ARO7
prerank,protein targeting to peroxisome (GO:0006625),-0.731957042511334,-1.2917944295538994,0.09832134292565947,0.7712769998618556,1.0,4/16,11.45%,CAJ1;PEX10;GPD1;PEX5
prerank,protein maturation (GO:0051604),-0.6742377624532401,-1.2912184738191228,0.07210031347962383,0.7702908453473432,1.0,9/35,15.28%,SSQ1;RIM8;KEX2;COX20;MET18;YPS1;HSP60;YME1;MAS2
prerank,positive regulation of sequence-specific DNA binding transcription factor activity (GO:0051091),0.7710779816107579,1.290010392930059,0.17579250720461095,0.8118498648167967,1.0,3/5,17.06%,SLT2;TOA2;KSS1
prerank,protein autophosphorylation (GO:0046777),-0.7347769536936022,-1.2897580415765586,0.11452184179456906,0.7772210495228619,1.0,3/15,4.21%,MPS1;GCN2;FPK1
prerank,"SRP-dependent cotranslational protein targeting to membrane, translocation (GO:0006616)",-0.7408042570118358,-1.2894086287697377,0.11449451887941535,0.7742597037992162,1.0,5/14,16.94%,SSA3;SSA2;SSA1;SRP14;SBH2
prerank,mitochondrial fission (GO:0000266),-0.8318697920750933,-1.2891810674720714,0.09956709956709957,0.7703250666585969,1.0,1/7,1.59%,SAR1
prerank,hexose metabolic process (GO:0019318),-0.7710424354592263,-1.2890213702755928,0.09859154929577464,0.765674855300512,1.0,1/11,6.75%,PGM1
prerank,regulation of macroautophagy (GO:0016241),-0.7079496955169305,-1.2874564315385888,0.10779816513761468,0.7737211507940231,1.0,5/19,10.53%,GCN2;FAR11;PCL1;KSP1;XRN1
prerank,box C/D snoRNA processing (GO:0034963),0.637744708985322,1.2857760158144027,0.15416666666666667,0.8164718428743212,1.0,6/10,25.12%,POP7;PXR1;POP1;RPR2;NOP1;POP6
prerank,negative regulation of Ras protein signal transduction (GO:0046580),-0.783856475724328,-1.2835165027794757,0.09007832898172324,0.8024971710766207,1.0,3/10,15.58%,IRA1;BUB2;NET1
prerank,protein lipoylation (GO:0009249),0.7681342994764775,1.2827324518757433,0.1896551724137931,0.8166130346375053,1.0,1/5,4.48%,LIP5
prerank,regulation of gluconeogenesis (GO:0006111),-0.7371419140371843,-1.2823580943130282,0.12985436893203883,0.8066366343939125,1.0,3/13,4.28%,FYV10;GSM1;TSA1
prerank,ubiquitin-dependent catabolism of misfolded proteins by cytoplasm-associated proteasome (GO:0071629),0.7258853309409637,1.2816069643360481,0.19798657718120805,0.8092174673519842,1.0,3/6,22.46%,UBC4;GIM3;RAD6
prerank,kinetochore assembly (GO:0051382),0.6790869287594008,1.2814749892109716,0.21292775665399238,0.7981089323134061,1.0,3/8,6.77%,SKP1;SCM3;ARP4
prerank,tRNA export from nucleus (GO:0006409),-0.763724593761272,-1.2811856398582993,0.09529553679131483,0.8056762977995923,1.0,5/12,10.06%,UTP8;NSP1;NUP145;RNA1;SOL2
prerank,tRNA-containing ribonucleoprotein complex export from nucleus (GO:0071431),-0.763724593761272,-1.2811856398582993,0.09529553679131483,0.8056762977995923,1.0,5/12,10.06%,UTP8;NSP1;NUP145;RNA1;SOL2
prerank,regulation of mitotic spindle organization (GO:0060236),-0.8315383155876384,-1.2806859175820766,0.11320754716981132,0.8039380452890018,1.0,4/6,13.04%,CLB3;ESP1;CLB2;CIK1
prerank,isoleucine metabolic process (GO:0006549),0.7402157878031951,1.2804180931153761,0.21148036253776434,0.7910431394267097,1.0,3/5,22.16%,LPD1;ILV5;MMF1
prerank,protein localization to cell cortex (GO:0072697),0.7725803207531977,1.2795218224081137,0.1855072463768116,0.7835560401534812,1.0,1/5,0.07%,PIL1
prerank,cellular macromolecule biosynthetic process (GO:0034645),-0.6509510234910134,-1.2788506427000335,0.025227043390514632,0.8141836583544513,1.0,13/66,15.11%,RPS5;DOM34;GAT3;TEA1;HBS1;RPS4A;BRE2;EFT2;EFT1;YEF3;RPS14A;TOS4;PIF1
prerank,vacuolar protein processing (GO:0006624),-0.860015070789106,-1.278407835985194,0.11212121212121212,0.8121515087976454,1.0,2/5,11.43%,VPS41;ENV9
prerank,mismatch repair (GO:0006298),-0.7133544799364746,-1.2780039139998742,0.09733487833140209,0.8099560844246073,1.0,5/18,10.35%,RAD34;RFC1;PMS1;DPB11;MSH2
prerank,intracellular protein transmembrane transport (GO:0065002),-0.7233459285604042,-1.2776811882120835,0.11884753901560624,0.8070921765210817,1.0,5/16,16.94%,SSA3;SSA2;SSA1;SRP14;SBH2
prerank,alpha-amino acid metabolic process (GO:1901605),-0.8339828968092092,-1.2776522041902547,0.12086330935251799,0.8018059552551535,1.0,1/6,0.72%,HPA3
prerank,positive regulation of spindle pole body separation (GO:0010696),-0.8228176711689229,-1.277572435124758,0.12338593974175036,0.7968021510145418,1.0,3/6,10.65%,CLB1;CLB3;CLB2
prerank,positive regulation of macromolecule biosynthetic process (GO:0010557),-0.8250349502339518,-1.277450985568296,0.09887005649717515,0.7923101507366233,1.0,3/7,11.86%,DOM34;HBS1;CLB6
prerank,inorganic cation transmembrane transport (GO:0098662),-0.7170726545442782,-1.2771214072247614,0.10969976905311778,0.7896386974792048,1.0,6/18,13.11%,PMA1;PIC2;FTR1;FET3;VNX1;FTH1
prerank,regulation of cell aging (GO:0090342),-0.867504246908226,-1.27636799440899,0.09230769230769231,0.7906000499357048,1.0,3/5,11.23%,TSA1;SSA2;SSA1
prerank,DNA conformation change (GO:0071103),-0.7682811910031409,-1.2749280243153986,0.125,0.7970184914479231,1.0,6/10,19.88%,RAD54;TOP3;SGS1;TOP2;RFA3;HMO1
prerank,thiamine metabolic process (GO:0006772),-0.8085579173506726,-1.274523951469326,0.11977715877437325,0.7951031012699734,1.0,2/8,3.12%,THI12;SNO3
prerank,cellular protein metabolic process (GO:0044267),-0.6521827293369796,-1.2745067737815552,0.0326530612244898,0.7899161084514921,1.0,11/57,13.54%,RPS5;DOM34;VMA1;VPS41;SNA2;HBS1;RPS4A;ASK10;ENV9;RPS14A;TOS4
prerank,transmembrane transport (GO:0055085),-0.6455556437681135,-1.2744956071510436,0.03229061553985873,0.7847645994130417,1.0,25/69,18.00%,GGC1;YOL163W;YBR241C;PMA1;FLC2;SNQ2;ARN2;YMC2;THI72;FLC1;NFT1;QDR2;VBA4;YOL075C;AZR1;TPO4;VBA5;PMC1;PCA1;THI7;GEX2;RIM2;YKR104W;STL1;ERS1
prerank,multivesicular body sorting pathway (GO:0071985),-0.8131932449023713,-1.2740432110569773,0.14985590778097982,0.7831920277848569,1.0,1/6,4.91%,SNA2
prerank,cation transport (GO:0006812),-0.6759246117159268,-1.2733689040564127,0.111358574610245,0.7837250679204756,1.0,4/25,5.54%,AVT1;YCT1;BSD2;MEP1
prerank,axial cellular bud site selection (GO:0007120),-0.8361069698811257,-1.2727100761656365,0.12142857142857143,0.7839906174126556,1.0,1/6,0.31%,BUD4
prerank,"termination of RNA polymerase II transcription, poly(A)-coupled (GO:0030846)",0.6993844647302396,1.272634008536435,0.20727272727272728,0.7989062006622821,1.0,1/7,0.04%,GLC7
prerank,heteroduplex formation (GO:0030491),-0.8108886068580456,-1.2711839008793773,0.12061711079943899,0.7911456057729197,1.0,2/7,2.60%,RAD54;RAD55
prerank,chromatin assembly (GO:0031497),-0.6971335536169181,-1.2707125232728633,0.12727272727272726,0.78964962083575,1.0,5/20,10.85%,CHD1;APC9;SIR3;NUP170;ISW2
prerank,chitin metabolic process (GO:0006030),0.6899665329801964,1.2706081836663476,0.26258992805755393,0.7955478179510072,1.0,3/7,13.02%,SHC1;CHS2;CRH1
prerank,intra-Golgi vesicle-mediated transport (GO:0006891),-0.6868339734017077,-1.269220924651742,0.11049723756906077,0.7967029771433911,1.0,3/24,4.89%,GTS1;RET3;TRS120
prerank,"transcription, DNA-templated (GO:0006351)",-0.6351375041218992,-1.268548886914001,0.046700507614213196,0.7968923637668957,1.0,15/68,12.66%,GAT3;TFC3;TEA1;RPA135;TAF13;TAF6;TFC4;TAF3;BRE2;RPB10;RAD2;RPB5;RSF1;RPB2;RPA49
prerank,peptidyl-S-diacylglycerol-L-cysteine biosynthetic process from peptidyl-cysteine (GO:0018231),0.7627647179309693,1.2681578375151499,0.2144927536231884,0.7837265062412406,1.0,2/5,10.13%,PFA4;PFA5
prerank,peptidyl-L-cysteine S-palmitoylation (GO:0018230),0.7627647179309693,1.2681578375151499,0.2144927536231884,0.7837265062412406,1.0,2/5,10.13%,PFA4;PFA5
prerank,mRNA modification (GO:0016556),-0.7764941983556579,-1.2681105509262898,0.12096774193548387,0.7953253683084238,1.0,1/9,0.13%,DEG1
prerank,kinetochore organization (GO:0051383),0.6613740372903061,1.2670390565718956,0.22131147540983606,0.7774750761615508,1.0,4/9,11.16%,SKP1;SCM3;ARP4;NUF2
prerank,regulation of spindle pole body separation (GO:0010695),-0.7890133830561714,-1.2663741678465286,0.12283044058744993,0.8042926137272923,1.0,3/8,10.65%,CLB1;CLB3;CLB2
prerank,protein export from nucleus (GO:0006611),-0.8038025498903894,-1.2652845069805978,0.12207792207792208,0.8079082148418586,1.0,2/8,0.92%,NUP60;NUP120
prerank,spindle pole body duplication (GO:0030474),-0.7195945532503963,-1.2645734122660461,0.13822115384615385,0.8086430083348278,1.0,2/14,3.65%,MPS1;SPC42
prerank,vitamin B6 biosynthetic process (GO:0042819),-0.7860914345385734,-1.264285943856325,0.13642384105960265,0.8060576535020784,1.0,1/8,3.12%,SNO3
prerank,signal peptide processing (GO:0006465),0.7355534024692497,1.2634502140611745,0.22560975609756098,0.7798843517534422,1.0,3/6,14.05%,AFG3;SPC3;YTA12
prerank,endosomal transport (GO:0016197),-0.6426297602730193,-1.2631106871285114,0.05198776758409786,0.8110154956777891,1.0,11/57,13.25%,VPS9;ENT5;SNA2;STP22;GGA1;VPS35;VPS54;VPS16;MUK1;PEP7;SNF7
prerank,negative regulation of programmed cell death (GO:0043069),-0.8411215713552964,-1.2624133063281633,0.14961832061068703,0.8119248145991262,1.0,1/5,3.09%,FYV10
prerank,"retrograde vesicle-mediated transport, Golgi to ER (GO:0006890)",-0.6813109458149874,-1.2621676112650302,0.11790878754171301,0.8088225165789839,1.0,3/24,5.63%,NEO1;RET3;SLY1
prerank,nuclear import (GO:0051170),-0.650648073598679,-1.2620833436330516,0.08565531475748193,0.8047121351048332,1.0,9/41,8.18%,MLP1;NUP120;NSP1;NUP145;RNA1;NUP100;KAP95;NUP170;RTP1
prerank,transcription elongation from RNA polymerase II promoter (GO:0006368),-0.6544240571902895,-1.2620385580282876,0.07246376811594203,0.8001670073112852,1.0,7/42,10.42%,HIR2;NOT5;CHD1;THO2;HIR3;RSC2;RSC9
prerank,mitochondrial respiratory chain complex II biogenesis (GO:0097032),0.756703555627481,1.260780164255343,0.2134502923976608,0.7603686393630229,1.0,2/5,14.14%,SDH5;TCM62
prerank,mitochondrial respiratory chain complex II assembly (GO:0034553),0.756703555627481,1.260780164255343,0.2134502923976608,0.7603686393630229,1.0,2/5,14.14%,SDH5;TCM62
prerank,respiratory chain complex II assembly (GO:0034552),0.756703555627481,1.260780164255343,0.2134502923976608,0.7603686393630229,1.0,2/5,14.14%,SDH5;TCM62
prerank,telomere maintenance via recombination (GO:0000722),-0.6972537781295854,-1.2605574449960781,0.11777777777777777,0.8071203099001599,1.0,7/19,19.50%,RAD54;IES3;SGS1;IES5;PIF1;RAD51;RFA3
prerank,regulation of proteolysis (GO:0030162),-0.8157599175101893,-1.2600263059497105,0.1353887399463807,0.8066626429449985,1.0,2/7,6.50%,NUP60;KAP95
prerank,positive regulation of cytoskeleton organization (GO:0051495),-0.7219855617243223,-1.2591448558901377,0.13510253317249699,0.8087153629506307,1.0,5/14,10.65%,CLB1;SSK1;TWF1;CLB3;CLB2
prerank,cellular response to heat (GO:0034605),-0.6444257407559726,-1.2588225930151646,0.06218144750254842,0.8066148165894301,1.0,13/57,13.81%,SSQ1;NUP60;YAK1;NUP120;MGA1;NUP100;SSA3;SFL1;SSA2;SSA1;NMA111;SSZ1;HSP78
prerank,peptidyl-lysine trimethylation (GO:0018023),-0.8273879343356069,-1.2586651046567274,0.12412831241283125,0.8031352519962737,1.0,2/6,12.48%,BRE2;EFM1
prerank,post-Golgi vesicle-mediated transport (GO:0006892),-0.6412416343425374,-1.25834721258243,0.05167173252279635,0.8010447959104356,1.0,13/58,13.90%,VPS9;ENT5;SEC15;GGA1;RSN1;BCH1;APM3;VPS54;VPS16;MUK1;PEP7;VAM3;AVL9
prerank,carbon catabolite repression of transcription from RNA polymerase II promoter (GO:0000437),0.6369890393732488,1.258263352831676,0.23504273504273504,0.7596636218163807,1.0,4/9,22.57%,NRG2;RDS2;SNF8;VPS36
prerank,protein import (GO:0017038),-0.6480186499888512,-1.2579816969253519,0.08574380165289257,0.7991903331393324,1.0,9/42,8.18%,MLP1;NUP120;NSP1;NUP145;RNA1;NUP100;KAP95;NUP170;RTP1
prerank,transcription from RNA polymerase I promoter (GO:0006360),-0.662615269634113,-1.2578481869864888,0.1038961038961039,0.7955899667585722,1.0,8/31,12.66%,CHD1;RRN3;RPA135;RRN9;RPB10;RPB5;REB1;RPA49
prerank,maintenance of chromatin silencing (GO:0006344),-0.8537942778644425,-1.2571178798558869,0.13777089783281735,0.792297907269142,1.0,2/5,3.59%,NUP120;NUP145
prerank,maintenance of chromatin silencing at telomere (GO:0035392),-0.8537942778644425,-1.2571178798558869,0.13777089783281735,0.792297907269142,1.0,2/5,3.59%,NUP120;NUP145
prerank,mRNA transport (GO:0051028),-0.681129423521503,-1.2570583617583766,0.11602209944751381,0.7839293115422387,1.0,5/26,11.30%,NUP120;THO2;GFD1;NUP100;IST3
prerank,mRNA-containing ribonucleoprotein complex export from nucleus (GO:0071427),-0.681129423521503,-1.2570583617583766,0.11602209944751381,0.7839293115422387,1.0,5/26,11.30%,NUP120;THO2;GFD1;NUP100;IST3
prerank,inorganic anion transmembrane transport (GO:0098661),-0.7895488086306219,-1.2563568824402196,0.13389121338912133,0.7848746412899373,1.0,3/8,9.03%,PIC2;SUL2;YPR003C
prerank,ER-associated misfolded protein catabolic process (GO:0071712),-0.8181431449917349,-1.255511278150785,0.14242424242424243,0.7868899379976045,1.0,1/6,9.75%,PMT2
prerank,modification-dependent macromolecule catabolic process (GO:0043632),0.7474599381900737,1.2551654614910603,0.2344632768361582,0.76148757423,1.0,4/5,25.30%,RUB1;RPS31;NGL3;RPL40A
prerank,regulation of cell division (GO:0051302),-0.8165298009535896,-1.2544257621674988,0.13423831070889894,0.7911636783462284,1.0,5/6,18.35%,SLI15;DBF2;VRP1;KEL1;KEL2
prerank,cytosolic transport (GO:0016482),-0.6580068940842859,-1.2540925735547608,0.0899581589958159,0.7894754331315706,1.0,8/38,12.46%,VPS9;ENT5;GGA1;VPS35;VPS54;VPS16;MUK1;PEP7
prerank,regulation of vacuole organization (GO:0044088),-0.767908359614397,-1.254078714676388,0.12630208333333334,0.7853056057387959,1.0,3/10,10.11%,VPS41;GYP7;VPS16
prerank,cytoplasmic translational initiation (GO:0002183),-0.733051441117635,-1.25291067669373,0.15498154981549817,0.7901337892371247,1.0,3/12,3.61%,TMA20;SUI2;TIF35
prerank,regulation of mitotic nuclear division (GO:0007088),-0.6654023378871494,-1.2526137285892873,0.10571736785329018,0.78817771597117,1.0,13/29,16.00%,CLB1;CLA4;CLN2;CLB3;RTT101;ESP1;CLB2;CDC15;CLB6;NIS1;GIC2;NET1;CLN1
prerank,glutathione catabolic process (GO:0006751),0.7483231072953416,1.2514627894118768,0.22093023255813954,0.7650914259429175,1.0,2/5,12.60%,DUG2;ECM38
prerank,protein transport to vacuole involved in ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway (GO:0043328),-0.7211396330097624,-1.2504289796005135,0.1449814126394052,0.7998655176100572,1.0,2/13,5.51%,TRE1;GGA1
prerank,regulation of translation (GO:0006417),-0.6436904973991734,-1.2502839434293715,0.06694129763130793,0.7966525354974531,1.0,14/46,17.97%,DOM34;NOT5;GCN2;PPH22;SLH1;ITT1;HBS1;RPL16B;VTS1;GCN3;SLF1;PAT1;POP2;NOT3
prerank,protein import into nucleus (GO:0006606),-0.6417247411231489,-1.2499849738270894,0.08709016393442623,0.7945927197109659,1.0,13/46,15.19%,NUP60;MLP1;NUP120;NSP1;NUP145;RNA1;NUP100;KAP95;NUP170;RTP1;SSA1;NUP57;KAP120
prerank,DNA repair (GO:0006281),-0.6133703786341367,-1.2498136148305563,0.019,0.7918611706861151,1.0,33/126,19.99%,NUP60;NUP120;RAD34;MGM101;NSE4;RFC1;RAD26;EAF1;NUP145;RTT107;PSO2;PAN2;POL2;PMS1;DPB11;SMC6;HTA2;SGS1;RSC2;MSH2;RRD1;RAD5;SRS2;APN1;SWC4;PDS5;EXO5;EAF3;HTA1;RSC1;RFA3;TDP1;NUP133
prerank,mRNA export from nucleus in response to heat stress (GO:0031990),-0.7748972880649903,-1.2495975156728691,0.1447721179624665,0.7892468991432825,1.0,3/9,6.14%,NUP60;NUP120;NUP100
prerank,protein localization to bud neck (GO:0097271),-0.7619412602607782,-1.2487729538272947,0.17842876165113183,0.7911766587943017,1.0,1/9,0.31%,BUD4
prerank,mitotic spindle checkpoint (GO:0071174),-0.6501711787888291,-1.2484417692651086,0.13085106382978723,0.7893685269450059,1.0,10/29,18.02%,MLP1;MPS1;IBD2;PPH22;BUB2;RTS1;SPC72;MAD3;MLP2;GAC1
prerank,regulation of protein serine/threonine kinase activity (GO:0071900),-0.6690548225811894,-1.2482036176184719,0.1309655937846837,0.7870541960839763,1.0,8/25,11.86%,CLB1;PKH1;CLN2;KOG1;CLB3;PCL1;CLB2;CLB6
prerank,positive regulation of transcription by galactose (GO:0000411),0.7537295908108744,1.247390979716712,0.22364217252396165,0.769366106495071,1.0,2/5,13.29%,SSN3;SSN8
prerank,vacuolar transport (GO:0007034),-0.6258996449366513,-1.2467894305332046,0.03838383838383838,0.7934645923224368,1.0,17/76,16.63%,VPS9;AVT1;BSD2;VPS41;VMA6;STP22;GGA1;APM3;VPS54;VPS16;PEP1;PEP7;VAM3;SNF7;VPS8;ROY1;EMP70
prerank,negative regulation of cell aging (GO:0090344),-0.8373737289153268,-1.2463464184812867,0.16232771822358347,0.7927163071277783,1.0,3/5,11.23%,TSA1;SSA2;SSA1
prerank,response to unfolded protein (GO:0006986),-0.7097943947687524,-1.2454478163590328,0.1652593486127865,0.7950408738902723,1.0,6/14,12.82%,SSQ1;ZIM17;SSA3;SSA2;SSA1;SSZ1
prerank,DNA recombination (GO:0006310),-0.6437317395902321,-1.2428973841895776,0.09518935516888434,0.8093299104126825,1.0,10/42,16.09%,MGM101;THO2;IRC8;POL2;DPB11;SMC6;SGS1;MSH2;PIF1;RAD51
prerank,SRP-dependent cotranslational protein targeting to membrane (GO:0006614),-0.7050824941910285,-1.2426338635593333,0.16448152562574495,0.8073197304106483,1.0,5/16,16.94%,SSA3;SSA2;SSA1;SRP14;SBH2
prerank,RNA-dependent DNA biosynthetic process (GO:0006278),-0.7059108416609904,-1.242406507187891,0.1691948658109685,0.8048903459638567,1.0,5/16,19.50%,TOP3;EST3;RIF2;EST2;RFA3
prerank,NLS-bearing protein import into nucleus (GO:0006607),-0.7245235068135545,-1.241733853276669,0.13793103448275862,0.8057081254414244,1.0,5/15,6.50%,NUP60;NSP1;NUP145;NUP100;KAP95
prerank,NAD biosynthetic process (GO:0009435),-0.7641428073255796,-1.2416875239204952,0.15824468085106383,0.8020998718621238,1.0,1/9,0.34%,QNS1
prerank,positive regulation of cell cycle process (GO:0090068),-0.6856942288965345,-1.2412419699900727,0.15639269406392695,0.8012906750698615,1.0,6/18,14.25%,CLB1;DUO1;DAD1;CLB3;CLB2;ASK1
prerank,protein localization to nuclear envelope (GO:0090435),-0.7830094665655618,-1.2404529453525783,0.16263440860215053,0.8030389358639063,1.0,5/8,13.83%,MLP1;NUP145;NUP100;NUP170;NUP57
prerank,transcription from RNA polymerase II promoter (GO:0006366),-0.6222317497555145,-1.2389469076965332,0.04032258064516129,0.8097325898681853,1.0,18/90,12.26%,HIR2;NOT5;CHD1;THO2;TAF13;TAF6;HIR3;TAF3;RPB10;RAD2;RPB5;RSC2;RSC9;RSF1;ISW2;REB1;SUB1;RPB2
prerank,telomere maintenance via telomerase (GO:0007004),-0.7212367162064864,-1.2381027748245037,0.19123020706455543,0.8119950420927984,1.0,5/13,19.50%,TOP3;EST3;RIF2;EST2;RFA3
prerank,barbed-end actin filament capping (GO:0051016),-0.8400622566969009,-1.2361972785054058,0.16691505216095381,0.8177269792397446,1.0,2/5,6.25%,TWF1;CAP2
prerank,actin filament capping (GO:0051693),-0.8400622566969009,-1.2361972785054058,0.16691505216095381,0.8177269792397446,1.0,2/5,6.25%,TWF1;CAP2
prerank,heme biosynthetic process (GO:0006783),-0.7354146968328349,-1.2361848166808658,0.14702154626108999,0.8139524682636573,1.0,4/11,17.62%,YAH1;COX10;HEM15;HEM4
prerank,regulation of nuclear division (GO:0051783),-0.6746573190028011,-1.236181819317521,0.1469248291571754,0.8101091369491915,1.0,8/19,16.00%,CLB1;CLN2;CLB3;RTT101;CLB2;CLB6;NIS1;CLN1
prerank,protein acylation (GO:0043543),-0.7718203018290243,-1.236171419814979,0.14093959731543623,0.8064014357715585,1.0,1/8,0.72%,HPA3
prerank,"DNA-templated transcription, elongation (GO:0006354)",-0.6375689518967392,-1.2357965380716458,0.09044193216855087,0.8048997655598233,1.0,12/47,18.78%,HIR2;NOT5;CHD1;THO2;HIR3;RSC2;RSC9;RPA49;EAF3;POP2;SET2;RSC1
prerank,pyridoxine metabolic process (GO:0008614),-0.8123423979767169,-1.2355913810831196,0.1615720524017467,0.8025214496286327,1.0,1/6,3.12%,SNO3
prerank,positive regulation of transcription from RNA polymerase I promoter (GO:0045943),-0.6982224704524804,-1.2347548901547145,0.1531322505800464,0.8044346346734007,1.0,2/16,2.64%,UTP8;THO2
prerank,ribosomal small subunit assembly (GO:0000028),-0.6699802932342139,-1.2344459102706862,0.12101210121012101,0.8028653944864514,1.0,4/25,12.19%,RPS5;RPS15;RRP5;RPS14A
prerank,establishment of protein localization to organelle (GO:0072594),-0.6345647793899805,-1.23410673651584,0.11237113402061856,0.8016943248014462,1.0,12/43,15.19%,MLP1;NUP120;NSP1;NUP145;RNA1;NUP100;KAP95;NUP170;RTP1;RTS1;NUP57;KAP120
prerank,organic hydroxy compound biosynthetic process (GO:1901617),-0.6757632549994373,-1.2339557466671776,0.13641364136413642,0.7990200148691449,1.0,2/22,3.12%,ERG3;SNO3
prerank,tubulin complex assembly (GO:0007021),0.6905986483033324,1.2338767321934312,0.26506024096385544,0.8021970141495287,1.0,3/6,15.78%,GIM5;GIM4;GIM3
prerank,organophosphate biosynthetic process (GO:0090407),-0.659513076935929,-1.2338185680702607,0.1406926406926407,0.7963014164222671,1.0,3/26,10.80%,SNO3;GUT1;URA8
prerank,regulation of mitotic cell cycle (GO:0007346),-0.6511306750940178,-1.233017237451573,0.13290460878885316,0.7980306750582877,1.0,15/30,16.00%,CLB1;CLA4;CLN2;CLB3;SIS2;RTT101;CLB2;SKG3;CDC15;CLB6;CIK1;MET32;NIS1;MKK2;CLN1
prerank,regulation of transcription from RNA polymerase II promoter by glucose (GO:0000430),0.6027817491779303,1.2327137573352005,0.25217391304347825,0.7962587525767927,1.0,4/9,22.57%,NRG2;SNF8;MIG3;VPS36
prerank,positive regulation of nucleic acid-templated transcription (GO:1903508),-0.7246003900714023,-1.2323270640577255,0.17533252720677148,0.7991223991593551,1.0,4/13,12.95%,NUP120;NUP145;NUP100;YKR023W
prerank,meiotic sister chromatid cohesion (GO:0051177),-0.7954682393635455,-1.2313994824503622,0.19730941704035873,0.8014966819331643,1.0,3/6,15.69%,SMC3;RTS1;MAD3
prerank,iron ion transport (GO:0006826),-0.6898400276148369,-1.2312050108304733,0.167816091954023,0.7991396403858222,1.0,7/17,17.55%,FTR1;GMC1;FET3;FRE4;FTH1;FRE7;FRE6
prerank,pseudouridine synthesis (GO:0001522),-0.712093570098508,-1.2310174165633916,0.19206939281288724,0.7967767727727295,1.0,1/12,0.13%,DEG1
prerank,TOR signaling (GO:0031929),-0.7134154330778573,-1.2301045947169436,0.16339066339066338,0.7993973399745062,1.0,4/13,18.33%,KOG1;KSP1;MDS3;TSC11
prerank,nucleosome assembly (GO:0006334),-0.6968501812206842,-1.230098200584192,0.18430439952437574,0.7959178890481409,1.0,2/15,5.18%,HIR2;HIR3
prerank,maturation of 5.8S rRNA (GO:0000460),-0.7015643933575921,-1.2297279494805193,0.16606929510155316,0.7948599493679005,1.0,3/16,6.03%,MAK11;PRP43;MTR4
prerank,assembly of large subunit precursor of preribosome (GO:1902626),0.6295197312373757,1.229224846528855,0.23754789272030652,0.7988545178861549,1.0,6/8,32.77%,RLP24;RPF2;SPB4;NIP7;DBP10;RPL24B
prerank,cellular amide metabolic process (GO:0043603),-0.7492481233229038,-1.2287817927708924,0.16582278481012658,0.7978548373420944,1.0,6/10,22.30%,FMP30;LRO1;OCT1;PRD1;NIT3;ORM1
prerank,regulation of transcription elongation from RNA polymerase I promoter (GO:2001207),-0.8274280408579011,-1.2286544899230862,0.1924812030075188,0.7917064337202189,1.0,1/5,2.64%,THO2
prerank,positive regulation of transcription elongation from RNA polymerase I promoter (GO:2001209),-0.8274280408579011,-1.2286544899230862,0.1924812030075188,0.7917064337202189,1.0,1/5,2.64%,THO2
prerank,DNA double-strand break attachment to nuclear envelope (GO:1990683),-0.8305397527429839,-1.228172785785902,0.15718562874251496,0.7917273169272456,1.0,3/5,12.17%,RTT107;SMC6;SIZ1
prerank,cell cycle G1/S phase transition (GO:0044843),-0.6740892097132622,-1.2281573805139037,0.17376681614349776,0.7884876624526381,1.0,8/20,14.70%,PPH22;PTK2;SAP185;MET30;CLB6;RRD1;VHS1;HRT1
prerank,chromatin assembly or disassembly (GO:0006333),-0.6678867533628852,-1.2270835642175546,0.154627539503386,0.7925134011380672,1.0,8/22,22.77%,APC9;HHF2;HTA2;HHT2;HTA1;TOP2;DOC1;TOP1
prerank,mitotic cell cycle phase transition (GO:0044772),-0.6256931947487595,-1.226712135261643,0.1316062176165803,0.7916345591576384,1.0,14/42,16.00%,CLB1;PPH22;CLN2;CLB3;PTK2;APC1;SAP185;MET30;CLB2;CLB6;RRD1;VHS1;HRT1;CLN1
prerank,stress granule assembly (GO:0034063),-0.7502778325144026,-1.225651162379645,0.18181818181818182,0.7950235396473271,1.0,1/10,2.64%,THO2
prerank,endocytic recycling (GO:0032456),0.7029999350360385,1.224924278942514,0.2730263157894737,0.8038123036359074,1.0,1/6,15.24%,RCY1
prerank,galactose catabolic process (GO:0019388),-0.7962293089657428,-1.2247048307626123,0.20470262793914246,0.7975463938905769,1.0,1/7,6.75%,PGM1
prerank,positive regulation of DNA-dependent DNA replication (GO:2000105),-0.8073272579730297,-1.2244966977969542,0.19627507163323782,0.7954680075831025,1.0,1/6,3.83%,SUM1
prerank,RNA import into nucleus (GO:0006404),-0.8349623591320436,-1.2235568568177002,0.16840536512667661,0.7983092146338515,1.0,3/5,11.32%,RNA1;SSA2;YDJ1
prerank,nucleotide-sugar metabolic process (GO:0009225),-0.8003966108887642,-1.2231445195336028,0.2002840909090909,0.7976343799543818,1.0,1/6,6.75%,PGM1
prerank,spliceosomal complex disassembly (GO:0000390),-0.8225276019380734,-1.2230880109665412,0.19124087591240876,0.794649478973768,1.0,1/5,2.55%,PRP43
prerank,regulation of TORC1 signaling (GO:1903432),-0.7658105825832519,-1.2224423425363,0.18717277486910994,0.7958186496805203,1.0,3/8,16.02%,GCN2;MTC5;SEA4
prerank,chromatin silencing at telomere (GO:0006348),-0.6221981095872001,-1.2223025879301348,0.08802456499488229,0.793384095408759,1.0,11/55,10.85%,HAT1;NUP120;IFH1;NUP145;RNA1;DOT6;SIR3;BRE2;SCP160;IES3;ISW2
prerank,mitotic spindle elongation (GO:0000022),-0.7129933927416942,-1.2221510461549416,0.1937046004842615,0.7911181989126355,1.0,5/12,17.23%,BIK1;KIP1;CIN8;SPC72;ASE1
prerank,DNA topological change (GO:0006265),-0.762240191194461,-1.2206256352447242,0.1910569105691057,0.7977186555042871,1.0,5/8,22.77%,TOP3;SGS1;TOP2;RFA3;TOP1
prerank,cellular macromolecular complex assembly (GO:0034622),0.440304352983122,1.2204261290201817,0.1686746987951807,0.8090881040674046,1.0,10/26,9.91%,SKP1;AFG3;VMA9;RPL38;RVS161;SAM50;TRS20;SGF73;TCA17;SKI8
prerank,folic acid-containing compound metabolic process (GO:0006760),0.6334134706988497,1.220377278487012,0.26573426573426573,0.8003490453019388,1.0,2/8,13.31%,DFR1;MTD1
prerank,regulation of transcription from RNA polymerase I promoter (GO:0006356),-0.6670716020281087,-1.219835732119624,0.1752808988764045,0.7993311887792661,1.0,2/21,2.64%,UTP8;THO2
prerank,regulation of ribosomal protein gene transcription from RNA polymerase II promoter (GO:0060962),-0.7413601759822364,-1.2180969176027547,0.20154043645699615,0.807451327335594,1.0,2/10,7.60%,IFH1;FHL1
prerank,protein targeting to vacuole (GO:0006623),-0.6231488137299295,-1.2171415733959199,0.12708333333333333,0.809978033730361,1.0,9/46,16.41%,VPS9;BSD2;VPS41;STP22;APM3;VPS16;PEP1;VPS8;ROY1
prerank,DNA duplex unwinding (GO:0032508),-0.7173118925099432,-1.2166077171760132,0.20947630922693267,0.8101503357108396,1.0,4/11,19.50%,SGS1;SRS2;PIF1;RFA3
prerank,proton transport (GO:0015992),-0.7417102361599356,-1.215905910706018,0.21128608923884515,0.8114412777468452,1.0,3/9,12.91%,PMA1;VNX1;VPH1
prerank,regulation of MAPK cascade (GO:0043408),-0.7558335930772346,-1.2158260792574804,0.21010638297872342,0.8086971061210866,1.0,1/9,3.16%,CLA4
prerank,protein localization to nucleus (GO:0034504),-0.626247058470501,-1.2147961743047586,0.1368312757201646,0.8121697797043356,1.0,9/47,8.18%,MLP1;NUP120;NSP1;NUP145;RNA1;NUP100;KAP95;NUP170;RTP1
prerank,"regulation of vacuole fusion, non-autophagic (GO:0032889)",-0.7690567892792723,-1.2144541587845685,0.17139001349527666,0.8110806465156886,1.0,3/8,10.11%,VPS41;GYP7;VPS16
prerank,positive regulation of endodeoxyribonuclease activity (GO:0032079),-0.8183490356004494,-1.2139335453403544,0.20489296636085627,0.8080236595986194,1.0,3/5,14.61%,RAD54;VTS1;SRS2
prerank,regulation of endodeoxyribonuclease activity (GO:0032071),-0.8183490356004494,-1.2139335453403544,0.20489296636085627,0.8080236595986194,1.0,3/5,14.61%,RAD54;VTS1;SRS2
prerank,positive regulation of glucose metabolic process (GO:0010907),-0.8172636661112914,-1.2128018260729043,0.1969465648854962,0.812042478953237,1.0,1/5,3.29%,GSM1
prerank,hydrogen ion transmembrane transport (GO:1902600),-0.7726237337579571,-1.2110875686702562,0.21329639889196675,0.8195880800674887,1.0,2/7,9.37%,PMA1;VNX1
prerank,homologous chromosome segregation (GO:0045143),-0.670038915320878,-1.2106916781315602,0.2066974595842956,0.8188816163832227,1.0,2/19,3.45%,TUB2;HOP2
prerank,regulation of GTPase activity (GO:0043087),-0.6932085749125985,-1.2102481091192683,0.21445497630331753,0.8182895021661708,1.0,4/16,16.41%,IRA1;TRS120;SED4;ROY1
prerank,regulation of transcription regulatory region DNA binding (GO:2000677),-0.7949902134932306,-1.2095866112558415,0.20434782608695654,0.8193636097203949,1.0,3/6,19.12%,SUA7;PHO2;GRX4
prerank,negative regulation of transcription involved in G1/S transition of mitotic cell cycle (GO:0071930),-0.8096960320519309,-1.209040489933831,0.23547400611620795,0.8195574539268041,1.0,4/5,16.85%,HIR3;WHI5;YOX1;NRM1
prerank,positive regulation of gluconeogenesis (GO:0045722),-0.819522211644085,-1.2087205037055084,0.18456883509833585,0.8185736624957695,1.0,1/5,3.29%,GSM1
prerank,intracellular protein transport (GO:0006886),-0.6027610293479954,-1.207474133609486,0.038,0.823287212366117,1.0,29/119,15.44%,NUP60;MLP1;NUP120;SAR1;TRE1;RET3;NSP1;NUP145;RNA1;YPT32;GGA1;ECM30;NUP100;KAP95;GYP7;NUP170;RTP1;BUB2;VPS35;APL3;PMT2;SLO1;SSA1;PIR1;VAM3;ERV25;NUP57;KAP120;GYP6
prerank,traversing start control point of mitotic cell cycle (GO:0007089),-0.7432928513949417,-1.206417498818313,0.23591087811271297,0.8267557532274311,1.0,5/9,16.00%,WHI5;CLN2;CDC25;XRN1;CLN1
prerank,"positive regulation of DNA-templated transcription, initiation (GO:2000144)",-0.8143699578602002,-1.2059978569882708,0.20539730134932535,0.8263030678522235,1.0,2/5,12.12%,XRN1;SUB1
prerank,regulation of phosphorylation of RNA polymerase II C-terminal domain (GO:1901407),0.7059315446307157,1.2056834329317883,0.2819767441860465,0.836544864525333,1.0,2/5,13.29%,PAF1;SSN8
prerank,negative regulation of protein dephosphorylation (GO:0035308),-0.7895047042611915,-1.2046352389528943,0.23958333333333334,0.8319827035182287,1.0,2/5,10.65%,ESP1;CLB2
prerank,DNA geometric change (GO:0032392),-0.7204935232867459,-1.2034514788442532,0.2360248447204969,0.8364165650680383,1.0,5/10,15.11%,RAD54;MGM101;SGS1;SRS2;PIF1
prerank,"tRNA splicing, via endonucleolytic cleavage and ligation (GO:0006388)",0.6371630607418319,1.2022510759917648,0.31092436974789917,0.8376541381371545,1.0,2/8,17.95%,CLP1;YMR087W
prerank,metal ion transport (GO:0030001),-0.7737756188393219,-1.2003669075940713,0.22759601706970128,0.8525248194150256,1.0,3/7,16.45%,BSD2;VNX1;RIM2
prerank,peptide biosynthetic process (GO:0043043),-0.6317527608389746,-1.1994990207796947,0.1601685985247629,0.8544495291474481,1.0,6/35,13.54%,RPS5;DOM34;HBS1;RPS4A;RPS14A;TOS4
prerank,5S class rRNA transcription from RNA polymerase III type 1 promoter (GO:0042791),-0.7967021182660751,-1.1994764057388947,0.23065693430656933,0.8514073923511248,1.0,2/6,6.10%,TFC3;TFC4
prerank,exonucleolytic nuclear-transcribed mRNA catabolic process involved in deadenylation-dependent decay (GO:0043928),0.5473726626501257,1.1990716314582763,0.22012578616352202,0.8378673164274226,1.0,5/14,12.28%,RRP45;RRP43;SKI6;SKI8;UPF3
prerank,Golgi vesicle budding (GO:0048194),0.6813892244467444,1.1986023997586321,0.30604982206405695,0.8303478255411602,1.0,1/6,14.37%,SEC13
prerank,generation of catalytic spliceosome for first transesterification step (GO:0000349),-0.7441684327159718,-1.198137584191602,0.2391304347826087,0.8567291037854313,1.0,2/8,11.30%,SPP381;IST3
prerank,regulation of cell cycle (GO:0051726),-0.621623954381925,-1.197395105825126,0.18443496801705758,0.8582431113127471,1.0,14/34,16.00%,CLB1;CLA4;CLN2;CLB3;SIS2;CDC25;CLB2;SKG3;CDC15;CLB6;CDC33;MET32;MKK2;CLN1
prerank,regulation of cellular pH (GO:0030641),-0.8007690744158885,-1.1968136559899722,0.2542372881355932,0.8555127038577196,1.0,2/5,9.03%,PMA1;YPR003C
prerank,regulation of intracellular pH (GO:0051453),-0.8007690744158885,-1.1968136559899722,0.2542372881355932,0.8555127038577196,1.0,2/5,9.03%,PMA1;YPR003C
prerank,nucleocytoplasmic transport (GO:0006913),-0.6873837322427749,-1.1953985042913162,0.21331689272503082,0.8579364409932441,1.0,2/14,7.87%,NUP60;NUP170
prerank,nuclear transport (GO:0051169),-0.6873837322427749,-1.1953985042913162,0.21331689272503082,0.8579364409932441,1.0,2/14,7.87%,NUP60;NUP170
prerank,cellular macromolecule catabolic process (GO:0044265),-0.6800250813771312,-1.1952659966403842,0.21453692848769051,0.8556494258277737,1.0,5/16,8.07%,DSS1;SNA2;PNG1;MTR4;ASK10
prerank,glutathione metabolic process (GO:0006749),0.4856880395269865,1.1946741567675148,0.2391304347826087,0.8327736085319521,1.0,5/18,13.85%,DUG2;GSH1;GRX2;ECM38;YFH1
prerank,nucleosome mobilization (GO:0042766),-0.7712208129296634,-1.1928251187133712,0.23777173913043478,0.8670106770418468,1.0,2/7,8.49%,CHD1;IES3
prerank,tetrahydrofolate metabolic process (GO:0046653),0.6855115066360981,1.1913758574500188,0.29449838187702265,0.8336315331804485,1.0,1/6,6.12%,DFR1
prerank,microtubule cytoskeleton organization involved in mitosis (GO:1902850),-0.6576730797439608,-1.1903730627995845,0.20634920634920634,0.8789758240183618,1.0,9/18,18.20%,CLB1;CNM67;STU2;RRD1;CIK1;RRD2;SLK19;ASE1;MIF2
prerank,positive regulation of phosphorylation of RNA polymerase II C-terminal domain (GO:1901409),0.6980704171541424,1.190059971353092,0.32571428571428573,0.8288759325390548,1.0,2/5,13.29%,PAF1;SSN8
prerank,mitotic nuclear division (GO:0140014),-0.627848752768679,-1.1899477177004067,0.18037974683544303,0.8781733339383994,1.0,11/37,14.52%,HIR2;TUB2;KIP1;SMC4;APC1;CIN8;SGS1;ESP1;CIK1;SPC72;SPC97
prerank,"positive regulation of gene expression, epigenetic (GO:0045815)",0.7240738709111918,1.1898150534025065,0.3256484149855908,0.8213518389166208,1.0,2/5,8.38%,RAP1;ELF1
prerank,organic substance transport (GO:0071702),-0.6734144040353911,-1.189483287209516,0.22632794457274827,0.8776524523473126,1.0,6/17,14.43%,SAM3;THI72;TPO5;PTK2;AZR1;THI7
prerank,positive regulation of G1/S transition of mitotic cell cycle (GO:1900087),-0.7169446893730398,-1.1889549981989453,0.2656449553001277,0.8778100195128047,1.0,5/10,16.00%,WHI5;CLN2;CDC25;XRN1;CLN1
prerank,termination of RNA polymerase I transcription (GO:0006363),-0.7620930012012782,-1.1889031886837502,0.27116212338593976,0.875010269278363,1.0,2/6,11.63%,CHD1;REB1
prerank,negative regulation of mitotic cell cycle (GO:0045930),0.7058284952451862,1.1882528693511747,0.3281733746130031,0.8179406102526533,1.0,1/5,3.25%,SKG6
prerank,carboxylic acid transport (GO:0046942),-0.6841086694027316,-1.1880398014168714,0.2376357056694813,0.8770689986027326,1.0,1/15,0.74%,AVT1
prerank,regulation of glycogen biosynthetic process (GO:0005979),0.6533950843994983,1.187972606503905,0.2912621359223301,0.8106248619989519,1.0,3/7,11.81%,PCL10;PCL6;PCL7
prerank,organelle fission (GO:0048285),-0.6931197998317911,-1.1874954449271873,0.2430471584038694,0.8772092939984917,1.0,3/13,11.39%,SAR1;DBF2;PEX11
prerank,positive regulation of nitrogen compound metabolic process (GO:0051173),0.6752499931352876,1.185147188671997,0.3161094224924012,0.8104372505258812,1.0,3/6,23.98%,TSC3;SWE1;PDR17
prerank,phosphatidylglycerol metabolic process (GO:0046471),0.7041271916177527,1.1844586245069602,0.3002754820936639,0.8044972113657254,1.0,2/5,10.31%,AFT1;UPS2
prerank,phosphorylation (GO:0016310),-0.593240987078341,-1.183698588562018,0.08926780341023069,0.8974158642285929,1.0,20/100,11.41%,YAK1;MPS1;GCN2;FMP48;CLA4;GSM1;PKC1;FPK1;CYT1;GUT1;YDR248C;KDX1;FRK1;PTK2;KSP1;SLI15;DBF2;PRR2;CDC15;RTK1
prerank,phosphate ion transport (GO:0006817),-0.7637921630246549,-1.1836078073546614,0.24621733149931224,0.8949515146974715,1.0,2/7,13.22%,PIC2;PHO90
prerank,"RNA splicing, via endonucleolytic cleavage and ligation (GO:0000394)",0.6644303873348402,1.1832793024521646,0.3159851301115242,0.8000110738197864,1.0,2/7,17.95%,CLP1;YMR087W
prerank,amino acid transport (GO:0006865),-0.6370491310306008,-1.1830151209058979,0.24172185430463577,0.8954020456456937,1.0,3/23,8.09%,AVT1;VBA4;AVT2
prerank,regulation of cellular biosynthetic process (GO:0031326),-0.7937638915882691,-1.1829527362379473,0.2641221374045801,0.892672689166993,1.0,1/5,11.27%,GIS1
prerank,regulation of microtubule polymerization (GO:0031113),-0.7256482452655079,-1.1815303633267018,0.2564102564102564,0.8984632759533725,1.0,3/9,4.95%,BIK1;DUO1;DAD1
prerank,negative regulation of phospholipid biosynthetic process (GO:0071072),-0.7360845150414537,-1.180955911412414,0.25869262865090403,0.8988486069992259,1.0,1/8,2.29%,GTS1
prerank,deadenylation-independent decapping of nuclear-transcribed mRNA (GO:0031087),-0.7625587272704619,-1.180485758288379,0.2714285714285714,0.8985762879197231,1.0,2/6,10.69%,NOT5;EDC3
prerank,protein localization to plasma membrane (GO:0072659),0.46783046288199903,1.1804718532172742,0.21897810218978103,0.8000804778698027,1.0,4/19,9.52%,NCE102;FHN1;SFH5;ARL1
prerank,ribosomal large subunit export from nucleus (GO:0000055),-0.6392310994371317,-1.179633646262499,0.2203023758099352,0.90072104102649,1.0,3/24,3.27%,NUP120;LOC1;NSP1
prerank,RNA polymerase II transcriptional preinitiation complex assembly (GO:0051123),-0.6247056127722561,-1.177835934081427,0.22258064516129034,0.9085655536809711,1.0,4/28,6.61%,SUA7;TAF13;TAF6;TAF3
prerank,lipid translocation (GO:0034204),-0.7189861531760922,-1.176126661134559,0.2628120893561104,0.9156094303768155,1.0,1/9,2.62%,NEO1
prerank,nucleosome positioning (GO:0016584),-0.7651355514366178,-1.1759015368769097,0.24929577464788732,0.9139067307207198,1.0,3/7,10.85%,CHD1;NUP170;ISW2
prerank,regulation of attachment of spindle microtubules to kinetochore (GO:0051988),-0.7379678166295138,-1.1751547624959238,0.2724867724867725,0.9152318749937439,1.0,3/8,4.95%,MPS1;DUO1;DAD1
prerank,transsulfuration (GO:0019346),-0.773433485191595,-1.1747397975820364,0.26323119777158777,0.9114929882384394,1.0,2/6,9.48%,YLL058W;YML082W
prerank,cysteine metabolic process (GO:0006534),-0.773433485191595,-1.1747397975820364,0.26323119777158777,0.9114929882384394,1.0,2/6,9.48%,YLL058W;YML082W
prerank,piecemeal microautophagy of nucleus (GO:0034727),-0.6151707544201965,-1.1746228535532328,0.22727272727272727,0.9090887036567987,1.0,10/32,19.81%,ATG14;VPS41;ATG29;OSH6;VAC8;VAM3;ATG16;ATG11;VAM7;ATG8
prerank,translational termination (GO:0006415),-0.6789151226146297,-1.1743438775826613,0.25794621026894865,0.9077170104357659,1.0,3/13,8.16%,TIF35;MRF1;YEF3
prerank,regulation of cytokinesis (GO:0032465),-0.7304963627949513,-1.1733812753350528,0.27489481065918653,0.9101105501122344,1.0,5/8,18.35%,SLI15;DBF2;VRP1;KEL1;KEL2
prerank,ribosomal subunit export from nucleus (GO:0000054),-0.6104042704010663,-1.1727252167791968,0.19230769230769232,0.9111528704460641,1.0,4/40,3.70%,NUP120;LOC1;NSP1;RNA1
prerank,"nuclear-transcribed mRNA catabolic process, exonucleolytic (GO:0000291)",0.5540588290555317,1.1711276682741794,0.29207920792079206,0.8181585571696794,1.0,4/11,9.91%,RRP45;RRP43;SKI6;SKI8
prerank,cellular respiration (GO:0045333),-0.603054255509344,-1.169906634195883,0.20372285418821096,0.9246304778898349,1.0,8/44,12.53%,OAR1;SDH1;MDH1;ADE16;COX20;RSF1;JAC1;COX10
prerank,respiratory chain complex IV assembly (GO:0008535),-0.6406901308425617,-1.1679934643751078,0.26477272727272727,0.9322510917834496,1.0,4/20,12.55%,COX12;COX20;COX16;RCF1
prerank,purine nucleobase metabolic process (GO:0006144),-0.7113803994119201,-1.1668636817367082,0.27622841965471445,0.9358945041343965,1.0,5/9,20.37%,ADO1;XPT1;PHO2;DAL1;HPT1
prerank,protein autoubiquitination (GO:0051865),0.6242963290654457,1.1667309785384008,0.30716723549488056,0.8218433364185054,1.0,2/7,13.69%,PEX4;HRD1
prerank,regulation of cell growth (GO:0001558),-0.6913040861607959,-1.1666017803845423,0.2710997442455243,0.93422606221067,1.0,4/11,18.33%,KOG1;KSP1;KAP123;TSC11
prerank,ornithine metabolic process (GO:0006591),-0.728256953612701,-1.1665783676675074,0.3028263795423957,0.9313202243948672,1.0,5/8,23.11%,SPE1;CAR1;ARG3;ARG7;CAR2
prerank,protein transport (GO:0015031),-0.5849441268642857,-1.1664524290444291,0.14472361809045226,0.9290097624537482,1.0,18/78,15.89%,LDB19;SAR1;VPS41;RET3;RIM8;YPT32;ECM30;GYP7;CSR2;BUB2;VPS35;APL3;SLO1;PIR1;VAM3;ERV25;GYP6;IMH1
prerank,DNA packaging (GO:0006323),-0.6719414424205492,-1.1662552929516496,0.2607626076260763,0.9271265680502679,1.0,2/14,4.57%,SMC4;APC9
prerank,chromatin remodeling (GO:0006338),-0.5926688532773164,-1.1661347286843222,0.19086294416243654,0.9249480950229602,1.0,13/61,15.73%,IOC2;RAD54;SWI1;CHD1;SIR3;IES3;RSC2;RSC9;ISW2;YOR338W;PHO2;SWC5;SWC4
prerank,phospholipid translocation (GO:0045332),-0.7212956771095648,-1.1646732698526294,0.28609625668449196,0.9303704345376814,1.0,1/8,2.62%,NEO1
prerank,mitochondrial respiratory chain complex IV assembly (GO:0033617),-0.6407652176189776,-1.164565599050308,0.2765714285714286,0.9249992830956256,1.0,4/19,12.55%,COX12;COX20;COX16;RCF1
prerank,mitochondrial respiratory chain complex IV biogenesis (GO:0097034),-0.6407652176189776,-1.164565599050308,0.2765714285714286,0.9249992830956256,1.0,4/19,12.55%,COX12;COX20;COX16;RCF1
prerank,protein prenylation (GO:0018342),0.6649362275070723,1.1645275236968726,0.3247588424437299,0.819979442447371,1.0,3/6,17.01%,BET4;RAM1;CDC43
prerank,meiotic recombination checkpoint (GO:0051598),-0.7461093109182722,-1.1643687697109983,0.2985507246376812,0.9231045354210553,1.0,3/7,22.19%,PSY2;PCH2;FPR3
prerank,sulfate assimilation (GO:0000103),-0.766215598308051,-1.1629830361121856,0.2696793002915452,0.9280848906565974,1.0,1/6,0.04%,MET14
prerank,organic cation transport (GO:0015695),-0.7142914493643803,-1.162013002648451,0.2929936305732484,0.9308083003960576,1.0,5/9,21.74%,SAM3;FAA4;TPO4;RSB1;TPC1
prerank,"nuclear-transcribed mRNA catabolic process, deadenylation-independent decay (GO:0031086)",-0.7334853486727188,-1.160931825723168,0.27475592747559274,0.9339227647087357,1.0,3/7,15.17%,NOT5;EDC3;DCS1
prerank,ribosomal large subunit biogenesis (GO:0042273),-0.5841740915964082,-1.1594353416881178,0.1402805611222445,0.939547691353746,1.0,11/83,10.15%,RPL7B;MAK11;LOC1;PRP43;RPL33A;JIP5;NOC2;RPL12A;REH1;SSF2;RPL26A
prerank,calcium ion homeostasis (GO:0055074),-0.6832481853470025,-1.1583708795243122,0.2975609756097561,0.9427064318499988,1.0,5/12,17.21%,FLC2;VNX1;ECM27;PMC1;PMR1
prerank,alcohol biosynthetic process (GO:0046165),-0.7195932337877265,-1.157962295899551,0.2923728813559322,0.9419361359926476,1.0,3/8,13.65%,ADH4;ADH1;SRT1
prerank,negative regulation of protein phosphorylation (GO:0001933),0.5818625840871782,1.157535654410041,0.30973451327433627,0.8316390206710782,1.0,3/11,11.36%,PIL1;NCE102;LSP1
prerank,autophagy of nucleus (GO:0044804),-0.607395059942305,-1.1572959704903618,0.25216450216450215,0.9426707321525374,1.0,10/33,19.81%,ATG14;VPS41;ATG29;OSH6;VAC8;VAM3;ATG16;ATG11;VAM7;ATG8
prerank,cellular response to nutrient levels (GO:0031669),-0.6499426287524184,-1.1572771995204942,0.28068043742405835,0.9398740337693283,1.0,4/15,15.17%,GSM1;KOG1;IRS4;DCS1
prerank,pore complex assembly (GO:0046931),-0.7748266292853104,-1.1572297822871664,0.2921174652241113,0.9343293314576288,1.0,3/5,7.87%,RTN1;KAP95;NUP170
prerank,nuclear pore complex assembly (GO:0051292),-0.7748266292853104,-1.1572297822871664,0.2921174652241113,0.9343293314576288,1.0,3/5,7.87%,RTN1;KAP95;NUP170
prerank,cellular sphingolipid homeostasis (GO:0090156),-0.7617982412389253,-1.1569760895489976,0.29577464788732394,0.9328342399017423,1.0,2/6,22.30%,VPS54;ORM1
prerank,rRNA transcription (GO:0009303),-0.6262540795632219,-1.1560118943209028,0.25386313465783666,0.9351610466265579,1.0,7/24,15.78%,TFC3;RPA135;RRN9;TFC4;RSC9;RPA49;HHT2
prerank,aerobic respiration (GO:0009060),-0.6052199992151563,-1.1554950565833342,0.2465753424657534,0.9350530884182213,1.0,6/35,11.07%,OAR1;MDH1;ADE16;COX20;RSF1;JAC1
prerank,nuclear migration (GO:0007097),-0.6792292432246951,-1.1539821654435571,0.27791563275434245,0.9409251498551938,1.0,7/13,24.99%,TUB2;SPC72;SLK19;DYN3;TUB1;TOP1;PAC11
prerank,negative regulation of intracellular signal transduction (GO:1902532),-0.6938223045745773,-1.1526048393739483,0.32,0.9457278358944184,1.0,1/10,10.74%,ROM2
prerank,histone H3-K79 methylation (GO:0034729),-0.7683043375059069,-1.152555977491911,0.30500758725341426,0.9431659900191195,1.0,1/5,9.12%,HHF2
prerank,nucleotide-excision repair (GO:0006289),-0.5921200570454547,-1.1520569407219279,0.24712041884816754,0.9431836603636327,1.0,4/38,6.21%,RAD34;THO2;RAD26;POL2
prerank,mitotic DNA replication (GO:1902969),0.5820405389453095,1.1517953238874372,0.27358490566037735,0.8394035934932403,1.0,4/10,9.39%,CDC7;SLD2;CDC9;PSF1
prerank,nucleotide transport (GO:0006862),-0.7743156471821729,-1.1516802142390363,0.30606060606060603,0.9423400547223945,1.0,2/5,5.45%,FLC2;FLC1
prerank,regulation of organelle organization (GO:0033043),-0.7280669846727436,-1.1516488549142376,0.324585635359116,0.9396819213968499,1.0,2/7,14.39%,SAR1;SED4
prerank,regulation of cyclin-dependent protein kinase activity (GO:1904029),-0.6294935855571488,-1.1511266212736395,0.2917620137299771,0.9398029745367908,1.0,6/20,11.86%,CLB1;CLN2;CLB3;PCL1;CLB2;CLB6
prerank,synaptonemal complex organization (GO:0070193),-0.641404192904893,-1.1510171034309067,0.27578215527230593,0.9375635696498646,1.0,3/18,7.28%,SMC4;GMC1;SMC3
prerank,translational elongation (GO:0006414),-0.6226590433589048,-1.150088492873659,0.26853932584269663,0.9396279102579428,1.0,5/23,12.82%,HBS1;EFT2;EFT1;YEF3;SSZ1
prerank,ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway (GO:0043162),-0.6267896785568864,-1.1498160173230922,0.31922196796338675,0.9382894062352571,1.0,5/20,13.25%,TRE1;STP22;GGA1;DOA4;SNF7
prerank,organelle inheritance (GO:0048308),-0.5833811623001177,-1.149383364998777,0.24871531346351491,0.9378195449033351,1.0,10/47,18.15%,VPS9;MDM1;CLA4;RTN1;VAC8;MYO2;PEP7;ARP3;INP1;ARC18
prerank,regulation of adenylate cyclase activity (GO:0045761),-0.7775961038087473,-1.148866325013191,0.31432973805855163,0.9378259361906963,1.0,1/5,3.00%,IRA1
prerank,negative regulation of macroautophagy (GO:0016242),-0.7668576829212599,-1.148809960919114,0.32344213649851633,0.9353833334543676,1.0,2/5,10.53%,KSP1;XRN1
prerank,vesicle budding from membrane (GO:0006900),-0.7049658768005643,-1.148494007317526,0.30971128608923887,0.9344024702926368,1.0,2/9,13.25%,DOA4;SNF7
prerank,tetrahydrofolate biosynthetic process (GO:0046654),0.6315302730416088,1.148412606802468,0.3576158940397351,0.8411084133863833,1.0,1/7,6.12%,DFR1
prerank,non-recombinational repair (GO:0000726),-0.632087180830447,-1.148382306279802,0.2737430167597765,0.9322393586025085,1.0,6/22,14.61%,PSO2;POL2;SIR3;RSC2;SUB1;SRS2
prerank,Golgi organization (GO:0007030),-0.6367036441663397,-1.1477751902507303,0.278436018957346,0.9329404845787841,1.0,5/18,14.59%,EMP46;YGR127W;MYO2;ERV25;UIP5
prerank,chromosome organization (GO:0051276),-0.6023737052212033,-1.147683974272454,0.2413793103448276,0.9306921306361212,1.0,15/37,22.70%,NUP60;SMC4;GMC1;NUP170;SGS1;MSH2;PIF1;SWC4;MLP2;TOP2;HMO1;NUP133;GMC2;CSM3;RAD7
prerank,septin ring organization (GO:0031106),-0.6100980924875016,-1.14760113476258,0.2570194384449244,0.9283986548629545,1.0,5/28,10.94%,BUD4;CLA4;PKC1;PCL1;RTS1
prerank,interstrand cross-link repair (GO:0036297),-0.7329036180837274,-1.1473439206196632,0.32538569424964936,0.927127421914255,1.0,4/7,16.90%,MGM101;PSO2;MSH2;EXO5
prerank,negative regulation of MAP kinase activity (GO:0043407),-0.7014473802578393,-1.147326787968186,0.31758530183727035,0.9218827023117112,1.0,1/9,1.26%,PTP3
prerank,inactivation of MAPK activity (GO:0000188),-0.7014473802578393,-1.147326787968186,0.31758530183727035,0.9218827023117112,1.0,1/9,1.26%,PTP3
prerank,protein localization to nuclear inner membrane (GO:0036228),-0.7392509178026163,-1.1470124678920566,0.3149931224209078,0.9208940198065577,1.0,4/7,13.83%,NUP145;NUP100;NUP170;NUP57
prerank,positive regulation of macroautophagy (GO:0016239),-0.6615617353556978,-1.1463877940027674,0.29826732673267325,0.921573411038192,1.0,3/13,7.69%,GCN2;FAR11;PCL1
prerank,glycoprotein metabolic process (GO:0009100),-0.7115488075417524,-1.1460510694857953,0.3249001331557923,0.9207227150200041,1.0,3/9,11.18%,MNN1;PNG1;RAD23
prerank,vesicle-mediated transport to the plasma membrane (GO:0098876),-0.6365249873884432,-1.1459391074611078,0.288,0.9187055177153907,1.0,3/20,8.02%,SEC15;RSN1;BCH1
prerank,postreplication repair (GO:0006301),-0.6614446170489079,-1.1452371149172913,0.3180169286577993,0.919854246563234,1.0,4/13,12.68%,PAN2;SGS1;MSH2;RAD5
prerank,double-strand break repair via nonhomologous end joining (GO:0006303),-0.6321388530009271,-1.1452327565706566,0.2786516853932584,0.9172671236856029,1.0,6/21,14.61%,PSO2;POL2;SIR3;RSC2;SUB1;SRS2
prerank,copper ion transport (GO:0006825),-0.6586556458758215,-1.1431509498219017,0.30669800235017625,0.9258200609444424,1.0,6/14,21.16%,PIC2;CTR1;FRE4;FRE7;FRE6;FRE3
prerank,septin ring assembly (GO:0000921),0.507334465112447,1.1429540533671818,0.26973684210526316,0.8479086908797967,1.0,7/15,28.89%,SKP1;CDC10;CDC11;CDC12;CTF13;SPR28;DMA1
prerank,nuclear migration along microtubule (GO:0030473),-0.7073311679221912,-1.1429380839182504,0.31648936170212766,0.9242677168210317,1.0,5/9,24.99%,TUB2;SPC72;DYN3;TUB1;PAC11
prerank,small GTPase mediated signal transduction (GO:0007264),-0.6475225810989115,-1.1422959003579218,0.30138568129330257,0.9249777274274638,1.0,8/16,24.41%,ROM1;CDC25;CYR1;ROM2;RSR1;BMH1;SRO7;CDC24
prerank,ubiquitin-dependent catabolism of misfolded proteins by nucleus-associated proteasome (GO:0071630),0.6719055934669074,1.1418155831618466,0.35376044568245124,0.8434743841968676,1.0,1/5,1.48%,VMS1
prerank,branched-chain amino acid biosynthetic process (GO:0009082),0.58058936402892,1.1415233183721136,0.2948207171314741,0.8368902562042532,1.0,6/9,30.10%,LEU1;LEU4;ILV5;MMF1;ILV2;LEU9
prerank,DNA-templated transcriptional start site selection (GO:0001173),-0.7394548626493231,-1.1415125519509068,0.3380084151472651,0.9238597511892631,1.0,3/6,19.88%,SUA7;REB1;HMO1
prerank,transcriptional start site selection at RNA polymerase II promoter (GO:0001174),-0.7394548626493231,-1.1415125519509068,0.3380084151472651,0.9238597511892631,1.0,3/6,19.88%,SUA7;REB1;HMO1
prerank,microtubule polymerization (GO:0046785),-0.6540975786141163,-1.1397845342708002,0.31850961538461536,0.9275116586030742,1.0,7/14,20.17%,CNM67;SPC42;STU2;SPC72;SPC97;SPC29;SPC25
prerank,microtubule nucleation (GO:0007020),-0.6540975786141163,-1.1397845342708002,0.31850961538461536,0.9275116586030742,1.0,7/14,20.17%,CNM67;SPC42;STU2;SPC72;SPC97;SPC29;SPC25
prerank,monocarboxylic acid metabolic process (GO:0032787),-0.6385584645957656,-1.1395412666632072,0.30751445086705204,0.9262048410312904,1.0,2/18,1.48%,OAR1;IAH1
prerank,regulation of meiosis I (GO:0060631),-0.7139311951574782,-1.1393903834610555,0.3113207547169811,0.9243829030675701,1.0,2/8,9.77%,CLB1;SGS1
prerank,organelle transport along microtubule (GO:0072384),-0.6768365715814401,-1.1391705310399036,0.3196004993757803,0.9229154767720767,1.0,4/11,21.11%,TUB2;SPC72;DYN3;TUB1
prerank,regulation of cyclin-dependent protein serine/threonine kinase activity (GO:0000079),-0.6091034460120338,-1.1388078349033026,0.29911699779249445,0.9221954262235537,1.0,6/24,11.86%,CLB1;CLN2;CLB3;PCL1;CLB2;CLB6
prerank,(1->3)-beta-D-glucan biosynthetic process (GO:0006075),-0.7379223391438199,-1.1386597693260623,0.3361462728551336,0.9204816053030372,1.0,2/6,13.85%,GSC2;GAS2
prerank,positive regulation of transcription involved in G1/S transition of mitotic cell cycle (GO:0071931),-0.754909011999322,-1.1385854332723182,0.3445255474452555,0.9183206329323155,1.0,1/6,6.19%,ASP1
prerank,nuclear pore distribution (GO:0031081),-0.7131381131020624,-1.1373031651452339,0.31469440832249673,0.9195635882779589,1.0,2/9,3.59%,NUP120;NUP145
prerank,nuclear pore localization (GO:0051664),-0.7131381131020624,-1.1373031651452339,0.31469440832249673,0.9195635882779589,1.0,2/9,3.59%,NUP120;NUP145
prerank,peptidyl-threonine phosphorylation (GO:0018107),-0.7186940447207726,-1.1362447316073083,0.3146374829001368,0.919738579365217,1.0,1/8,1.86%,PKH1
prerank,peptidyl-threonine modification (GO:0018210),-0.7186940447207726,-1.1362447316073083,0.3146374829001368,0.919738579365217,1.0,1/8,1.86%,PKH1
prerank,synapsis (GO:0007129),-0.6226176807081022,-1.135889406333503,0.3127147766323024,0.9190648888542761,1.0,3/21,7.28%,SMC4;HOP2;SMC3
prerank,histone H4 acetylation (GO:0043967),-0.7637068445525359,-1.1348669753617513,0.35968992248062015,0.921732491671378,1.0,4/5,22.28%,HAT1;SWC4;EAF3;ELP4
prerank,NADP metabolic process (GO:0006739),-0.6373812716268059,-1.1348358687794229,0.29698375870069604,0.9194369523330556,1.0,7/16,21.56%,UTR1;TKL1;SOL2;YEF1;ZWF1;RPE1;RKI1
prerank,protein polyubiquitination (GO:0000209),-0.6018686923562238,-1.1333220236494388,0.27747551686615884,0.9247377493678642,1.0,6/28,12.68%,PEX10;ITT1;APC1;MET30;SSA1;RAD5
prerank,steroid biosynthetic process (GO:0006694),-0.6552697232069005,-1.1326553203194254,0.319672131147541,0.9257974990079328,1.0,1/14,0.16%,ERG3
prerank,plasma membrane bounded cell projection assembly (GO:0120031),0.6421393157789994,1.1315783871388443,0.35987261146496813,0.8474964648959912,1.0,4/6,26.96%,CDC10;CDC11;CDC12;SPR28
prerank,cilium assembly (GO:0060271),0.6421393157789994,1.1315783871388443,0.35987261146496813,0.8474964648959912,1.0,4/6,26.96%,CDC10;CDC11;CDC12;SPR28
prerank,sterol transport (GO:0015918),-0.6292230223656146,-1.1313297727931062,0.3179255918827508,0.9298771533857473,1.0,6/18,15.40%,CLA4;SNQ2;OSH6;PRY2;DAN1;PRY1
prerank,tRNA thio-modification (GO:0034227),0.655819538154273,1.1312895963138934,0.38650306748466257,0.8409369922224071,1.0,2/6,2.26%,URM1;NFS1
prerank,"regulation of transcription, DNA-templated (GO:0006355)",-0.5622052535025233,-1.130693731681673,0.149,0.9304877623048842,1.0,31/132,18.38%,HIR2;NUP120;SWI1;NOT5;GTS1;GSM1;IFH1;NUP145;TAF13;DOT6;NUP100;CSR2;SPN1;ELP2;SRB7;MET30;RSC9;YOR338W;ELP3;REB1;CRZ1;SET3;YKR023W;MET32;HOS3;LEU3;MLP2;EAF3;POP2;NOT3;SET2
prerank,lipid homeostasis (GO:0055088),-0.6187528974507143,-1.1305347884732988,0.31986531986531985,0.928853198184929,1.0,7/20,25.55%,OSH6;VPS54;MCP1;POX1;ORM1;APQ12;SPF1
prerank,nucleotide biosynthetic process (GO:0009165),-0.6338174141671995,-1.1304607231815966,0.3142857142857143,0.9267758028973202,1.0,2/19,4.71%,RNR2;ADE16
prerank,regulation of protein phosphorylation (GO:0001932),-0.6654894972820683,-1.1297992179710188,0.3316582914572864,0.9274476707064336,1.0,4/11,16.92%,CLA4;DPB11;RTS1;ATG11
prerank,UDP-N-acetylglucosamine metabolic process (GO:0006047),0.6618443472344239,1.129545193271111,0.37091988130563797,0.8377461614848795,1.0,1/5,17.41%,YMR084W
prerank,regulation of sphingolipid biosynthetic process (GO:0090153),0.6385467013799394,1.1295068525848067,0.39792387543252594,0.8307727063771315,1.0,3/7,15.26%,TSC3;YPK1;SWE1
prerank,protein-DNA complex subunit organization (GO:0071824),-0.7559157424048313,-1.1291774021313272,0.3545586107091172,0.9277930051831271,1.0,2/5,14.61%,CHD1;SRS2
prerank,monovalent inorganic cation transport (GO:0015672),-0.7119597426671237,-1.129149955063082,0.35269709543568467,0.9255067720689774,1.0,2/7,12.91%,VNX1;VPH1
prerank,cellular response to acid chemical (GO:0071229),-0.717877787194909,-1.127858892521353,0.36151603498542273,0.9292907552327433,1.0,1/7,6.59%,KOG1
prerank,riboflavin metabolic process (GO:0006771),0.675261450377183,1.127814798528816,0.39308176100628933,0.8214262432210694,1.0,2/5,10.85%,RIB1;RIB3
prerank,riboflavin biosynthetic process (GO:0009231),0.675261450377183,1.127814798528816,0.39308176100628933,0.8214262432210694,1.0,2/5,10.85%,RIB1;RIB3
prerank,positive regulation of deoxyribonuclease activity (GO:0032077),-0.7270989253370097,-1.1263713450309731,0.3719599427753934,0.9340165774244866,1.0,3/6,14.61%,RAD54;VTS1;SRS2
prerank,formation of translation preinitiation complex (GO:0001731),-0.7071731610500299,-1.1263358222525452,0.3310626702997275,0.9317553800871122,1.0,2/8,2.69%,TMA20;SUI2
prerank,positive regulation of organelle assembly (GO:1902117),-0.7401761625345089,-1.1263153930986638,0.35650887573964496,0.9294332865210607,1.0,2/6,4.08%,PKH1;PKC1
prerank,actin polymerization or depolymerization (GO:0008154),-0.7527007128792506,-1.1261954347439775,0.38088012139605465,0.9276014861938408,1.0,1/5,5.74%,TWF1
prerank,spindle assembly (GO:0051225),-0.6827638588074483,-1.1258444271141097,0.3435960591133005,0.9269138140611088,1.0,4/11,14.52%,MPS1;KIP1;CIN8;SPC97
prerank,RNA processing (GO:0006396),0.4363806193393131,1.124914110988912,0.24647887323943662,0.8220312876604133,1.0,3/18,9.30%,RNA14;CLP1;MRS1
prerank,synaptonemal complex assembly (GO:0007130),-0.6497785324836584,-1.124509718203598,0.31868131868131866,0.9310501104588977,1.0,2/14,7.28%,SMC4;SMC3
prerank,glucan catabolic process (GO:0009251),-0.7404763361796375,-1.124491905334065,0.36916548797736914,0.9287279191286205,1.0,1/6,1.10%,SPR1
prerank,protein phosphorylation (GO:0006468),-0.5596236703627055,-1.1243492897864278,0.2032032032032032,0.927090632277657,1.0,17/102,11.41%,YAK1;MPS1;PKH1;GCN2;FMP48;CLA4;PKC1;FPK1;KDX1;FRK1;PTK2;KSP1;SLI15;DBF2;PRR2;CDC15;RTK1
prerank,polyphosphate metabolic process (GO:0006797),-0.7013285589526076,-1.1240222255881087,0.3390501319261214,0.926163653290759,1.0,6/8,29.27%,VPH1;PHO90;VTC4;PHO84;VTC1;PHO87
prerank,cortical actin cytoskeleton organization (GO:0030866),0.4905918069980613,1.1238934280183055,0.2947976878612717,0.8178947387374959,1.0,4/13,9.37%,SLA1;SCD5;ARK1;ARC19
prerank,cellular response to organic substance (GO:0071310),0.6014782326385695,1.123730348945715,0.3592592592592593,0.811761001139257,1.0,3/7,17.06%,SLT2;YPK1;KSS1
prerank,protein insertion into membrane (GO:0051205),-0.7341110712019578,-1.1236588508090763,0.3563218390804598,0.9256436730330643,1.0,1/6,14.75%,GET4
prerank,oligosaccharide-lipid intermediate biosynthetic process (GO:0006490),0.5578367081503437,1.1230268705872406,0.32242990654205606,0.807092968976268,1.0,3/9,6.97%,ALG2;DPM1;ALG14
prerank,"retrograde transport, endosome to Golgi (GO:0042147)",-0.5910505848110299,-1.1229894991799332,0.31696905016008536,0.9263987222252801,1.0,5/35,9.93%,ENT5;YPT32;TRS120;VPS35;VPS54
prerank,meiotic sister chromatid segregation (GO:0045144),-0.7209797383447548,-1.1220448534694654,0.35639097744360904,0.9283431425404786,1.0,1/6,7.28%,SMC3
prerank,negative regulation of gene expression (GO:0010629),-0.6089867774046427,-1.1217627178244214,0.31,0.9273970792613393,1.0,9/24,22.88%,NOT5;CLA4;RPL16B;VTS1;EAF3;POP2;NOT3;SAS3;ASC1
prerank,cellular metal ion homeostasis (GO:0006875),-0.6216653171100929,-1.1210504854448429,0.3438556933483653,0.9286411044996499,1.0,6/19,17.21%,VNX1;ECM27;FRE8;PMC1;PCA1;PMR1
prerank,regulation of protein complex disassembly (GO:0043244),-0.7491175167421747,-1.120600646431388,0.3727544910179641,0.928365313681088,1.0,1/5,4.73%,ITT1
prerank,sulfur compound transport (GO:0072348),-0.6562860201546935,-1.1204624783413226,0.33176470588235296,0.9266814241231259,1.0,3/13,4.50%,SAM3;SUL2;THI72
prerank,negative regulation of autophagy (GO:0010507),-0.6744772220977796,-1.1196947239788753,0.3492268041237113,0.9278753979921734,1.0,2/10,10.53%,KSP1;XRN1
prerank,regulation of cellular amide metabolic process (GO:0034248),-0.695764512636454,-1.1195766501878823,0.33462033462033464,0.9215861530735453,1.0,3/9,14.41%,PPH22;SLH1;SLF1
prerank,posttranscriptional regulation of gene expression (GO:0010608),-0.695764512636454,-1.1195766501878823,0.33462033462033464,0.9215861530735453,1.0,3/9,14.41%,PPH22;SLH1;SLF1
prerank,regulation of cellular protein metabolic process (GO:0032268),-0.695764512636454,-1.1195766501878823,0.33462033462033464,0.9215861530735453,1.0,3/9,14.41%,PPH22;SLH1;SLF1
prerank,protein import into peroxisome matrix (GO:0016558),-0.6096646573841688,-1.1191382384642858,0.34812286689419797,0.9214458099018439,1.0,5/21,14.28%,CAJ1;PEX10;GPD1;PEX5;PEX14
prerank,rRNA catabolic process (GO:0016075),-0.5935898624276934,-1.1191222830431207,0.2973856209150327,0.9192577787691425,1.0,6/30,10.53%,DOM34;HBS1;MTR4;RRP6;RTT101;XRN1
prerank,iron chelate transport (GO:0015688),-0.7371777560939402,-1.1191001941226866,0.3495575221238938,0.9170829644650306,1.0,2/6,9.44%,ARN2;FRE4
prerank,establishment of spindle orientation (GO:0051294),-0.6935029846334096,-1.1185958253343768,0.3527080581241744,0.9148844420384694,1.0,3/9,13.04%,NIP100;MYO2;CIK1
prerank,establishment of mitotic spindle orientation (GO:0000132),-0.6935029846334096,-1.1185958253343768,0.3527080581241744,0.9148844420384694,1.0,3/9,13.04%,NIP100;MYO2;CIK1
prerank,positive regulation of transport (GO:0051050),-0.7340400008481014,-1.115718876852817,0.3789173789173789,0.9255574265266527,1.0,3/6,12.01%,ASK10;ROM2;SEC1
prerank,ATP export (GO:1904669),-0.636151120557577,-1.1145631400269733,0.3568818514007308,0.928453202424873,1.0,3/14,13.25%,STP22;DOA4;SNF7
prerank,proteolysis (GO:0006508),-0.5789082859730855,-1.1141569190898728,0.30929989550679204,0.9279796016311344,1.0,11/39,21.25%,YPS5;RIM8;STE23;COX20;YPS1;OCT1;YME1;MAS2;PRD1;AAP1;MDM30
prerank,positive regulation of cellular response to amino acid starvation (GO:1903833),-0.7161413147282549,-1.113922759724594,0.37749287749287747,0.926726148530132,1.0,2/6,13.38%,GCN2;GCN3
prerank,positive regulation of response to nutrient levels (GO:0032109),-0.695165133844279,-1.113781987200507,0.3687002652519894,0.9251346624735671,1.0,2/8,13.38%,GCN2;GCN3
prerank,carbon catabolite activation of transcription from RNA polymerase II promoter (GO:0000436),-0.6374319834472654,-1.11287615680329,0.33727810650887574,0.9271768232309768,1.0,3/15,9.57%,SWI1;USV1;HAP4
prerank,regulation of chromatin silencing at silent mating-type cassette (GO:0090054),0.5910339057212817,1.1125279311246101,0.3805970149253731,0.8264101001889986,1.0,3/8,12.68%,WTM2;BDF1;RPD3
prerank,transition metal ion transport (GO:0000041),-0.6008764373818039,-1.1123772818438484,0.3366228070175439,0.9270677475670378,1.0,8/25,21.16%,GMC1;FET3;FRE4;FRE7;PCA1;PMR1;FRE6;FRE3
prerank,disaccharide catabolic process (GO:0046352),-0.6984139046194603,-1.1108512359837805,0.37771739130434784,0.9318404093476703,1.0,1/8,1.41%,SWI1
prerank,mitochondrial translational initiation (GO:0070124),-0.7201576294859283,-1.1092879192741785,0.4031117397454031,0.9363262388548304,1.0,1/6,1.14%,AEP3
prerank,mitotic sister chromatid cohesion (GO:0007064),-0.5884149565142855,-1.1088087286307757,0.3300865800865801,0.9362176560169103,1.0,8/29,17.26%,TOP3;MCM16;POL2;SMC3;RAD61;DCC1;PDS5;IRR1
prerank,sterol metabolic process (GO:0016125),-0.5967605216163987,-1.1087850426332928,0.3286334056399132,0.9340793308951496,1.0,8/25,22.52%,ERG3;OSH6;GRE2;ATG26;HMG2;HMG1;ERG12;MVD1
prerank,positive regulation of cell communication (GO:0010647),-0.6949503604826794,-1.1082321790467715,0.3746518105849582,0.934279225061704,1.0,2/7,13.38%,GCN2;GCN3
prerank,nuclear-transcribed mRNA poly(A) tail shortening (GO:0000289),-0.7132739193665906,-1.107307102842401,0.3676056338028169,0.9359615573354442,1.0,5/7,17.97%,NOT5;PAN2;VTS1;POP2;NOT3
prerank,replicative cell aging (GO:0001302),-0.5881693674383991,-1.1068152019309496,0.3224789915966387,0.936132340663989,1.0,6/34,9.77%,SOD2;MDH1;TSA1;GUT2;CDC25;SGS1
prerank,nucleobase biosynthetic process (GO:0046112),-0.6981495802088487,-1.106330011294593,0.3980169971671388,0.9361461619484129,1.0,2/7,12.86%,URA8;PHO2
prerank,triglyceride metabolic process (GO:0006641),-0.657260734576523,-1.1058980992029268,0.3626237623762376,0.9359191533185887,1.0,5/12,15.84%,TGL4;GUT1;LRO1;YJU3;SAH1
prerank,polysaccharide catabolic process (GO:0000272),-0.7524241621691998,-1.1056634270843866,0.40657698056801195,0.9347606704562723,1.0,1/5,1.10%,SPR1
prerank,positive regulation of protein phosphorylation (GO:0001934),-0.6285018809387419,-1.1055714791149618,0.35499398315282793,0.9329826775976631,1.0,6/15,22.88%,SSK1;DPB11;RPP2B;ATG11;SSP2;ASC1
prerank,late nucleophagy (GO:0044805),-0.6511440654387798,-1.104535293893701,0.35192069392812886,0.9354671621621796,1.0,3/12,19.81%,ATG29;ATG16;ATG8
prerank,mitochondrion localization (GO:0051646),0.5981619099179556,1.1043407329489903,0.36585365853658536,0.8386072931063695,1.0,1/7,1.05%,YPT11
prerank,peptide transport (GO:0015833),-0.6880514666642921,-1.1040990472372603,0.3642297650130548,0.9352672372246864,1.0,1/9,2.76%,VPS41
prerank,positive regulation of histone modification (GO:0031058),-0.6658528829668332,-1.1034559920911973,0.3891687657430731,0.9359734434369898,1.0,4/10,19.12%,HIR3;YOR338W;SET2;GRX4
prerank,protein targeting (GO:0006605),-0.5490247815084925,-1.1030561442924993,0.2872983870967742,0.9355591342009308,1.0,14/77,16.41%,VPS9;BSD2;VPS41;STP22;KAP95;APM3;VPS16;PEP1;SSA1;YDJ1;SRP14;TOM70;VPS8;ROY1
prerank,ribosome biogenesis (GO:0042254),-0.5462740915022564,-1.1011771153254748,0.223,0.9416024369934467,1.0,19/141,10.53%,RPS5;TMA20;RPL7B;MAK11;LOC1;PRP43;RPS15;DSS1;RNA1;RPL33A;JIP5;NOC2;NOC3;SGD1;NEW1;HCA4;REH1;RPL26A;XRN1
prerank,deadenylation-dependent decapping of nuclear-transcribed mRNA (GO:0000290),-0.6441017675503604,-1.1010428316335272,0.3707865168539326,0.9400441120445976,1.0,4/12,17.97%,NOT5;DCS1;PAT1;NOT3
prerank,telomere maintenance (GO:0000723),-0.56950628165919,-1.1005856922371555,0.31275720164609055,0.9398914201994916,1.0,9/46,16.09%,RAD54;GBP2;BRE2;IES3;SGS1;IES5;RIF2;PIF1;RAD51
prerank,DNA unwinding involved in DNA replication (GO:0006268),-0.6867447092716563,-1.0996442010763194,0.39077340569877883,0.9420040961444537,1.0,2/7,19.50%,SGS1;RFA3
prerank,nucleic acid phosphodiester bond hydrolysis (GO:0090305),-0.6627815843024372,-1.0992365895946092,0.3671875,0.9417003525412767,1.0,2/10,10.69%,NOT5;EDC3
prerank,acetyl-CoA metabolic process (GO:0006084),-0.683805319619244,-1.0991904596157465,0.38386648122392214,0.9397451509712277,1.0,6/8,22.52%,ERG13;HMG1;ERG12;ACS2;CIT1;MVD1
prerank,asparagine catabolic process (GO:0006530),-0.7565485866280139,-1.0987574444774255,0.38544891640866874,0.9394548228778474,1.0,1/5,6.19%,ASP1
prerank,inositolphosphoceramide metabolic process (GO:0006673),0.6490270008005126,1.0975377769092183,0.40584415584415584,0.8478965598752918,1.0,4/6,23.51%,AUR1;KEI1;IPT1;TLG2
prerank,cytoplasmic translation (GO:0002181),-0.544850203532588,-1.0966163271016696,0.212,0.9466657255207515,1.0,23/142,14.86%,RPS5;RPL21B;RPL7B;TMA7;RPS15;RPL33A;SLH1;RPL12A;RPL29;RPS4A;RPL42A;RPL26A;RPL16B;RPL20B;SSA1;RPS14A;SSZ1;RPS22A;RPP2B;RPL28;RPL18B;RPL31B;RPL9B
prerank,regulation of transcription involved in G1/S transition of mitotic cell cycle (GO:0000083),-0.5998677135970131,-1.095365533237232,0.3860619469026549,0.9499701816452615,1.0,7/23,16.85%,HIR3;ASP1;WHI5;MET30;HOS3;YOX1;NRM1
prerank,nucleosome organization (GO:0034728),-0.5668907886217458,-1.0951938199384914,0.3391933815925543,0.9485917611810457,1.0,16/44,25.93%,CHD1;NUP170;IES3;RSC2;RSC9;ISW2;SWC5;SWC4;CAC2;RSC1;FPR3;SWC3;NAP1;NPL6;DPB4;VPS71
prerank,mitochondrial RNA metabolic process (GO:0000959),-0.6621944647929554,-1.0951478393097407,0.3987096774193548,0.9466226589695405,1.0,3/10,16.07%,DSS1;RSF1;SUV3
prerank,"maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000463)",-0.560769836775667,-1.0949816486952275,0.36544502617801045,0.9451855531341044,1.0,4/40,5.78%,RPL7B;MAK11;PRP43;RRP5
prerank,regulation of transcription from RNA polymerase III promoter (GO:0006359),-0.6795825779971945,-1.0941252229236411,0.40341655716162944,0.9466492507239548,1.0,2/9,12.12%,MAF1;SUB1
prerank,response to salt stress (GO:0009651),-0.6178578624775158,-1.0932558421694887,0.3981042654028436,0.9482506484731975,1.0,5/17,14.79%,SIS2;HAL9;PSR2;BZZ1;CTT1
prerank,pantothenate metabolic process (GO:0015939),-0.7300133021116895,-1.093039245754593,0.42208774583963693,0.9470894748450654,1.0,1/5,3.47%,SPE1
prerank,RNA 3'-end processing (GO:0031123),-0.6034294284656951,-1.0916682357000749,0.38687782805429866,0.9505813718278374,1.0,6/20,16.07%,REX3;THO2;RTT103;NRD1;REF2;SUV3
prerank,aspartate family amino acid metabolic process (GO:0009066),-0.7411465393323805,-1.0913404860897278,0.4223880597014925,0.9499464048112215,1.0,3/5,20.51%,SAM1;SAH1;NIT3
prerank,cellular protein catabolic process (GO:0044257),-0.5960058622351231,-1.089753085098129,0.3717805151175812,0.9544821313284625,1.0,3/22,8.07%,STE23;SNA2;ASK10
prerank,tryptophan metabolic process (GO:0006568),-0.6408896922628894,-1.0889588643565127,0.40175219023779724,0.955731768146248,1.0,3/12,8.76%,TRP3;TRP4;BNA1
prerank,positive regulation of translation (GO:0045727),-0.5717474589114752,-1.088425016257439,0.36037934668071653,0.9557635863996544,1.0,8/40,12.10%,DOM34;HBS1;EFT2;EFT1;MSS51;RPS9B;PET111;CBS1
prerank,Golgi to vacuole transport (GO:0006896),-0.5906087301881103,-1.0882050722626002,0.3687089715536105,0.9545168663090555,1.0,5/23,12.98%,GGA1;APM3;VPS54;PEP7;VAM3
prerank,regulation of translational elongation (GO:0006448),-0.7223680111818589,-1.0866069227401085,0.42592592592592593,0.9588363623840203,1.0,2/6,8.14%,EFT2;EFT1
prerank,positive regulation of transcription initiation from RNA polymerase II promoter (GO:0060261),0.47163312117352973,1.0864022307505516,0.34394904458598724,0.8674286141428196,1.0,4/14,8.34%,RPT2;RPT5;RPT3;SGF73
prerank,protein localization to cell periphery (GO:1990778),0.5180595493448084,1.0853960838312133,0.3333333333333333,0.8630211739297382,1.0,2/10,5.31%,NCE102;FHN1
prerank,regulation of phosphatase activity (GO:0010921),-0.7363681938350182,-1.0853926010371444,0.4045112781954887,0.9618949992749607,1.0,1/5,1.01%,GIP1
prerank,negative regulation of transcription from RNA polymerase II promoter by glucose (GO:0000433),0.5879284349466269,1.0853635213388095,0.40293040293040294,0.8499974961293257,1.0,3/7,22.57%,NRG2;SNF8;VPS36
prerank,negative regulation of transcription by glucose (GO:0045014),0.5879284349466269,1.0853635213388095,0.40293040293040294,0.8499974961293257,1.0,3/7,22.57%,NRG2;SNF8;VPS36
prerank,porphyrin-containing compound biosynthetic process (GO:0006779),-0.6853058034384214,-1.0832478851028937,0.4265927977839335,0.9685230022169159,1.0,3/8,17.62%,COX10;HEM15;HEM4
prerank,cellular bud neck septin ring organization (GO:0032186),-0.6979860127185675,-1.0826338651806577,0.4171270718232044,0.9667736981032728,1.0,2/7,10.94%,PKC1;RTS1
prerank,"cytokinesis, site selection (GO:0007105)",-0.6979860127185675,-1.0826338651806577,0.4171270718232044,0.9667736981032728,1.0,2/7,10.94%,PKC1;RTS1
prerank,transfer RNA gene-mediated silencing (GO:0061587),-0.6302118455304686,-1.0818503792374836,0.37375,0.967994383002755,1.0,5/13,10.42%,DOT6;MAF1;MOD5;HHF2;RSC9
prerank,telomere capping (GO:0016233),-0.6621166219136065,-1.0816890784612567,0.41229193341869397,0.9665498829069301,1.0,3/10,10.56%,PSO2;SGS1;RIF2
prerank,copper ion import (GO:0015677),-0.6818472297151942,-1.0810100270187328,0.44324324324324327,0.9671245797109401,1.0,5/8,21.16%,CTR1;FRE4;FRE7;FRE6;FRE3
prerank,protein import into mitochondrial inner membrane (GO:0045039),0.554571966857331,1.08071209021628,0.3939393939393939,0.8537552546203576,1.0,5/9,11.88%,TIM12;MGR2;TIM13;TIM54;TIM22
prerank,anion transmembrane transport (GO:0098656),-0.6578626739780233,-1.0797933003147693,0.4221938775510204,0.9697814971745823,1.0,4/10,14.95%,FTR1;FET3;PHO90;GEX2
prerank,ATP-dependent chromatin remodeling (GO:0043044),-0.5862169055121921,-1.0794016409321359,0.3938730853391685,0.9692740394952984,1.0,7/25,18.78%,SWI1;CHD1;RSC2;RSC9;SWC5;SWC4;RSC1
prerank,"maturation of 5.8S rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000466)",-0.541444172811895,-1.078729146653231,0.3528816986855409,0.9699734649065828,1.0,9/73,7.19%,MAK11;LOC1;REX3;PRP43;RRP5;MTR4;BUD21;RCL1;RRP6
prerank,polyol transport (GO:0015791),-0.73032251075332,-1.0785785978156404,0.4350453172205438,0.9685121587503254,1.0,3/5,19.97%,GUP1;STL1;GUP2
prerank,DNA strand elongation (GO:0022616),-0.6372608149608164,-1.078523255858095,0.40272614622057,0.9666429186456479,1.0,4/12,22.77%,SGS1;MCM3;TOP2;TOP1
prerank,ATP transport (GO:0015867),-0.6081228052878952,-1.0784689901825593,0.4019138755980861,0.9648032286480819,1.0,3/16,13.25%,STP22;DOA4;SNF7
prerank,snRNA 3'-end processing (GO:0034472),-0.6043286405330841,-1.0781716527949414,0.4016393442622951,0.9638779375402979,1.0,4/16,9.17%,REX3;MTR4;RRP6;NRD1
prerank,snoRNA processing (GO:0043144),-0.6505720478938046,-1.0778606112708982,0.4281984334203655,0.9630916450678868,1.0,3/10,15.82%,NRD1;XRN1;REF2
prerank,protein palmitoylation (GO:0018345),0.5910015759819757,1.077749522831133,0.4280442804428044,0.8540132362024146,1.0,2/7,10.13%,PFA4;PFA5
prerank,aromatic amino acid family biosynthetic process (GO:0009073),-0.6663023381409644,-1.0767859644494695,0.4128065395095368,0.9652305679186952,1.0,3/9,15.80%,TRP3;TRP4;ARO7
prerank,regulation of apoptotic process (GO:0042981),-0.6376739130630518,-1.076213132288221,0.42297979797979796,0.9655909379094801,1.0,1/11,3.09%,FYV10
prerank,ATP synthesis coupled proton transport (GO:0015986),0.5173021654040457,1.075918490838541,0.3681592039800995,0.8519471308710964,1.0,6/11,10.58%,ATP20;ATP14;ATP16;ATP19;ATP15;ATP7
prerank,cell cycle G2/M phase transition (GO:0044839),-0.5857330697394711,-1.0750527654346105,0.4150513112884835,0.968051997496571,1.0,6/20,16.00%,CLB1;CLN2;CLB3;CLB2;CLB6;CLN1
prerank,macroautophagy (GO:0016236),-0.547270701173929,-1.0749423787486299,0.37871033776867963,0.9663644826119347,1.0,7/50,14.16%,ATG14;VPS41;ATG29;VAC8;NFT1;VAM3;ATG16
prerank,negative regulation of DNA-dependent DNA replication (GO:2000104),-0.7067750366997284,-1.0738061931928795,0.4263233190271817,0.9687010927839921,1.0,2/6,10.35%,CHD1;MSH2
prerank,actin cytoskeleton reorganization (GO:0031532),0.640453789976398,1.073494657818978,0.4358974358974359,0.8512337538044333,1.0,3/5,10.29%,RVS161;RHO5;RHO1
prerank,polyol metabolic process (GO:0019751),-0.7201636425636775,-1.0730050731973608,0.4230769230769231,0.9697368226346922,1.0,2/5,21.27%,INM2;IRE1
prerank,siderophore transport (GO:0015891),-0.6714738010510062,-1.0729723681836694,0.4397834912043302,0.967824101755878,1.0,5/8,24.36%,ARN2;FRE4;GEX2;FRE3;ARN1
prerank,lysosomal microautophagy (GO:0016237),-0.5506066999865659,-1.0722625853217533,0.3756558237145855,0.9686592138673003,1.0,10/39,19.81%,ATG14;VPS41;ATG29;OSH6;VAC8;VAM3;ATG16;ATG11;VAM7;ATG8
prerank,RNA metabolic process (GO:0016070),-0.5546286214609047,-1.0714907367657445,0.386128364389234,0.9694866182257587,1.0,5/42,6.21%,AEP3;RFC1;DSS1;MTR4;POL2
prerank,tryptophan biosynthetic process (GO:0000162),-0.726983811564967,-1.0708208429487729,0.4475743348982786,0.9680628604753033,1.0,2/5,8.67%,TRP3;TRP4
prerank,indolalkylamine biosynthetic process (GO:0046219),-0.726983811564967,-1.0708208429487729,0.4475743348982786,0.9680628604753033,1.0,2/5,8.67%,TRP3;TRP4
prerank,fungal-type cell wall organization (GO:0031505),-0.5359374099282301,-1.0697226457509532,0.3336683417085427,0.9702991576094825,1.0,32/96,24.45%,YPS5;PAU2;SKN1;HLR1;ZEO1;CSR2;SKG1;PMT2;TIR4;YPS1;CHS1;LRE1;PIR1;NCA3;DAN1;GAS2;IRS4;SRL1;CMP2;TSC11;TPS2;SPS22;IRE1;GAS1;PAU11;SED1;EXG2;PMT7;SUN4;GPI14;MHP1;PUN1
prerank,telomere maintenance via telomere lengthening (GO:0010833),-0.6149606665073675,-1.0694787672674357,0.40762812872467225,0.9693455738201353,1.0,5/15,19.50%,TOP3;EST3;RIF2;EST2;RFA3
prerank,"pentose-phosphate shunt, oxidative branch (GO:0009051)",-0.6744399319933797,-1.0688714696499109,0.4371508379888268,0.9696176703611558,1.0,3/7,26.47%,SOL2;ZWF1;SOL4
prerank,organophosphate ester transport (GO:0015748),0.4860710908284488,1.0681877636754382,0.3770491803278688,0.856502819316174,1.0,7/14,27.48%,SFH5;UPS2;MDM35;PDR16;PDR17;MDM10;MDM34
prerank,protein N-linked glycosylation via asparagine (GO:0018279),0.6456101619576765,1.0678238299022327,0.453804347826087,0.8449325722651004,1.0,2/5,19.27%,WBP1;OST1
prerank,peptidyl-asparagine modification (GO:0018196),0.6456101619576765,1.0678238299022327,0.453804347826087,0.8449325722651004,1.0,2/5,19.27%,WBP1;OST1
prerank,vacuolar acidification (GO:0007035),-0.5821100410939312,-1.0676201022904226,0.43097643097643096,0.9703222336734036,1.0,6/22,15.53%,VMA1;STV1;VMA6;DBF2;VPH1;RAV2
prerank,intracellular pH reduction (GO:0051452),-0.5821100410939312,-1.0676201022904226,0.43097643097643096,0.9703222336734036,1.0,6/22,15.53%,VMA1;STV1;VMA6;DBF2;VPH1;RAV2
prerank,regulation of DNA recombination (GO:0000018),-0.6136345993005383,-1.0674844009902842,0.42789034564958284,0.9687869652912997,1.0,7/15,26.67%,TOP3;SGS1;SRS2;TOP2;TOP1;PAP2;SPO16
prerank,spindle disassembly (GO:0051230),-0.7125075725462251,-1.0670753588633646,0.4565868263473054,0.9683334478317731,1.0,1/5,10.91%,CDC15
prerank,phosphorylation of RNA polymerase II C-terminal domain (GO:0070816),0.4987619922057158,1.0661340478190193,0.37681159420289856,0.8427580869307022,1.0,1/12,0.34%,SSN3
prerank,DNA metabolic process (GO:0006259),-0.5292225168312683,-1.0652370975951762,0.304,0.973346792933937,1.0,22/162,10.35%,RAD54;TOP3;MGM101;RAD55;THO2;NSE4;RFC1;EAF1;TSA1;PSO2;NOC3;POL2;GBP2;SIR3;BRE2;DPB11;IES3;SMC6;HTA2;SGS1;MET30;MSH2
prerank,nuclear mRNA surveillance of mRNA 3'-end processing (GO:0071031),-0.6821275660979143,-1.0644936037194948,0.44244105409153955,0.9741294954014662,1.0,2/7,7.19%,MTR4;RRP6
prerank,mitochondrial genome maintenance (GO:0000002),-0.5576329244083557,-1.0643335043878928,0.3944856839872747,0.9727077295167746,1.0,8/38,16.90%,GGC1;MGM101;OXA1;HSP78;PIF1;REX2;RIM2;EXO5
prerank,positive regulation of cell growth (GO:0030307),-0.683740298573426,-1.0632809859449937,0.4579310344827586,0.9746821292542202,1.0,1/7,6.59%,KOG1
prerank,protein oligomerization (GO:0051259),0.51365106515793,1.0631554780428454,0.36764705882352944,0.8427098319691331,1.0,4/11,19.41%,ATP20;ATP19;CLC1;ATP18
prerank,sulfur amino acid metabolic process (GO:0000096),-0.648681625333028,-1.0625859400423525,0.4372623574144487,0.9753980784307799,1.0,4/10,15.84%,MET14;SAM1;MET5;SAH1
prerank,negative regulation of gene silencing (GO:0060969),0.6381507730302092,1.0625108427358125,0.447887323943662,0.8379512641551131,1.0,1/5,1.03%,RAP1
prerank,autophagosome organization (GO:1905037),-0.5790509026085447,-1.061833764056889,0.4292185730464326,0.976270159081613,1.0,6/20,19.81%,ATG29;EMC6;ATG16;ATG11;VPS34;ATG8
prerank,G1/S transition of mitotic cell cycle (GO:0000082),-0.5633410115545074,-1.060578186418309,0.42443729903536975,0.9790412978583615,1.0,9/30,14.70%,PPH22;PTK2;SAP185;MET30;CLB6;RRD1;HOS3;VHS1;HRT1
prerank,positive regulation of supramolecular fiber organization (GO:1902905),-0.6237035027605191,-1.0600509583916968,0.4296028880866426,0.9790333149381721,1.0,3/12,5.74%,DUO1;DAD1;TWF1
prerank,regulation of transcription from RNA polymerase II promoter by pheromones (GO:0046019),-0.6189133482513612,-1.0600431316197594,0.4425,0.977071682980244,1.0,4/12,12.15%,PRR2;ISW2;SUB1;CRZ1
prerank,negative regulation of reciprocal meiotic recombination (GO:0045128),-0.7131276012877652,-1.0595908331529527,0.4541284403669725,0.9767521847643432,1.0,3/5,18.38%,SGS1;MSH2;SET2
prerank,regulation of meiotic nuclear division (GO:0040020),-0.6200347336888039,-1.0585242657706588,0.4294478527607362,0.9787532113482162,1.0,5/12,23.35%,CLB1;SET3;SNF3;IME1;RCK2
prerank,DNA repair complex assembly (GO:0090735),-0.6659775029483423,-1.0583923075466073,0.453015427769986,0.9753007851526063,1.0,2/7,16.09%,RAD55;RAD51
prerank,DNA recombinase assembly (GO:0000730),-0.6659775029483423,-1.0583923075466073,0.453015427769986,0.9753007851526063,1.0,2/7,16.09%,RAD55;RAD51
prerank,homocysteine metabolic process (GO:0050667),-0.6706031754783353,-1.0582126055435617,0.44638069705093836,0.9740082742349213,1.0,2/8,9.48%,YLL058W;YML082W
prerank,tRNA aminoacylation (GO:0043039),-0.6720605388950861,-1.0579805526956518,0.46218487394957986,0.972993245253,1.0,2/8,9.05%,MSY1;THS1
prerank,heterochromatin organization (GO:0070828),-0.6603441355394757,-1.0571041880109155,0.4631432545201669,0.9741445078248616,1.0,2/8,7.35%,POL2;SIR3
prerank,protein localization to membrane (GO:0072657),-0.5686463743273678,-1.0562451605374463,0.42075892857142855,0.975343047406839,1.0,7/23,16.63%,NUP145;SPO71;VAC8;NUP100;NUP170;NUP57;EMP70
prerank,autophagy of peroxisome (GO:0030242),-0.6060239862131281,-1.0560030354808463,0.4518879415347138,0.974154261824527,1.0,5/14,18.58%,ATG14;PKC1;MKK2;ATG11;VPS34
prerank,"positive regulation of transcription, DNA-templated (GO:0045893)",-0.5248497451621783,-1.0554462120192998,0.315,0.9741442110356904,1.0,27/177,13.98%,YAK1;NUP120;SWI1;UTP8;GTS1;BAS1;THO2;NUP145;NDT80;ARO80;NUP100;ASP1;ZAP1;PDR1;SFL1;HAL9;YLL054C;SRB7;GIS1;YOR338W;SUB1;CRZ1;PHO2;YKR023W;MET32;MED1;HOS3
prerank,regulation of reciprocal meiotic recombination (GO:0010520),-0.6418184316750201,-1.055190896820807,0.4406779661016949,0.9731290304198889,1.0,6/10,26.67%,SGS1;MSH2;SET2;SLX4;SWI6;SPO16
prerank,"positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay (GO:1900153)",-0.7108343580912084,-1.0551544822707117,0.46907993966817496,0.9713778309367902,1.0,1/5,10.69%,EDC3
prerank,basic amino acid transport (GO:0015802),-0.670058199364474,-1.05489751781778,0.4711815561959654,0.9703918405001916,1.0,3/7,20.80%,VBA4;VBA5;VBA1
prerank,mitochondrial ATP synthesis coupled electron transport (GO:0042775),-0.5603018097889108,-1.0544803627635897,0.43293347873500543,0.9699734010546028,1.0,5/27,13.27%,SDH1;CYT1;COX6;CAT5;SHH4
prerank,fungal-type cell wall biogenesis (GO:0009272),-0.6678650514265106,-1.0541693465635773,0.46554149085794655,0.9692222068911972,1.0,2/8,5.45%,FLC2;FLC1
prerank,regulation of telomerase activity (GO:0051972),0.6366532342938349,1.0541458658403444,0.47648902821316613,0.8501264822030791,1.0,2/5,35.19%,CDC48;UFD1
prerank,ammonium transport (GO:0015696),-0.5833503260616207,-1.0540913600572703,0.41828571428571426,0.9676297837474198,1.0,4/18,11.95%,SAM3;FAA4;MEP1;TPO4
prerank,G2/M transition of mitotic cell cycle (GO:0000086),-0.5696425813502211,-1.0538576165956082,0.4360135900339751,0.9664805159565713,1.0,6/21,16.00%,CLB1;CLN2;CLB3;CLB2;CLB6;CLN1
prerank,regulation of cellular response to amino acid starvation (GO:1903832),-0.6726590809468301,-1.053172764574998,0.4553072625698324,0.9670565952799225,1.0,2/7,13.38%,GCN2;GCN3
prerank,ubiquinone metabolic process (GO:0006743),-0.6142780856246268,-1.0527025590628885,0.46115288220551376,0.9649801564022032,1.0,2/12,11.77%,YAH1;CAT5
prerank,quinone biosynthetic process (GO:1901663),-0.6142780856246268,-1.0527025590628885,0.46115288220551376,0.9649801564022032,1.0,2/12,11.77%,YAH1;CAT5
prerank,"DNA-templated transcription, initiation (GO:0006352)",-0.5750563350228629,-1.052636439153601,0.43666666666666665,0.96334917159787,1.0,2/21,3.25%,TFC3;RRN3
prerank,protein monoubiquitination (GO:0006513),0.48249979285485706,1.052080486125972,0.3811881188118812,0.8483811873784957,1.0,2/12,10.42%,UBC4;PEX4
prerank,exonucleolytic trimming involved in rRNA processing (GO:0000459),-0.5857092426548701,-1.0518894820538627,0.4290617848970252,0.964293586249039,1.0,3/17,7.19%,REX3;MTR4;RRP6
prerank,tRNA aminoacylation for mitochondrial protein translation (GO:0070127),-0.6332934456187007,-1.0518041987659537,0.4548919949174079,0.962736070357365,1.0,2/11,7.42%,MSY1;MSE1
prerank,folic acid-containing compound biosynthetic process (GO:0009396),0.5143266467116769,1.0512519935354,0.4025974025974026,0.8443702403870726,1.0,2/10,13.31%,DFR1;MTD1
prerank,purine ribonucleotide biosynthetic process (GO:0009152),-0.6101199535737797,-1.049061379760114,0.4485749690210657,0.9705746957648558,1.0,4/13,16.29%,IMD3;SIS2;IMD4;VHS3
prerank,"base-excision repair, AP site formation (GO:0006285)",0.6289354042953945,1.0488702003794041,0.4638888888888889,0.8436831734650273,1.0,2/5,26.13%,NTG1;MAG1
prerank,DNA double-strand break processing (GO:0000729),-0.6873022039095795,-1.048852334963442,0.4755927475592748,0.9693409854389813,1.0,1/6,9.77%,SGS1
prerank,protein processing (GO:0016485),-0.5526560262839197,-1.0487453048472046,0.440084835630965,0.967892503723509,1.0,7/33,16.32%,VPS41;RIM8;COX20;YPS1;ENV9;MAS2;PSD1
prerank,histone lysine methylation (GO:0034968),-0.6147614384735092,-1.0485300871379073,0.44499381953028433,0.966764749262033,1.0,2/12,9.12%,BRE2;HHF2
prerank,regulation of growth of unicellular organism as a thread of attached cells (GO:0070784),-0.6862184934268376,-1.048423813511601,0.4692982456140351,0.9652902879044369,1.0,4/6,24.79%,KSP1;KAP123;SDS3;UBA4
prerank,phosphatidylethanolamine metabolic process (GO:0046337),-0.6454777061285577,-1.048159057058027,0.46835443037974683,0.9644321730473964,1.0,3/9,16.32%,FMP30;PSD2;PSD1
prerank,small nucleolar ribonucleoprotein complex assembly (GO:0000491),-0.6518632170738864,-1.047853392776406,0.4620505992010652,0.9637187287913617,1.0,2/9,13.40%,SHQ1;TAH1
prerank,ribonucleoprotein complex assembly (GO:0022618),-0.5222523778155471,-1.0476712308905456,0.372,0.9624968677680823,1.0,14/130,12.19%,RPS5;TMA20;MAK11;SPP381;THO2;SUI2;RPS15;NAM8;RRP5;RPL12A;SSF2;EDC3;IST3;RPS14A
prerank,cellular zinc ion homeostasis (GO:0006882),-0.6507208655874768,-1.0476106510187768,0.455026455026455,0.959044843782193,1.0,1/9,2.96%,IZH3
prerank,zinc ion homeostasis (GO:0055069),-0.6507208655874768,-1.0476106510187768,0.455026455026455,0.959044843782193,1.0,1/9,2.96%,IZH3
prerank,negative regulation of transcription by pheromones (GO:0045996),-0.6495630732398561,-1.0475957044337962,0.4828532235939643,0.9572679358590485,1.0,2/8,10.85%,PRR2;ISW2
prerank,regulation of telomere maintenance via telomerase (GO:0032210),0.5412733167869789,1.0458538590117568,0.41150442477876104,0.8443162330608512,1.0,2/9,5.69%,TGS1;PXR1
prerank,negative regulation of chromatin silencing at telomere (GO:0031939),0.48334911856089663,1.0458051502080312,0.37777777777777777,0.8386447762650976,1.0,6/12,26.40%,WTM2;SIF2;RPD3;YAP5;MCM5;WTM1
prerank,protein localization to organelle (GO:0033365),-0.5832423309728985,-1.0457276008555072,0.4362801377726751,0.9618026687178675,1.0,6/19,23.82%,VPS9;MUK1;GET4;CUR1;IRE1;ARL3
prerank,DNA-templated transcriptional preinitiation complex assembly (GO:0070897),-0.5512568552570468,-1.0452363869268309,0.44089456869009586,0.961771029278043,1.0,6/31,15.42%,SUA7;TAF13;TAF6;TAF3;SUB1;TAF9
prerank,macromolecular complex assembly (GO:0065003),0.3933567381270851,1.0451813547019373,0.36633663366336633,0.8344553698764432,1.0,8/22,9.91%,SKP1;AFG3;VMA9;SAM50;TRS20;SGF73;TCA17;SKI8
prerank,transcription initiation from RNA polymerase II promoter (GO:0006367),-0.5426034778276149,-1.0447031306200925,0.4356020942408377,0.9616923665386288,1.0,6/37,15.42%,SUA7;TAF13;TAF6;TAF3;REB1;TAF9
prerank,mitotic spindle orientation checkpoint (GO:0031578),-0.6266435884294963,-1.044591673706204,0.47388059701492535,0.9603077855402675,1.0,4/11,20.35%,BUB2;RTS1;SPC72;BMH1
prerank,leading strand elongation (GO:0006272),-0.6109698013757476,-1.0437038564773586,0.48203221809169766,0.9614701729558125,1.0,2/12,6.21%,RFC1;POL2
prerank,aspartate family amino acid catabolic process (GO:0009068),-0.6483110676220787,-1.0435606679068843,0.4776902887139108,0.960154937214601,1.0,3/9,22.90%,ASP1;AAT1;SWI6
prerank,cellular protein complex localization (GO:0034629),0.4656034349504582,1.0430645754166485,0.39072847682119205,0.8334047736681601,1.0,3/14,9.52%,CDC7;WTM2;ARL1
prerank,cytoplasmic mRNA processing body assembly (GO:0033962),-0.6839511222467494,-1.0421676261997324,0.4921985815602837,0.9630594916393466,1.0,3/6,24.23%,EDC3;PAT1;LSM3
prerank,ergosterol metabolic process (GO:0008204),-0.567252091199309,-1.0413825306226498,0.45261984392419174,0.9639972939841692,1.0,8/22,20.62%,ERG3;ERG26;GRE2;ERG28;ERG13;HMG2;HMG1;ERG12
prerank,DNA-templated transcriptional open complex formation (GO:0001112),-0.697274688843329,-1.0411267235000399,0.5051698670605613,0.9631601832683515,1.0,1/5,1.99%,SUA7
prerank,positive regulation of phosphorylation (GO:0042327),-0.6868342928790794,-1.0399615153488764,0.5,0.9653394620267503,1.0,3/6,22.88%,DPB11;ATG11;ASC1
prerank,mitotic G2/M transition checkpoint (GO:0044818),-0.6304041327179915,-1.0393130576982006,0.4621409921671018,0.9656622045015895,1.0,3/10,7.93%,POL2;SIR3;DPB11
prerank,protein glycosylation (GO:0006486),-0.5295447675151524,-1.0390971968107174,0.44354018311291965,0.9645299671801467,1.0,13/46,18.67%,OST5;MNN1;MNT4;ANP1;EOS1;MNN5;PMT2;YSY6;SRT1;PSA1;KTR4;ALG9;MNN10
prerank,ribosomal small subunit export from nucleus (GO:0000056),-0.6186259923055384,-1.037720898366843,0.4918444165621079,0.9674128048395613,1.0,1/11,3.27%,NSP1
prerank,regulation of macromolecule metabolic process (GO:0060255),0.42602718555747277,1.0376152578224092,0.37012987012987014,0.8389250576002225,1.0,5/18,17.06%,SLT2;SPP1;ASF1;HOG1;KSS1
prerank,"exonucleolytic trimming to generate mature 3'-end of 5.8S rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000467)",-0.5893455173174551,-1.037072886588612,0.4628975265017668,0.9677835231005991,1.0,3/15,7.19%,REX3;MTR4;RRP6
prerank,glutamine family amino acid catabolic process (GO:0009065),-0.6666231874650773,-1.0363675967747414,0.4868238557558946,0.9683981428883812,1.0,3/7,23.11%,ASP1;SWI6;CAR2
prerank,organic anion transport (GO:0015711),-0.5458565395013943,-1.0363310659343323,0.4676180021953897,0.9667133010638573,1.0,3/27,9.03%,FLC2;FLC1;YPR003C
prerank,cellular protein modification process (GO:0006464),-0.5122962790069249,-1.0360100123258225,0.404,0.9659312521426895,1.0,42/161,20.04%,YAK1;MPS1;GCN2;FMP48;CLA4;PPH22;PKC1;FPK1;PSY2;PNG1;MNN5;KDX1;PTC5;FRK1;PTK2;KSP1;SLI15;DBF2;PRR2;CDC15;RTS1;RAD23;RTK1;YSY6;PSR2;PPQ1;GRX1;SRT1;VHS1;PSA1;MKK2;REF2;CTK3;ALG9;PHO8;VPS34;SSK2;ALK2;HUB1;PKP1;SIW14;YCK1
prerank,negative regulation of macromolecule metabolic process (GO:0010605),-0.677707563240231,-1.035894811916033,0.4943342776203966,0.9645450153067517,1.0,1/6,3.16%,CLA4
prerank,regulation of phospholipid metabolic process (GO:1903725),-0.7011066483334791,-1.034479674099323,0.5172955974842768,0.9674841319816752,1.0,3/5,29.72%,GIS1;SCS22;IST2
prerank,ncRNA 3'-end processing (GO:0043628),-0.6127814383152073,-1.0337313262798566,0.48936170212765956,0.9680717718942926,1.0,3/12,15.82%,REX3;NRD1;REF2
prerank,positive regulation of TORC1 signaling (GO:1904263),-0.6638093419009066,-1.0335066086013571,0.5055096418732782,0.9653353241494592,1.0,2/7,16.02%,MTC5;SEA4
prerank,positive regulation of TOR signaling (GO:0032008),-0.6638093419009066,-1.0335066086013571,0.5055096418732782,0.9653353241494592,1.0,2/7,16.02%,MTC5;SEA4
prerank,rDNA condensation (GO:0070550),-0.6602149184612347,-1.0324307583881775,0.4992867332382311,0.9671467515968812,1.0,1/7,3.43%,SMC4
prerank,ribosome assembly (GO:0042255),-0.5275893662536101,-1.0323152078946063,0.4683673469387755,0.9657715432140919,1.0,6/61,12.19%,RPS5;MAK11;RPS15;RPL12A;SSF2;RPS14A
prerank,cellular response to salt stress (GO:0071472),-0.6006903924419678,-1.0316179416350446,0.4861809045226131,0.9661849441862956,1.0,3/12,14.79%,USV1;PSR2;CTT1
prerank,cellular amino acid biosynthetic process (GO:0008652),-0.6272287801656731,-1.0312415246564544,0.5186666666666667,0.9656840456593546,1.0,2/9,15.80%,MET5;ARO7
prerank,positive regulation of mitochondrial translation (GO:0070131),-0.5957148923753927,-1.0300929897385924,0.48931116389548696,0.9675521814890581,1.0,4/13,12.51%,MSS51;PET111;CBS1;PET309
prerank,cellular cation homeostasis (GO:0030003),-0.6059425492667931,-1.0284239680684333,0.4836759371221282,0.9712452811918241,1.0,4/12,16.29%,SNQ2;FRE8;PCA1;VHS3
prerank,nonfunctional rRNA decay (GO:0070651),-0.5687360708091868,-1.0278374405862667,0.49474912485414235,0.9713978091464839,1.0,4/20,10.53%,DOM34;HBS1;RTT101;XRN1
prerank,pyrimidine-containing compound biosynthetic process (GO:0072528),-0.6482685440672117,-1.027382432391214,0.5033738191632928,0.9710455059837768,1.0,2/8,18.40%,URA8;URH1
prerank,"negative regulation of transcription, DNA-templated (GO:0045892)",-0.513653279401866,-1.0250287569867083,0.4779559118236473,0.9767117914640926,1.0,27/92,21.58%,HIR2;NUP120;YGR122W;SUM1;HIR3;MAF1;WHI5;SRB7;ISW2;RAD23;GIS1;MET32;MED1;YOX1;LEU3;NRM1;EAF3;MOT3;SET2;HTA1;NUP133;SDS3;BMH1;RIM101;RTT106;SAS3;YTA7
prerank,translation (GO:0006412),-0.5051136075180929,-1.0238330442537162,0.411,0.9787689346615754,1.0,39/258,14.86%,RPS5;DOM34;MRPL16;RPL21B;RPL7B;TMA7;RPS15;TIF35;RPL33A;SLH1;HBS1;MRF1;RPL12A;MRPL44;RPL29;RPS4A;MSE1;EFT2;EFT1;YEF3;RPL42A;PTH1;THS1;RPL26A;RPL16B;MRP7;RPL20B;MRPS28;SSA1;RPS14A;SSZ1;RPS22A;TOS4;MRP20;RPP2B;RPL28;RPL18B;RPL31B;RPL9B
prerank,U5 snRNA 3'-end processing (GO:0034476),-0.628092179362573,-1.0237037335554653,0.5111695137976346,0.9774379098725074,1.0,3/9,7.19%,REX3;MTR4;RRP6
prerank,glucan biosynthetic process (GO:0009250),-0.6426749163900551,-1.0234135392141108,0.5073627844712182,0.974793577533157,1.0,1/8,6.75%,PGM1
prerank,glycogen biosynthetic process (GO:0005978),-0.6426749163900551,-1.0234135392141108,0.5073627844712182,0.974793577533157,1.0,1/8,6.75%,PGM1
prerank,cell wall chitin biosynthetic process (GO:0006038),-0.5838763988800627,-1.0228155237221492,0.5131578947368421,0.9748740157126654,1.0,4/13,23.42%,BCH1;CRZ1;BMH1;CHS7
prerank,asparagine metabolic process (GO:0006528),-0.6344491318414736,-1.0227925234377495,0.5126162018592297,0.9732172028190159,1.0,4/9,27.19%,ASP1;NIT3;SWI6;ASN1
prerank,negative regulation of cellular amide metabolic process (GO:0034249),-0.5658305626099969,-1.022606860902011,0.5017301038062284,0.9720987901086023,1.0,7/18,22.88%,NOT5;RPL16B;VTS1;POP2;NOT3;ORM1;ASC1
prerank,establishment of mitotic spindle localization (GO:0040001),-0.6088274197554554,-1.0224037950720728,0.5133418043202033,0.9709631213801881,1.0,3/11,13.04%,NIP100;MYO2;CIK1
prerank,histone ubiquitination (GO:0016574),-0.6426831599480579,-1.0219630535319224,0.5083102493074793,0.9705631186099402,1.0,1/7,4.82%,UBX3
prerank,regulation of transcription from RNA polymerase II promoter (GO:0006357),-0.5050458941089013,-1.0216702531510937,0.435,0.9697526847071543,1.0,38/247,13.98%,YAK1;HIR2;NUP120;YGR122W;SWI1;MGA1;NOT5;GTS1;BAS1;GSM1;IFH1;SUM1;TAF13;NDT80;DOT6;ARO80;ZAP1;PDR1;CSR2;SFL1;SPN1;HAL9;ELP2;YLL054C;SRB7;RSC9;RAD23;GIS1;YOR338W;ELP3;REB1;SUB1;CRZ1;RRD1;PHO2;MET32;MED1;HOS3
prerank,rRNA 5'-end processing (GO:0000967),-0.5471104153164641,-1.0215193427418805,0.49064906490649063,0.9684742416270007,1.0,4/27,6.54%,LOC1;RRP5;BUD21;RCL1
prerank,positive regulation of transcription from RNA polymerase II promoter (GO:0045944),-0.508068068323417,-1.0211058613349235,0.448,0.9681140106058831,1.0,28/195,13.98%,MLP1;YAK1;NUP120;SWI1;NOT5;GTS1;BAS1;PDR8;IFH1;NDT80;ARO80;ZAP1;PDR1;FHL1;SFL1;HAL9;YLL054C;SRB7;WAR1;XRN1;GIS1;YOR338W;SUB1;CRZ1;PHO2;MET32;MED1;HOS3
prerank,'de novo' pyrimidine nucleobase biosynthetic process (GO:0006207),0.6146878692706308,1.020763420251405,0.5028901734104047,0.8678016808892769,1.0,3/5,31.26%,URA10;URA6;URA1
prerank,regulation of autophagy (GO:0010506),-0.596422612928567,-1.0207624413415575,0.49812734082397003,0.9675414438982848,1.0,2/12,8.29%,KOG1;SFL1
prerank,protein complex subunit organization (GO:0071822),0.4480715857099971,1.0206449656961907,0.3888888888888889,0.8624139412765747,1.0,7/16,17.50%,AFG3;NUP49;ASM4;POM33;NUF2;YTA12;NIC96
prerank,negative regulation of apoptotic process (GO:0043066),-0.663322793945962,-1.0203541958550906,0.5212298682284041,0.9671666159957497,1.0,1/6,3.09%,FYV10
prerank,positive regulation of chromosome segregation (GO:0051984),-0.6364672287432943,-1.0202218709482624,0.5187165775401069,0.9658666704836358,1.0,3/8,14.25%,DUO1;DAD1;ASK1
prerank,coenzyme biosynthetic process (GO:0009108),-0.539643483999999,-1.0200989747253857,0.5057833859095688,0.9645520805867114,1.0,4/30,10.82%,SNO3;SPE1;SIS2;SAM1
prerank,tRNA metabolic process (GO:0006399),-0.5850665223262439,-1.0192338810723072,0.5041916167664671,0.9655561579990991,1.0,1/16,0.90%,MSY1
prerank,"endonucleolytic cleavage to generate mature 5'-end of SSU-rRNA from (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000472)",-0.5495404949822624,-1.018912924238969,0.4977827050997783,0.9649391654957576,1.0,4/25,6.54%,LOC1;RRP5;BUD21;RCL1
prerank,inositol metabolic process (GO:0006020),-0.6589195317909544,-1.0187611610538574,0.515625,0.9637213524730509,1.0,3/6,28.01%,INM2;IRE1;INO1
prerank,ribosome localization (GO:0033750),-0.6096955616739616,-1.018423772259379,0.50125,0.9630370064141466,1.0,1/11,3.70%,RNA1
prerank,"nuclear-transcribed mRNA catabolic process, endonucleolytic cleavage-dependent decay (GO:0000294)",0.5407482048414589,1.0183160803525997,0.4727272727272727,0.8615940680611789,1.0,2/8,16.54%,POP7;POP1
prerank,ribosomal small subunit biogenesis (GO:0042274),-0.5172506356187361,-1.017742859689878,0.4989816700610998,0.9632856835380212,1.0,6/56,6.79%,RPS5;PRP43;RPS15;RRP5;SGD1;NEW1
prerank,mitotic spindle assembly (GO:0090307),-0.6452887220837146,-1.016379826917787,0.5216251638269986,0.9657432753386637,1.0,3/8,14.52%,KIP1;CIN8;SPC97
prerank,transcription from RNA polymerase III promoter (GO:0006383),-0.5522880492422931,-1.016254384432759,0.5060773480662983,0.9644446811954673,1.0,8/24,18.87%,TFC3;RPC82;TFC4;RPB10;RPB5;RPC53;RPC40;TFC7
prerank,mitochondrial transmembrane transport (GO:1990542),0.49780207352948563,1.014911713030461,0.42924528301886794,0.8623785245934975,1.0,4/10,6.21%,TIM12;MGR2;TIM13;TIM54
prerank,(1->6)-beta-D-glucan biosynthetic process (GO:0006078),-0.6861108437874672,-1.0135451944294989,0.5598159509202454,0.9694781734007534,1.0,1/5,4.44%,SKN1
prerank,(1->6)-beta-D-glucan metabolic process (GO:0006077),-0.6861108437874672,-1.0135451944294989,0.5598159509202454,0.9694781734007534,1.0,1/5,4.44%,SKN1
prerank,negative regulation of cytoskeleton organization (GO:0051494),0.5997895472505423,1.0130714954211106,0.5107692307692308,0.8609613123983535,1.0,2/5,20.28%,SWE1;EFB1
prerank,regulation of TOR signaling (GO:0032006),0.6110884358336763,1.0129304745021968,0.5013698630136987,0.855691471335735,1.0,4/5,37.88%,CDC60;GTR2;GTR1;HSF1
prerank,cofactor biosynthetic process (GO:0051188),-0.5614791183761358,-1.011680466372381,0.5218390804597701,0.9734970871323165,1.0,3/19,11.07%,SSQ1;YAH1;JAC1
prerank,tRNA methylation (GO:0030488),-0.566854373021057,-1.0115670406635369,0.5067720090293454,0.9721770427251923,1.0,4/18,12.60%,TYW3;PPM2;GCD14;ABP140
prerank,regulation of cellular catabolic process (GO:0031329),-0.6846428302566655,-1.0115502028454466,0.5464743589743589,0.9705765695166194,1.0,1/5,6.59%,KOG1
prerank,mitochondria-associated ubiquitin-dependent protein catabolic process (GO:0072671),0.5934923479714567,1.0103530627758333,0.5311653116531165,0.8557916940097644,1.0,1/5,1.48%,VMS1
prerank,selective autophagy (GO:0061912),0.4889929249551966,1.0097051019959016,0.45188284518828453,0.851745500798633,1.0,1/10,0.22%,UBP3
prerank,water-soluble vitamin biosynthetic process (GO:0042364),-0.5629620522116299,-1.0095212351140967,0.5212527964205816,0.9749699950084643,1.0,2/20,3.47%,SNO3;SPE1
prerank,histone acetylation (GO:0016573),-0.5279779616818784,-1.008853800367049,0.5042283298097252,0.9753510825028013,1.0,11/34,23.91%,HAT1;TAF6;AHC1;TAF9;SWC4;EAF3;SAS3;ACS2;ELP4;TAF5;SPT7
prerank,Golgi vesicle transport (GO:0048193),-0.503194591671295,-1.008773060094672,0.5125376128385155,0.9739451736047355,1.0,18/109,15.33%,SAR1;EMP46;GTS1;NEO1;RET3;ENT5;YPT32;TRS120;SLY1;YIF1;SMY2;SOP4;COY1;ERV25;AVL9;UIP5;YET2;AGE1
prerank,nuclear-transcribed mRNA catabolic process (GO:0000956),-0.5048041913617685,-1.0086082104263656,0.5081135902636917,0.9727456685365355,1.0,17/74,17.97%,DOM34;YGR122W;NOT5;HBS1;PAN2;GBP2;RRP6;SIR3;NRD1;XRN1;CDC33;VTS1;DCS1;PAT1;DBP2;POP2;NOT3
prerank,positive regulation of peptidyl-lysine acetylation (GO:2000758),-0.663959482661352,-1.0085332921366086,0.5411255411255411,0.9680366478356337,1.0,3/6,18.38%,HIR3;YOR338W;SET2
prerank,regulation of histone acetylation (GO:0035065),-0.663959482661352,-1.0085332921366086,0.5411255411255411,0.9680366478356337,1.0,3/6,18.38%,HIR3;YOR338W;SET2
prerank,positive regulation of histone acetylation (GO:0035066),-0.663959482661352,-1.0085332921366086,0.5411255411255411,0.9680366478356337,1.0,3/6,18.38%,HIR3;YOR338W;SET2
prerank,iron-sulfur cluster assembly (GO:0016226),-0.5646463263797254,-1.007722167817205,0.5348027842227379,0.9670655180004372,1.0,3/18,11.07%,SSQ1;YAH1;JAC1
prerank,metallo-sulfur cluster assembly (GO:0031163),-0.5646463263797254,-1.007722167817205,0.5348027842227379,0.9670655180004372,1.0,3/18,11.07%,SSQ1;YAH1;JAC1
prerank,tricarboxylic acid metabolic process (GO:0072350),-0.687053876959214,-1.0065896942128447,0.5542347696879644,0.9687447769953347,1.0,3/5,22.79%,CIT2;CIT1;IDP2
prerank,regulation of sterol import by regulation of transcription from RNA polymerase II promoter (GO:0035968),-0.6492676544098765,-1.0064236480346753,0.5635838150289018,0.9675930928564233,1.0,1/6,3.16%,CLA4
prerank,positive regulation of cellular catabolic process (GO:0031331),-0.634250953591674,-1.0059796932709046,0.551490514905149,0.9672394373495866,1.0,3/8,25.62%,SFL1;GAT1;PIP2
prerank,negative regulation of DNA biosynthetic process (GO:2000279),0.5099812343028548,1.0049975109815925,0.4703389830508475,0.8553708025963849,1.0,3/9,9.97%,PXR1;SIR2;PNC1
prerank,"mitochondrial electron transport, succinate to ubiquinone (GO:0006121)",-0.664796557333747,-1.0049774473448345,0.537117903930131,0.9684376420866254,1.0,2/6,13.27%,SDH1;SHH4
prerank,negative regulation of cellular protein metabolic process (GO:0032269),-0.561352847586254,-1.0048249484275638,0.5186480186480187,0.9672655446516972,1.0,5/18,17.97%,NOT5;RPL16B;VTS1;POP2;NOT3
prerank,bipolar cellular bud site selection (GO:0007121),-0.619853497569734,-1.0047283413553671,0.538562091503268,0.9659342960920013,1.0,4/9,26.04%,VRP1;BUD6;RSR1;SPH1
prerank,heterochromatin organization involved in chromatin silencing (GO:0070868),-0.5956522645005842,-1.0045854285288647,0.5226700251889169,0.9647303626530558,1.0,8/11,30.23%,POL2;NUP170;GIC1;RTT106;DPB2;DPB4;DLS1;ISW1
prerank,cellular lipid biosynthetic process (GO:0097384),-0.5513548542850174,-1.0034700351714585,0.518140589569161,0.9615613110979392,1.0,7/20,20.62%,ERG3;ERG26;ERG28;ERG13;HMG2;HMG1;ERG12
prerank,cellular alcohol biosynthetic process (GO:0044108),-0.5513548542850174,-1.0034700351714585,0.518140589569161,0.9615613110979392,1.0,7/20,20.62%,ERG3;ERG26;ERG28;ERG13;HMG2;HMG1;ERG12
prerank,ergosterol biosynthetic process (GO:0006696),-0.5513548542850174,-1.0034700351714585,0.518140589569161,0.9615613110979392,1.0,7/20,20.62%,ERG3;ERG26;ERG28;ERG13;HMG2;HMG1;ERG12
prerank,phytosteroid biosynthetic process (GO:0016129),-0.5513548542850174,-1.0034700351714585,0.518140589569161,0.9615613110979392,1.0,7/20,20.62%,ERG3;ERG26;ERG28;ERG13;HMG2;HMG1;ERG12
prerank,nitrogen compound transport (GO:0071705),-0.5222995011798832,-1.0032819376851225,0.5131440588853838,0.9605045770397082,1.0,6/38,10.60%,AVT1;THI72;MEP1;TPO5;PTK2;AZR1
prerank,calcium ion transport (GO:0006816),-0.6565021806718299,-1.0029610166613383,0.5574712643678161,0.9598213356642137,1.0,4/6,23.24%,VNX1;PMC1;PMR1;ECM7
prerank,cellular protein localization (GO:0034613),-0.49972765560717686,-1.00128717237583,0.5045135406218656,0.9630036678144764,1.0,25/97,20.57%,BUD4;SAR1;ATG29;RET3;YPT32;ECM30;GYP7;BUB2;VPS35;APL3;KSP1;SLO1;RTS1;GSF2;PIR1;VAM3;ERV25;GYP6;EMP70;ATG11;RAS1;VAM7;ATG8;RIC1;CUR1
prerank,positive regulation of translational initiation (GO:0045948),0.5960002442638944,1.0006506265479658,0.5235294117647059,0.8582759528167448,1.0,3/5,7.24%,CDC123;RPB4;HYP2
prerank,phosphate-containing compound metabolic process (GO:0006796),-0.5242274383726272,-0.9991580885921071,0.5312169312169313,0.9674426974547122,1.0,6/32,14.10%,SPO14;TGL4;GUT1;PGM1;PHO3;YSA1
prerank,regulation of cellular amino acid metabolic process (GO:0006521),-0.6630794097215017,-0.9984822008574011,0.5427728613569321,0.9677415763415967,1.0,2/5,13.13%,CAR1;MET32
prerank,negative regulation of meiotic nuclear division (GO:0045835),-0.6086704280992361,-0.9983647756223998,0.5380577427821522,0.9664726147359036,1.0,4/10,22.19%,SET3;SNF3;PCH2;FPR3
prerank,nuclear mRNA surveillance (GO:0071028),-0.5494086932430451,-0.9977735274532303,0.5241301907968574,0.966577986428415,1.0,4/21,9.17%,MTR4;GBP2;RRP6;NRD1
prerank,ion transport (GO:0006811),-0.6613287898400246,-0.9974052646506124,0.5568022440392707,0.9660315958943552,1.0,4/6,32.70%,PMP3;POR2;POR1;ALR2
prerank,"positive regulation of DNA-templated transcription, elongation (GO:0032786)",-0.5175521353919347,-0.9972575224564605,0.5314757481940144,0.9648642526396837,1.0,9/37,20.08%,NOT5;THO2;XRN1;SUB1;CTK3;POP2;NOT3;VPS34;ELC1
prerank,alpha-amino acid biosynthetic process (GO:1901607),-0.5277099035420966,-0.9967425499377435,0.5377875136911281,0.964711990564793,1.0,6/28,15.80%,SER3;TRP3;ARO9;TRP4;PHO2;ARO7
prerank,secondary alcohol biosynthetic process (GO:1902653),-0.5433523046350215,-0.9965887174071713,0.5206703910614525,0.9635991705749885,1.0,7/21,20.62%,ERG3;ERG26;ERG28;ERG13;HMG2;HMG1;ERG12
prerank,cellular protein complex disassembly (GO:0043624),-0.5545962988910442,-0.9964416287528073,0.5528735632183908,0.9624494892395682,1.0,3/18,8.16%,TIF35;MRF1;YEF3
prerank,cellular calcium ion homeostasis (GO:0006874),-0.5969701098773845,-0.9957729441313471,0.5653798256537983,0.9626410932088336,1.0,4/11,17.21%,VNX1;ECM27;PMC1;PMR1
prerank,Ras protein signal transduction (GO:0007265),-0.5248066881667622,-0.9950670242802107,0.5392051557465092,0.9630449760722498,1.0,4/29,10.04%,CLA4;YPT32;CDC25;CYR1
prerank,positive regulation of microtubule polymerization or depolymerization (GO:0031112),-0.6198329636450781,-0.9937669176885168,0.5542483660130719,0.9635080319674837,1.0,2/8,4.95%,DUO1;DAD1
prerank,positive regulation of microtubule polymerization (GO:0031116),-0.6198329636450781,-0.9937669176885168,0.5542483660130719,0.9635080319674837,1.0,2/8,4.95%,DUO1;DAD1
prerank,regulation of formin-nucleated actin cable assembly (GO:0090337),-0.6063486527959772,-0.9929148946710082,0.5600522193211488,0.9642119528310082,1.0,5/9,18.35%,KEL1;GIC2;BUD6;HOF1;KEL2
prerank,Golgi to plasma membrane transport (GO:0006893),-0.5265170884157487,-0.9923860480152445,0.5450597176981542,0.9641796636718543,1.0,9/29,26.00%,SEC15;RSN1;BCH1;IMH1;SRO77;SEC5;ARL3;SRO7;ARF2
prerank,transcription of nuclear large rRNA transcript from RNA polymerase I promoter (GO:0042790),-0.5731885983880829,-0.9906048987490356,0.5440289505428226,0.9674914340766156,1.0,3/13,12.66%,RPA135;RRN9;RPA49
prerank,organic cyclic compound catabolic process (GO:1901361),-0.6427630161424585,-0.9895859155801122,0.5424460431654676,0.9686393198046468,1.0,3/6,19.54%,ARO80;POT1;DAL7
prerank,pentose-phosphate shunt (GO:0006098),-0.5758635837601578,-0.9883177675944508,0.5559655596555966,0.9705347497165088,1.0,5/13,21.56%,TKL1;SOL2;ZWF1;RPE1;RKI1
prerank,cell wall beta-glucan biosynthetic process (GO:0034410),-0.6601931200818092,-0.986179724192667,0.5699708454810496,0.9686039193120335,1.0,3/5,28.53%,GAS2;GAS1;GAS5
prerank,fungal-type cell wall (1->3)-beta-D-glucan biosynthetic process (GO:0071970),-0.6601931200818092,-0.986179724192667,0.5699708454810496,0.9686039193120335,1.0,3/5,28.53%,GAS2;GAS1;GAS5
prerank,cell wall (1->3)-beta-D-glucan metabolic process (GO:0034407),-0.6601931200818092,-0.986179724192667,0.5699708454810496,0.9686039193120335,1.0,3/5,28.53%,GAS2;GAS1;GAS5
prerank,fungal-type cell wall (1->3)-beta-D-glucan metabolic process (GO:0071969),-0.6601931200818092,-0.986179724192667,0.5699708454810496,0.9686039193120335,1.0,3/5,28.53%,GAS2;GAS1;GAS5
prerank,cell wall (1->3)-beta-D-glucan biosynthetic process (GO:0034411),-0.6601931200818092,-0.986179724192667,0.5699708454810496,0.9686039193120335,1.0,3/5,28.53%,GAS2;GAS1;GAS5
prerank,pantothenate biosynthetic process (GO:0015940),-0.6474067144286098,-0.9860063195740367,0.5588235294117647,0.9675619843414006,1.0,1/6,3.47%,SPE1
prerank,organelle assembly (GO:0070925),-0.497773430143682,-0.9857884596532607,0.5575757575757576,0.9666242755280796,1.0,13/60,21.07%,MPS1;THO2;ATG29;VAC8;EMC6;EDC3;PAT1;ATG11;MIF2;VPS34;ATG8;PUB1;CBF2
prerank,cellular hyperosmotic salinity response (GO:0071475),-0.6679520148865077,-0.985023555221781,0.5959752321981424,0.9670722395211772,1.0,3/5,31.85%,CRZ1;HOT1;MSN2
prerank,"endonucleolytic cleavage in 5'-ETS of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000480)",-0.5311286296601772,-0.9850101393138021,0.5430167597765363,0.9655894725726795,1.0,3/24,6.54%,LOC1;RRP5;RCL1
prerank,fatty acid metabolic process (GO:0006631),-0.5668043554085991,-0.9848465736385483,0.5548996458087367,0.9645179590815298,1.0,2/15,11.39%,OAR1;PEX11
prerank,ERAD pathway (GO:0036503),0.3256083402192116,0.9841117255132082,0.5277777777777778,0.8872756657595179,1.0,6/46,2.76%,RPT2;YOS9;VMS1;RPT5;RPT3;SHP1
prerank,"nucleotide-excision repair, DNA incision (GO:0033683)",-0.6169967830484794,-0.9839891022669823,0.5634807417974322,0.9652335859018852,1.0,1/7,7.80%,RAD2
prerank,actin cortical patch assembly (GO:0000147),0.44100024037900026,0.9831543709805892,0.42105263157894735,0.8838630667572083,1.0,3/12,9.37%,SLA1;ARK1;ARC19
prerank,pyrimidine nucleobase biosynthetic process (GO:0019856),-0.6303507045508069,-0.9828518645712854,0.579250720461095,0.9667028914322099,1.0,1/7,10.80%,URA8
prerank,regulation of invasive growth in response to glucose limitation (GO:2000217),-0.635660931489525,-0.9824326616451616,0.5821529745042493,0.9662409381687107,1.0,3/7,24.52%,SDS3;YTA7;GAL11
prerank,ribosomal large subunit assembly (GO:0000027),-0.5152046911520838,-0.9818258377154239,0.5647181628392485,0.9663202393349242,1.0,4/37,9.82%,MAK11;RRP5;RPL12A;SSF2
prerank,spliceosomal conformational changes to generate catalytic conformation (GO:0000393),-0.537807474047018,-0.9812471414713153,0.5438799076212472,0.9663806012993089,1.0,2/18,11.30%,SPP381;IST3
prerank,fungal-type cell wall beta-glucan biosynthetic process (GO:0070880),-0.6211125647311688,-0.9810707994346216,0.5774278215223098,0.9653489353920808,1.0,3/8,28.53%,GAS2;GAS1;GAS5
prerank,regulation of mitotic recombination (GO:0000019),-0.6361811650515974,-0.9808165378902823,0.5746799431009957,0.9645270019908674,1.0,3/6,22.77%,SGS1;TOP2;TOP1
prerank,protein localization to chromosome (GO:0034502),-0.5515396370842046,-0.9802708782471269,0.5656324582338902,0.9644099952734556,1.0,2/16,10.94%,TFC3;RTS1
prerank,cellular divalent inorganic cation homeostasis (GO:0072503),-0.5408961504201792,-0.9801186237747103,0.5582959641255605,0.9632839702052668,1.0,5/22,17.21%,IZH3;VNX1;ECM27;PMC1;PMR1
prerank,protein targeting to mitochondrion (GO:0006626),0.3146567312470154,0.9799702426610668,0.4166666666666667,0.8845650897519589,1.0,12/53,8.87%,SAM35;MIC60;TIM12;MGR2;TIM44;AFG3;STI1;TIM13;TIM54;SAM50;MAS1;TIM21
prerank,cellular response to glucose stimulus (GO:0071333),0.5246721041455058,0.9760841372713762,0.5036764705882353,0.8764140288515087,1.0,2/7,5.63%,GPA2;RGT2
prerank,glucose mediated signaling pathway (GO:0010255),0.5246721041455058,0.9760841372713762,0.5036764705882353,0.8764140288515087,1.0,2/7,5.63%,GPA2;RGT2
prerank,hexose mediated signaling (GO:0009757),0.5246721041455058,0.9760841372713762,0.5036764705882353,0.8764140288515087,1.0,2/7,5.63%,GPA2;RGT2
prerank,DNA-dependent DNA replication maintenance of fidelity (GO:0045005),-0.5830502139128344,-0.9759096278449663,0.5857687420584498,0.9725163450835066,1.0,4/11,10.35%,POL2;SGS1;RTT101;MSH2
prerank,cellular response to starvation (GO:0009267),-0.5184909133351774,-0.9751632838229816,0.5644104803493449,0.9729941293760171,1.0,5/28,15.17%,GSM1;PHM8;KOG1;IRS4;DCS1
prerank,protein-DNA complex assembly (GO:0065004),-0.5500130886285741,-0.9741229969088985,0.5534441805225653,0.9741515650853593,1.0,6/16,26.80%,RAD55;RAD51;CAC2;FPR3;NAP1;PSY3
prerank,fungal-type cell wall polysaccharide biosynthetic process (GO:0051278),-0.5365921758918215,-0.9732755641012104,0.5839909808342728,0.9746453779699388,1.0,5/20,23.42%,BCH1;GAS2;BMH1;GAS1;CHS7
prerank,cellular transition metal ion homeostasis (GO:0046916),-0.49311951028814516,-0.9729070371428254,0.5959390862944163,0.9741068385069744,1.0,15/59,19.12%,GGC1;PIC2;IZH3;ARN2;UTR1;FRE4;OCT1;PCA1;SLF1;GEX2;EMP70;PMR1;FRE6;HMX1;GRX4
prerank,glycoprotein biosynthetic process (GO:0009101),-0.5470136992614566,-0.9722000940444141,0.5539906103286385,0.9743890619203865,1.0,7/16,23.73%,MNN5;YSY6;SRT1;PSA1;ALG9;YND1;ERD1
prerank,rRNA 3'-end processing (GO:0031125),-0.5348272484897869,-0.970492929371368,0.5791245791245792,0.977186814716448,1.0,3/20,7.19%,REX3;MTR4;RRP6
prerank,regulation of translational termination (GO:0006449),-0.6193734279678034,-0.9702604970823502,0.5852660300136425,0.9762064403970058,1.0,1/7,4.73%,ITT1
prerank,chromatin organization involved in negative regulation of transcription (GO:0097549),-0.6126659576124869,-0.9656146677878611,0.574438202247191,0.986254945624464,1.0,4/7,25.75%,POL2;GIC1;DPB2;DPB4
prerank,sister chromatid biorientation (GO:0031134),-0.6179089895389651,-0.9654582675067845,0.5794655414908579,0.9851799167979637,1.0,2/7,10.94%,MPS1;RTS1
prerank,acetyl-CoA biosynthetic process (GO:0006085),-0.6337092077682497,-0.9643712787980926,0.5988200589970502,0.9865575099640572,1.0,4/6,29.87%,LAT1;PDA1;ACS2;PDB1
prerank,cellular bud site selection (GO:0000282),-0.5027977493467247,-0.9631982707045668,0.5881104033970276,0.987807810204485,1.0,3/33,9.95%,BUD4;BCH1;VRP1
prerank,maturation of LSU-rRNA (GO:0000470),-0.49498128352275056,-0.963097000889145,0.5908141962421712,0.9865228359105648,1.0,3/42,2.55%,RPL7B;MAK11;PRP43
prerank,termination of RNA polymerase II transcription (GO:0006369),-0.537183723632667,-0.9626620319168008,0.5790094339622641,0.9860827841501669,1.0,6/19,15.82%,CHD1;NRD1;ISW2;REB1;SUB1;REF2
prerank,nuclear RNA surveillance (GO:0071027),-0.5620216453506464,-0.9621175238251202,0.5844471445929527,0.9859587851701249,1.0,3/13,9.17%,GBP2;RRP6;NRD1
prerank,steroid metabolic process (GO:0008202),-0.5745387456726174,-0.9620012497416022,0.6094527363184079,0.9847398124617371,1.0,3/11,20.62%,OSH6;ATG26;ERG12
prerank,negative regulation of chromatin organization (GO:1905268),-0.59981194819271,-0.9618504151691353,0.6011004126547456,0.9836180360504697,1.0,1/8,2.51%,CHD1
prerank,double-strand break repair via homologous recombination (GO:0000724),-0.49395004713197543,-0.9615818290233443,0.6194871794871795,0.9828310114204685,1.0,11/50,19.50%,RAD54;SMC3;DPB11;SMC6;SGS1;RSC2;AHC1;PIF1;MCM3;PSF3;RFA3
prerank,chromatin silencing at silent mating-type cassette (GO:0030466),-0.5075038920962492,-0.9605959350825117,0.5942796610169492,0.9836917537993736,1.0,5/32,10.35%,NUP60;SUM1;SIR3;SCP160;MSH2
prerank,purine nucleotide metabolic process (GO:0006163),-0.5645510969262637,-0.9605473886401147,0.5714285714285714,0.982324285736698,1.0,4/13,17.50%,ADE16;AMD1;ADE8;ADE6
prerank,tRNA modification (GO:0006400),-0.4910753730827313,-0.9589615268121423,0.6193415637860082,0.984771216819102,1.0,6/46,12.60%,DEG1;TYW3;PPM2;MOD5;GCD14;ABP140
prerank,regulation of ubiquitin protein ligase activity (GO:1904666),-0.6453686915057537,-0.9588792242486438,0.6114551083591331,0.9835035437208821,1.0,2/5,22.21%,BMH1;DOC1
prerank,membrane lipid biosynthetic process (GO:0046467),-0.5394962320403678,-0.9583683655684988,0.5935334872979214,0.983242836052429,1.0,3/17,5.45%,FLC2;SKN1;FLC1
prerank,cellular iron ion homeostasis (GO:0006879),-0.4983362725585257,-0.9580698924146358,0.6117523609653726,0.9810602135639327,1.0,10/37,19.12%,GGC1;ARN2;UTR1;FRE4;OCT1;PCA1;GEX2;FRE6;HMX1;GRX4
prerank,iron ion homeostasis (GO:0055072),-0.4983362725585257,-0.9580698924146358,0.6117523609653726,0.9810602135639327,1.0,10/37,19.12%,GGC1;ARN2;UTR1;FRE4;OCT1;PCA1;GEX2;FRE6;HMX1;GRX4
prerank,endoplasmic reticulum organization (GO:0007029),-0.5112913879274521,-0.9580486739697457,0.5897155361050328,0.9796492868510988,1.0,7/25,23.04%,EMP46;RTN1;UIP5;GET4;SEC5;SWC3;SCS22
prerank,sterol biosynthetic process (GO:0016126),-0.5135915531355153,-0.9571408295809612,0.5932754880694143,0.9803841590684202,1.0,2/26,1.84%,ERG3;ERG26
prerank,regulation of protein localization (GO:0032880),-0.5291528697449033,-0.9570017587634821,0.6013745704467354,0.9792989517247283,1.0,3/19,16.54%,PTP3;DBF2;BUD6
prerank,coenzyme A metabolic process (GO:0015936),-0.5991554747410841,-0.9567579969054214,0.6046511627906976,0.9783947677948357,1.0,2/8,16.29%,SIS2;VHS3
prerank,peptidyl-serine phosphorylation (GO:0018105),-0.5055067602172978,-0.9557913719824332,0.6002155172413793,0.979111962793469,1.0,6/29,20.04%,PKH1;PKC1;DBF2;VHS1;PKP1;YCK1
prerank,DNA-dependent DNA replication (GO:0006261),-0.48207175315569123,-0.9549286640062977,0.6194871794871795,0.9796512290152515,1.0,18/58,23.64%,SWI1;NOC3;POL2;SIR3;DPB11;SGS1;MET30;SLX1;SUV3;MCM3;TOP2;PSF3;RFA3;SLX4;SAK1;TOP1;DPB2;RFC2
prerank,IMP biosynthetic process (GO:0006188),-0.5872634630723494,-0.9548979734497907,0.6153846153846154,0.9782976066656068,1.0,5/9,20.37%,ADE16;XPT1;ADE8;ADE6;HPT1
prerank,"endonucleolytic cleavage in ITS1 to separate SSU-rRNA from 5.8S rRNA and LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000447)",-0.49450196963932114,-0.9524921030913787,0.60695468914647,0.9823999347159083,1.0,4/36,6.54%,LOC1;RRP5;BUD21;RCL1
prerank,negative regulation of actin nucleation (GO:0051126),0.517058830398375,0.9522258793975101,0.5387205387205387,0.9129460665157024,1.0,1/6,0.74%,SLA1
prerank,negative regulation of Arp2/3 complex-mediated actin nucleation (GO:0034316),0.517058830398375,0.9522258793975101,0.5387205387205387,0.9129460665157024,1.0,1/6,0.74%,SLA1
prerank,"termination of RNA polymerase II transcription, exosome-dependent (GO:0030847)",0.519357384412292,0.9513535590880995,0.5268817204301075,0.9092846713280267,1.0,1/7,0.04%,GLC7
prerank,ER to Golgi vesicle-mediated transport (GO:0006888),-0.479183887692545,-0.9509495231760612,0.6511627906976745,0.9845662316614305,1.0,15/71,19.81%,SAR1;EMP46;GTS1;SLY1;YIF1;SMY2;SOP4;ERV25;UIP5;YET2;AGE1;YET1;RUD3;BET5;ATG8
prerank,protein catabolic process in the vacuole (GO:0007039),0.45798300836893435,0.9504395943976393,0.4888888888888889,0.9056372069186318,1.0,4/10,23.58%,PRC1;PRB1;YGR066C;PAI3
prerank,sulfate transport (GO:0008272),-0.6208854848069435,-0.9498855568894851,0.6057553956834533,0.9855878690227718,1.0,2/6,9.03%,SUL2;YPR003C
prerank,regulation of response to DNA damage stimulus (GO:2001020),-0.6083316731285128,-0.9493916586337781,0.6165730337078652,0.985267469865472,1.0,2/7,4.37%,NSE4;RTT107
prerank,negative regulation of transcription from RNA polymerase II promoter (GO:0000122),-0.47188964129194166,-0.9492787888479368,0.6636636636636637,0.9840619797318038,1.0,18/110,13.42%,HIR2;NUP120;YGR122W;SUM1;DOT6;MAF1;FHL1;SFL1;MOD5;HHF2;SRB7;PRR2;RSC9;ISW2;RAD23;GIS1;MET32;MED1
prerank,regulation of DNA replication (GO:0006275),-0.6123191262602703,-0.948954183494228,0.6148459383753502,0.983360135260182,1.0,3/7,13.47%,DOA4;CLB6;DCC1
prerank,positive regulation of phospholipid biosynthetic process (GO:0071073),0.5551685031730991,0.9484514746112447,0.5830618892508144,0.9041750083499376,1.0,3/6,30.37%,SPO7;PDR17;NEM1
prerank,regulation of transport (GO:0051049),-0.6082439631075885,-0.9482274564991486,0.5973254086181278,0.9836167931969926,1.0,3/6,18.47%,KEL1;KEL2;ALY2
prerank,"nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay (GO:0000288)",-0.5048792176084504,-0.9477851062862802,0.6054644808743169,0.9832165507666817,1.0,7/24,17.97%,NOT5;PAN2;VTS1;DCS1;PAT1;POP2;NOT3
prerank,glycolipid biosynthetic process (GO:0009247),0.3554070022383739,0.9473704571219747,0.5089285714285714,0.9009419492542333,1.0,7/23,18.56%,CSH1;DPM1;GPI19;GPI12;ACP1;ERI1;PER1
prerank,negative regulation of nitrogen compound metabolic process (GO:0051172),0.5499328029880732,0.9461475787147209,0.5718475073313783,0.8981322157293672,1.0,2/5,11.68%,UPS2;YPK1
prerank,cellular response to alkaline pH (GO:0071469),-0.6146113829554005,-0.9459783544601066,0.611271676300578,0.9857629668648128,1.0,2/6,20.60%,CRZ1;RIM101
prerank,positive regulation of protein polymerization (GO:0032273),-0.5844582058905536,-0.9455796579438406,0.6344916344916345,0.9853011645003047,1.0,2/9,4.95%,DUO1;DAD1
prerank,ribose phosphate metabolic process (GO:0019693),-0.5930046977542066,-0.9454544664820417,0.6108108108108108,0.9841307733893065,1.0,4/8,21.56%,TKL1;YSA1;RPE1;RKI1
prerank,positive regulation of cellular component organization (GO:0051130),-0.6183700073046858,-0.9451853845321778,0.6329479768786127,0.983265300879576,1.0,2/6,10.74%,FPK1;ROM2
prerank,protein ubiquitination (GO:0016567),-0.47919704800085555,-0.9451098104486267,0.6527494908350305,0.9820013408578723,1.0,14/64,20.44%,NOT5;PEX10;APC9;ITT1;APC1;MET30;SSA1;RAD5;HRT1;HUL4;NOT3;RFA3;HEL2;DEF1
prerank,regulation of signal transduction (GO:0009966),-0.5854162978725737,-0.9449497145144258,0.6133879781420765,0.9809665236134524,1.0,2/8,13.94%,PMT2;YJU3
prerank,spliceosomal complex assembly (GO:0000245),-0.5334353301882213,-0.9443477887769668,0.6283084004602992,0.9808945681961447,1.0,4/17,22.61%,NAM8;IST3;PRP24;HSH155
prerank,N-glycan processing (GO:0006491),-0.609220302951629,-0.9436468377464603,0.6277777777777778,0.9810937953381486,1.0,1/7,4.93%,MNN1
prerank,cellular response to DNA damage stimulus (GO:0006974),-0.4670465569729477,-0.9420274606763727,0.6746746746746747,0.9831520169013104,1.0,29/119,22.39%,MGM101;GCN2;NSE4;RFC1;EAF1;TSA1;PSO2;PSY2;SMC6;HTA2;SGS1;RRD1;DCC1;TOS4;SRS2;SWC4;PDS5;EAF3;IRC21;HOF1;HTA1;RFA3;TDP1;BMH1;DEF1;UFO1;SLX4;TFB1;CSM3
prerank,negative regulation of translation (GO:0017148),-0.505568879046159,-0.9413729430708117,0.6222707423580786,0.9832022787324182,1.0,7/24,17.97%,NOT5;RPL16B;XRN1;VTS1;PAT1;POP2;NOT3
prerank,positive regulation of attachment of spindle microtubules to kinetochore (GO:0051987),-0.5867153176619502,-0.9404057826021697,0.6277850589777195,0.9838967901001113,1.0,2/8,4.95%,DUO1;DAD1
prerank,'de novo' NAD biosynthetic process (GO:0034627),-0.6119705103370019,-0.9401064177911187,0.6343283582089553,0.9831504604091262,1.0,3/6,24.76%,BNA1;BNA2;NMA2
prerank,hyperosmotic response (GO:0006972),-0.6005378824523304,-0.9391545926573552,0.6143057503506312,0.9838888587648972,1.0,4/7,18.60%,SGD1;SUB1;MOT3;SSK2
prerank,purine nucleoside bisphosphate biosynthetic process (GO:0034033),-0.6051883847687706,-0.938542613544761,0.6165951359084406,0.9809715089953872,1.0,2/7,16.29%,SIS2;VHS3
prerank,coenzyme A biosynthetic process (GO:0015937),-0.6051883847687706,-0.938542613544761,0.6165951359084406,0.9809715089953872,1.0,2/7,16.29%,SIS2;VHS3
prerank,ribonucleoside bisphosphate biosynthetic process (GO:0034030),-0.6051883847687706,-0.938542613544761,0.6165951359084406,0.9809715089953872,1.0,2/7,16.29%,SIS2;VHS3
prerank,internal peptidyl-lysine acetylation (GO:0018393),-0.4905191859020698,-0.9380431213245402,0.6251319957761352,0.9806771623928732,1.0,10/33,23.91%,HAT1;TAF6;AHC1;TAF9;SWC4;EAF3;SAS3;ACS2;TAF5;SPT7
prerank,maintenance of protein localization in organelle (GO:0072595),-0.6340369058937294,-0.9379294473325296,0.6367713004484304,0.9795197152452693,1.0,3/5,24.47%,EMP65;FAR1;GZF3
prerank,cellular modified amino acid biosynthetic process (GO:0042398),-0.5574871737439153,-0.9358865693427191,0.6198243412797992,0.9826067387468778,1.0,1/11,3.47%,SPE1
prerank,regulation of vesicle-mediated transport (GO:0060627),0.4248377763445338,0.9358278396183469,0.5174418604651163,0.912672197897678,1.0,3/13,9.32%,UBP3;SFH5;ARK1
prerank,positive regulation of cyclin-dependent protein serine/threonine kinase activity (GO:0045737),-0.6230139137758144,-0.9348102035669685,0.6433990895295902,0.9821469277909316,1.0,1/5,10.65%,CLB2
prerank,positive regulation of cyclin-dependent protein kinase activity (GO:1904031),-0.6230139137758144,-0.9348102035669685,0.6433990895295902,0.9821469277909316,1.0,1/5,10.65%,CLB2
prerank,RNA catabolic process (GO:0006401),-0.5256682836805524,-0.9343678797680748,0.6132723112128147,0.9816905105019585,1.0,2/17,6.03%,DSS1;MTR4
prerank,respiratory electron transport chain (GO:0022904),-0.49079289259644854,-0.9341938718853542,0.6309523809523809,0.9807034481310104,1.0,4/31,13.27%,SDH1;CYT1;COX6;SHH4
prerank,N-terminal protein amino acid modification (GO:0031365),0.47916580117504776,0.9340416710523078,0.5289855072463768,0.9106305959573588,1.0,3/8,22.68%,NAT4;ARD1;NAT5
prerank,divalent metal ion transport (GO:0070838),-0.5308696131296713,-0.9334327391631285,0.6352128883774454,0.9808970577151804,1.0,5/16,23.24%,PMC1;PCA1;RIM2;PMR1;ECM7
prerank,vesicle-mediated transport (GO:0016192),-0.46571312433258655,-0.9328402138124599,0.739,0.9807622945317703,1.0,26/152,16.41%,PKH1;GTS1;NEO1;VPS41;OSH6;YPT32;STP22;GYP7;SSA3;MYO2;VPS35;DOA4;COY1;VPS54;VRP1;VPS16;SSA2;SSA1;PEP7;VAM3;FTH1;SNF7;BZZ1;SPO20;IMH1;ROY1
prerank,hydrogen peroxide catabolic process (GO:0042744),-0.6394941200081662,-0.9325959006631794,0.6366459627329193,0.9798944864292954,1.0,2/5,14.79%,TSA1;CTT1
prerank,DNA replication initiation (GO:0006270),-0.5016267126909852,-0.9321977397498381,0.6312910284463895,0.9793293603238598,1.0,4/25,10.13%,NOC3;SIR3;DPB11;MET30
prerank,ER-dependent peroxisome organization (GO:0032581),-0.5858722009207491,-0.9311743034865355,0.6293103448275862,0.980110867938885,1.0,2/7,17.71%,RTN1;PEX29
prerank,glucose metabolic process (GO:0006006),-0.5023239949546878,-0.9305403143415667,0.6359600443951166,0.9801206658621646,1.0,5/24,18.04%,TDH1;PGM1;FBA1;PYC2;PCK1
prerank,regulation of protein complex assembly (GO:0043254),-0.5327340901541616,-0.9303632356099873,0.626360338573156,0.9791230579337082,1.0,5/14,15.53%,SAR1;VPS41;VPS16;SED4;RAV2
prerank,nucleus organization (GO:0006997),-0.4902203552814645,-0.9296753248335188,0.6256684491978609,0.979176060061817,1.0,3/33,3.59%,NUP120;MDM1;NUP145
prerank,anatomical structure homeostasis (GO:0060249),-0.4954485736723067,-0.9285276948402852,0.6638388123011665,0.9801791559532538,1.0,5/30,15.11%,GBP2;BRE2;IES3;SGS1;PIF1
prerank,removal of nonhomologous ends (GO:0000735),-0.618367499369726,-0.926805064214648,0.6457055214723927,0.9825096312510351,1.0,3/5,27.07%,MSH2;SLX4;RAD1
prerank,actin filament bundle organization (GO:0061572),-0.5404313052459433,-0.9264477524822025,0.6273062730627307,0.9805118923508491,1.0,3/12,16.54%,LSB3;ABP140;BUD6
prerank,actin filament bundle assembly (GO:0051017),-0.5404313052459433,-0.9264477524822025,0.6273062730627307,0.9805118923508491,1.0,3/12,16.54%,LSB3;ABP140;BUD6
prerank,regulation of protein dephosphorylation (GO:0035304),-0.5754287306018591,-0.9249359608397075,0.6334269662921348,0.9821560701294673,1.0,2/8,10.65%,GIP1;CLB2
prerank,homoserine metabolic process (GO:0009092),-0.5523716691657387,-0.9242493813765134,0.6456310679611651,0.9821740086185217,1.0,2/11,9.48%,YLL058W;YML082W
prerank,endocytosis (GO:0006897),-0.467961983290406,-0.9230275585351926,0.7063572149344097,0.9832600292717437,1.0,16/68,20.04%,LDB19;PKH1;GTS1;NEO1;RIM8;OSH6;CSR2;DOA4;VRP1;FTH1;BZZ1;ROY1;ALY2;VPS34;SIW14;YCK1
prerank,serine family amino acid metabolic process (GO:0009069),-0.5973312873140877,-0.9226060401197097,0.6558265582655827,0.9828017144541162,1.0,1/7,1.73%,SER3
prerank,negative regulation of transcription from RNA polymerase I promoter (GO:0016479),0.5449377347208896,0.9220922549232717,0.5898203592814372,0.9286648688673971,1.0,2/5,26.00%,RPD3;SPT4
prerank,"mitochondrial electron transport, ubiquinol to cytochrome c (GO:0006122)",-0.5491796242482412,-0.9220741641605795,0.6522277227722773,0.9825362013102923,1.0,1/11,5.24%,CYT1
prerank,regulation of transcription elongation from RNA polymerase II promoter (GO:0034243),-0.4834205366133675,-0.9211924888896585,0.667017913593256,0.9829732346427658,1.0,9/34,22.25%,NOT5;SPN1;XRN1;SUB1;POP2;NOT3;VPS34;ELC1;JHD1
prerank,purine nucleobase biosynthetic process (GO:0009113),-0.5978238692935687,-0.9208566914583031,0.6242603550295858,0.982267086551794,1.0,2/6,17.28%,PHO2;ADE8
prerank,gluconeogenesis (GO:0006094),-0.545828562270075,-0.9204652400389235,0.6480099502487562,0.9803137593416168,1.0,4/12,18.04%,TDH1;FBA1;PYC2;PCK1
prerank,hexose biosynthetic process (GO:0019319),-0.545828562270075,-0.9204652400389235,0.6480099502487562,0.9803137593416168,1.0,4/12,18.04%,TDH1;FBA1;PYC2;PCK1
prerank,glycogen metabolic process (GO:0005977),0.3754120737604443,0.9202681679565587,0.5245901639344263,0.9267562054068188,1.0,2/20,2.76%,GLC7;SHP1
prerank,C-terminal protein amino acid modification (GO:0018410),-0.6139797433265297,-0.9201498780936503,0.6622023809523809,0.9796018121194581,1.0,2/6,18.80%,ATG16;STE14
prerank,peptidyl-serine modification (GO:0018209),-0.48276706069994835,-0.919329858808914,0.6470588235294118,0.9798266547913552,1.0,7/31,22.08%,PKH1;PKC1;DBF2;VHS1;PKP1;YCK1;YIR042C
prerank,mRNA processing (GO:0006397),-0.45896524383606857,-0.9189689771437693,0.7301905717151455,0.9792333223875413,1.0,12/100,11.65%,MUD1;SPP381;THO2;RTT103;NAM8;SNU66;NRD1;CBC2;NTC20;IST3;QRI5;PRP46
prerank,nuclear pore organization (GO:0006999),-0.5130681920274435,-0.9176226648551372,0.6401384083044983,0.9805689207460028,1.0,5/17,18.13%,RTN1;KAP95;NUP170;NUP57;NUP192
prerank,regulation of mitotic cell cycle phase transition (GO:1901990),-0.5073440538058526,-0.9175598712575542,0.6528089887640449,0.9793881631422096,1.0,5/19,15.58%,CLA4;ESP1;CDC15;GIC2;NET1
prerank,actin filament organization (GO:0007015),-0.4891874212904588,-0.9174559342239484,0.6702241195304163,0.9782799313523741,1.0,8/30,21.54%,PPH22;PKC1;TWF1;BZZ1;ARP3;ARC18;SIW14;CRN1
prerank,glycerophospholipid biosynthetic process (GO:0046474),0.36779999238803096,0.9173570186326051,0.5189873417721519,0.92779460239086,1.0,3/24,1.52%,CDS1;OPI3;CMD1
prerank,protein N-linked glycosylation (GO:0006487),-0.48128344085468344,-0.914683928604806,0.6603174603174603,0.9823358853883298,1.0,6/30,18.67%,OST5;ANP1;EOS1;KTR4;ALG9;MNN10
prerank,positive regulation of protein modification by small protein conjugation or removal (GO:1903322),-0.5950217145994618,-0.9145810937882174,0.6390101892285298,0.9812212427788345,1.0,4/6,26.74%,SPO22;UFD2;SPO16;ZIP2
prerank,glucose 6-phosphate metabolic process (GO:0051156),-0.5198205859075532,-0.9143984662239184,0.6528436018957346,0.9802504068227086,1.0,6/15,21.56%,PGM1;TKL1;SOL2;ZWF1;RPE1;RKI1
prerank,negative regulation of cellular carbohydrate metabolic process (GO:0010677),-0.5813478956346676,-0.9141740263551165,0.6431535269709544,0.9780667906657756,1.0,1/7,3.09%,FYV10
prerank,negative regulation of gluconeogenesis (GO:0045721),-0.5813478956346676,-0.9141740263551165,0.6431535269709544,0.9780667906657756,1.0,1/7,3.09%,FYV10
prerank,DNA replication (GO:0006260),-0.4820603911093767,-0.9134319984000628,0.6680851063829787,0.9782219076108468,1.0,11/33,23.64%,SWI1;POL2;SLX1;PIF1;PSF3;RFA3;SLX4;SAK1;TOP1;DPB2;RFC2
prerank,organonitrogen compound biosynthetic process (GO:1901566),-0.4819939087708288,-0.9127894603205179,0.6869109947643979,0.9781221083528221,1.0,7/38,10.51%,TYW3;FLC2;SKN1;FLC1;KAP95;PPM2;PSD2
prerank,GPI anchor biosynthetic process (GO:0006506),0.33132030601646945,0.9117536707388961,0.616822429906542,0.9336138701012544,1.0,10/23,23.62%,GPI17;DPM1;GPI19;GPI12;GAB1;ERI1;PER1;SPT14;GPI8;PBN1
prerank,phospholipid transport (GO:0015914),-0.5017031113448518,-0.9115202271804903,0.6516203703703703,0.9792073055016194,1.0,1/19,2.62%,NEO1
prerank,monocarboxylic acid catabolic process (GO:0072329),-0.5197677667713168,-0.9096502539314498,0.6501766784452296,0.9814794548077496,1.0,3/16,22.90%,ASP1;POT1;SWI6
prerank,regulation of DNA-dependent DNA replication (GO:0090329),-0.5083704322360166,-0.9087054408561619,0.6546929316338355,0.9820583507616769,1.0,5/17,21.52%,CHD1;MET30;EAF3;SET2;RIX1
prerank,regulation of cellular macromolecule biosynthetic process (GO:2000112),-0.46700561327904916,-0.9076431084556863,0.7025641025641025,0.9827589228295884,1.0,11/47,19.99%,PPH22;SLH1;DOA4;CRZ1;SET3;DCC1;SLF1;LEU3;MLP2;SET2;NUP133
prerank,ubiquinone biosynthetic process (GO:0006744),-0.5243181232803169,-0.9067539955013446,0.6452410383189122,0.9831312565442634,1.0,2/13,11.77%,YAH1;CAT5
prerank,histidine biosynthetic process (GO:0000105),0.502499173309601,0.9063282098896123,0.607773851590106,0.9335450994649932,1.0,1/7,0.65%,HIS3
prerank,histidine metabolic process (GO:0006547),0.502499173309601,0.9063282098896123,0.607773851590106,0.9335450994649932,1.0,1/7,0.65%,HIS3
prerank,tRNA processing (GO:0008033),0.31087545589188126,0.9061136889100331,0.65,0.9288757275369265,1.0,10/34,17.95%,POP7;TGS1;CLP1;AIR2;PUS4;POP1;RPR2;SNM1;DUS4;YMR087W
prerank,acylglycerol catabolic process (GO:0046464),-0.6155681308189109,-0.905264077991431,0.7009063444108762,0.9832659717477535,1.0,1/5,4.06%,TGL4
prerank,triglyceride catabolic process (GO:0019433),-0.6155681308189109,-0.905264077991431,0.7009063444108762,0.9832659717477535,1.0,1/5,4.06%,TGL4
prerank,cation homeostasis (GO:0055080),-0.6086313378560262,-0.9050240927536544,0.6760355029585798,0.9824277946626047,1.0,1/5,4.15%,SNQ2
prerank,"maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000462)",-0.4572542520930022,-0.9049954518504009,0.748991935483871,0.9811900338759864,1.0,11/85,13.09%,UTP8;LOC1;PRP43;FYV7;RRP5;BUD21;RCL1;SOF1;RPS9B;RPS14A;ECM16
prerank,protein catabolic process (GO:0030163),-0.4821722912316615,-0.9045900521647705,0.6769911504424779,0.9805920109442322,1.0,4/27,11.61%,SNA2;PNG1;ASK10;NMA111
prerank,CUT catabolic process (GO:0071034),-0.5315283823156325,-0.9039987641464636,0.674937965260546,0.9803326196743296,1.0,2/12,9.17%,RRP6;NRD1
prerank,mitochondrion distribution (GO:0048311),-0.49061105935108285,-0.9038413066990691,0.6715909090909091,0.97804376984452,1.0,5/21,21.65%,MDM1;MYO2;ARP3;ARC18;MDM20
prerank,mitochondrion inheritance (GO:0000001),-0.49061105935108285,-0.9038413066990691,0.6715909090909091,0.97804376984452,1.0,5/21,21.65%,MDM1;MYO2;ARP3;ARC18;MDM20
prerank,sphingolipid biosynthetic process (GO:0030148),-0.49375781580657774,-0.9030802106212971,0.6748057713651499,0.9781403392453043,1.0,3/22,5.45%,FLC2;SKN1;FLC1
prerank,maturation of SSU-rRNA (GO:0030490),-0.45681767955099645,-0.9017308373301622,0.7255297679112008,0.979403519360671,1.0,13/71,18.18%,UTP8;PRP43;FYV7;RRP5;BUD21;SOF1;RPS9B;RPS14A;ECM16;BUD22;RIO2;RRP12;UTP30
prerank,"mRNA splicing, via spliceosome (GO:0000398)",-0.450103502473806,-0.9014670617572393,0.7439759036144579,0.978634595523653,1.0,10/88,11.65%,MUD1;SPP381;PRP43;NAM8;SNU66;NRD1;CBC2;NTC20;IST3;PRP46
prerank,mitochondrion organization (GO:0007005),-0.4514221630713923,-0.901286813061335,0.7642928786359077,0.9776425652243326,1.0,19/99,16.90%,GGC1;SAR1;MGM101;ZIM17;MCP1;SSA1;YDJ1;OXA1;HSP60;RCF1;NCA3;HSP78;YME1;PIF1;TOM70;FZO1;REX2;RIM2;EXO5
prerank,Rho protein signal transduction (GO:0007266),-0.5323341997794864,-0.9006240581820043,0.660217654171705,0.9776536926512469,1.0,1/12,3.16%,CLA4
prerank,protein dephosphorylation (GO:0006470),-0.4657257512325927,-0.9004196795750564,0.6997885835095138,0.9767587713026772,1.0,11/36,21.36%,PTP3;PPH22;PSY2;PTC5;RTS1;PSR2;PPQ1;REF2;PHO8;SIW14;LTP1
prerank,fungal-type cell wall chitin biosynthetic process (GO:0034221),-0.521758437529932,-0.9002694069569634,0.656441717791411,0.9757298086440025,1.0,3/12,23.42%,BCH1;BMH1;CHS7
prerank,regulation of cell size (GO:0008361),-0.483459262172367,-0.9001999436956188,0.6785714285714286,0.9745869742946575,1.0,6/24,15.67%,WHI5;KOG1;PTK2;RPA49;YCR061W;YGR111W
prerank,autophagosome assembly (GO:0000045),-0.48241057389388103,-0.9001764809090869,0.6721311475409836,0.9733542564952424,1.0,5/23,19.81%,ATG29;EMC6;ATG11;VPS34;ATG8
prerank,protein insertion into mitochondrial membrane (GO:0051204),-0.5874944350825003,-0.9000186978937409,0.6651651651651652,0.9723742394080099,1.0,2/6,20.55%,OXA1;BCS1
prerank,methionine biosynthetic process (GO:0009086),0.5530993936350072,0.8997098295744218,0.6055045871559633,0.935872954028463,1.0,3/5,19.34%,MET2;HOM6;MET6
prerank,chromosome condensation (GO:0030261),-0.5115694873964549,-0.8977656315271367,0.6786570743405276,0.9751316531798082,1.0,6/15,24.61%,SMC4;PDS5;HMO1;TOP1;LRS4;YCG1
prerank,trehalose biosynthetic process (GO:0005992),-0.5982996848926548,-0.895178755192535,0.6853582554517134,0.9772550426739678,1.0,3/5,19.72%,PGM1;TPS3;TPS2
prerank,disaccharide biosynthetic process (GO:0046351),-0.5982996848926548,-0.895178755192535,0.6853582554517134,0.9772550426739678,1.0,3/5,19.72%,PGM1;TPS3;TPS2
prerank,misfolded or incompletely synthesized protein catabolic process (GO:0006515),-0.48582027308304393,-0.8939721783732146,0.6693181818181818,0.9781839646304822,1.0,4/21,14.32%,PNG1;SSA3;PMT2;YME1
prerank,lysine biosynthetic process via aminoadipic acid (GO:0019878),-0.6026346714185952,-0.8938197415772894,0.6998491704374057,0.9772235053464291,1.0,1/5,8.90%,LYS1
prerank,peptidyl-methionine modification (GO:0018206),-0.6060692427734672,-0.893681219177457,0.701095461658842,0.9749100422387527,1.0,2/5,29.02%,MDM20;NAT2
prerank,N-terminal peptidyl-methionine acetylation (GO:0017196),-0.6060692427734672,-0.893681219177457,0.701095461658842,0.9749100422387527,1.0,2/5,29.02%,MDM20;NAT2
prerank,apoptotic process (GO:0006915),-0.5097596677454515,-0.8934916400369414,0.6851211072664359,0.9739781993100751,1.0,4/16,18.31%,ESP1;NMA111;HSP60;OYE2
prerank,"vacuole fusion, non-autophagic (GO:0042144)",-0.48273144847384086,-0.8933998750564781,0.6722222222222223,0.9716600791624218,1.0,4/24,12.98%,VPS41;VAC8;VPS16;VAM3
prerank,vacuole fusion (GO:0097576),-0.48273144847384086,-0.8933998750564781,0.6722222222222223,0.9716600791624218,1.0,4/24,12.98%,VPS41;VAC8;VPS16;VAM3
prerank,azole transport (GO:0045117),-0.6086957793312218,-0.8911330533702957,0.7043478260869566,0.9742156004006747,1.0,3/5,14.43%,THI72;AZR1;THI7
prerank,exit from mitosis (GO:0010458),0.4880346360006906,0.8904690752903018,0.6312056737588653,0.9483814495791257,1.0,5/7,14.46%,SKP1;TEM1;CDC10;CDC5;DBF20
prerank,regulation of exit from mitosis (GO:0007096),-0.4862615315968627,-0.8901101417655248,0.6807563959955506,0.9747196109652043,1.0,9/22,20.71%,CLA4;ESP1;CDC15;SLK19;KEL1;GIC2;NET1;KEL2;GIC1
prerank,negative regulation of chromatin silencing at silent mating-type cassette (GO:0061186),0.4956007865488742,0.889884997069302,0.5923344947735192,0.944207000009709,1.0,2/7,12.68%,WTM2;RPD3
prerank,DNA strand renaturation (GO:0000733),-0.5846378159064871,-0.8896799996414019,0.7045454545454546,0.9742512561381909,1.0,1/6,1.70%,MGM101
prerank,protein targeting to ER (GO:0045047),-0.4925241519776763,-0.8895584066295247,0.6836027713625866,0.9732247775139072,1.0,5/19,16.94%,YDJ1;SRP14;GET4;BTT1;SBH2
prerank,regulation of mitochondrial translation (GO:0070129),-0.5113531386949507,-0.8890814160074287,0.6776084407971864,0.9728184637389325,1.0,3/14,12.10%,MSS51;PET111;CBS1
prerank,regulation of DNA metabolic process (GO:0051052),-0.5477126720007103,-0.888627324389567,0.6809078771695594,0.9724042294521682,1.0,3/9,13.47%,TOP3;DOA4;DCC1
prerank,purine-containing compound biosynthetic process (GO:0072522),-0.49617351376157726,-0.8878852098447024,0.6700913242009132,0.9724728358742396,1.0,4/18,17.50%,ADE16;PHO2;ADE8;ADE6
prerank,regulation of phosphate metabolic process (GO:0019220),-0.5784919695971519,-0.8875195720674276,0.6838995568685377,0.9718699237730224,1.0,3/6,26.94%,PHO2;TSC11;PHO4
prerank,organelle fusion (GO:0048284),0.4613131049311268,0.8861405427711055,0.5895522388059702,0.9457945859726089,1.0,4/8,17.75%,AFG3;MPS3;YTA12;MPS2
prerank,cellular response to pH (GO:0071467),0.5124305934657813,0.8857917052051124,0.5979020979020979,0.9413419222193747,1.0,1/6,2.44%,INP51
prerank,ncRNA polyadenylation (GO:0043629),-0.5769309325924113,-0.8852009267530216,0.6788321167883211,0.9745942297532872,1.0,1/6,6.03%,MTR4
prerank,phospholipid metabolic process (GO:0006644),-0.4704660620695915,-0.8843986645207937,0.6943231441048034,0.9747336344300783,1.0,3/27,10.80%,SPO14;TGL4;URA8
prerank,negative regulation of exit from mitosis (GO:0001100),-0.5017349923931627,-0.8833595170198357,0.6918604651162791,0.9753723720219979,1.0,6/16,20.35%,BUB2;RTS1;SPC72;KEL1;KEL2;BMH1
prerank,"endonucleolytic cleavage of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000479)",-0.45478124535379827,-0.882645054172127,0.7473903966597077,0.9753072616774022,1.0,4/47,6.54%,LOC1;RRP5;BUD21;RCL1
prerank,peroxisome organization (GO:0007031),-0.4659644201213301,-0.8822771818567325,0.7051705170517052,0.9746665297602422,1.0,6/28,20.98%,RTN1;MYO2;PEX11;PEX29;INP1;PEX28
prerank,purine nucleotide biosynthetic process (GO:0006164),-0.5234101455587807,-0.8820854261453676,0.6761433868974042,0.9737512861060549,1.0,3/12,17.50%,ADE16;ADE8;ADE6
prerank,mitotic DNA replication checkpoint (GO:0033314),-0.5542473543292823,-0.8817378829554705,0.6816326530612244,0.9731166624024467,1.0,2/8,7.35%,POL2;SIR3
prerank,tRNA gene clustering (GO:0070058),-0.5835604994667711,-0.8815695880359876,0.7138643067846607,0.9721766165497022,1.0,1/5,3.43%,SMC4
prerank,protein O-linked glycosylation (GO:0006493),-0.49524494773585126,-0.8813464076137963,0.6928487690504103,0.9713171715571766,1.0,3/16,9.75%,MNN1;MNT4;PMT2
prerank,pyruvate metabolic process (GO:0006090),0.33874992000020965,0.8810930279472372,0.6222222222222222,0.9454217079138285,1.0,4/25,4.66%,CDC19;PGI1;LPD1;EMI2
prerank,dolichol metabolic process (GO:0019348),0.5156375262196401,0.8799892200261719,0.64,0.9425156669891673,1.0,3/5,7.13%,RER2;DPM1;NUS1
prerank,protein neddylation (GO:0045116),0.4862128476120935,0.8753960572825152,0.6088560885608856,0.9463344764536161,1.0,2/7,12.17%,SKP1;RUB1
prerank,RNA methylation (GO:0001510),-0.46728237657655924,-0.8737899551170374,0.7246531483457844,0.9825787878685527,1.0,4/29,12.60%,TYW3;PPM2;GCD14;ABP140
prerank,protein-DNA complex disassembly (GO:0032986),-0.4965193894508685,-0.8734209354903442,0.7124711316397229,0.9819450842425417,1.0,6/17,24.72%,RSC2;RSC9;SRS2;RSC1;NAP1;NPL6
prerank,protein localization to kinetochore (GO:0034501),-0.5510392956930773,-0.8720296198097632,0.7022792022792023,0.9829258621833844,1.0,1/7,1.05%,MPS1
prerank,phosphatidylcholine metabolic process (GO:0046470),-0.5337582855183165,-0.8691513215902961,0.6924050632911393,0.986297269423114,1.0,4/10,16.32%,KAP95;PSD2;SAH1;PSD1
prerank,copper ion homeostasis (GO:0055070),-0.517522350244417,-0.8690255538996918,0.7077114427860697,0.9852725591327052,1.0,3/12,16.63%,PIC2;SLF1;EMP70
prerank,telomere organization (GO:0032200),-0.461599102035921,-0.8688406679318256,0.7465681098204857,0.9843443387840753,1.0,5/31,15.11%,GBP2;BRE2;IES3;SGS1;PIF1
prerank,reticulophagy (GO:0061709),-0.5846772123683139,-0.868703751259369,0.7357032457496137,0.9833421309485372,1.0,2/5,19.81%,ATG11;ATG8
prerank,transcription initiation from RNA polymerase III promoter (GO:0006384),-0.531893704023676,-0.8684719126113319,0.6893840104849279,0.9825123239145596,1.0,2/9,12.12%,TFC3;SUB1
prerank,positive regulation of invasive growth in response to glucose limitation (GO:2000219),-0.5697780320612486,-0.8680014259130868,0.7077363896848138,0.982025215458944,1.0,2/6,24.52%,YTA7;GAL11
prerank,nucleobase-containing compound catabolic process (GO:0034655),-0.5182952629299813,-0.8678758012069483,0.7104622871046229,0.9809810218531992,1.0,2/12,6.03%,DSS1;MTR4
prerank,glycolytic fermentation to ethanol (GO:0019655),-0.565335721104723,-0.8675591918784628,0.7140740740740741,0.9802518261591128,1.0,1/6,6.81%,ADH1
prerank,ethanol metabolic process (GO:0006067),-0.5084544866482579,-0.8675503542397673,0.7191011235955056,0.9790545433727772,1.0,1/11,6.81%,ADH1
prerank,snoRNA metabolic process (GO:0016074),-0.5470681997626243,-0.8674680838108308,0.7316421895861148,0.9779732068486748,1.0,1/8,10.53%,XRN1
prerank,response to metal ion (GO:0010038),-0.5248842240763325,-0.8672045254498318,0.711864406779661,0.9771995917927812,1.0,3/10,16.38%,FET3;MET30;YCR102C
prerank,regulation of cellular protein localization (GO:1903827),-0.5044731113401327,-0.8665809661496456,0.7170035671819263,0.976966635455728,1.0,5/13,25.68%,SFL1;VPS34;SAK1;GAL11;SIN4
prerank,cellular copper ion homeostasis (GO:0006878),-0.5182294318689127,-0.8645790660254682,0.7090680100755667,0.9789880226117055,1.0,3/11,16.63%,PIC2;SLF1;EMP70
prerank,mitochondrial respiratory chain complex assembly (GO:0033108),-0.4499214003208586,-0.8637431183946296,0.7347368421052631,0.9790709487047791,1.0,4/36,12.55%,COX12;COX20;COX16;RCF1
prerank,negative regulation of cellular macromolecule biosynthetic process (GO:2000113),-0.46561078025080427,-0.8628549219630736,0.72,0.9792277067364028,1.0,8/24,22.88%,NOT5;RPL16B;VTS1;EAF3;POP2;NOT3;SAS3;ASC1
prerank,ubiquitin-dependent protein catabolic process (GO:0006511),-0.4249988368617552,-0.8616233301845766,0.8313253012048193,0.9800039850752462,1.0,17/99,16.05%,BSD2;ELA1;FYV10;RPN9;RPN8;ITT1;STP22;DOA4;RTT101;SSA2;RAD23;SSA1;YDJ1;SNF7;HRT1;UBX2;CUE5
prerank,cell morphogenesis (GO:0000902),-0.5353803745813119,-0.860090526658872,0.7127937336814621,0.9812202530652756,1.0,1/9,6.25%,CAP2
prerank,tryptophan catabolic process (GO:0006569),-0.5786213284820283,-0.8597281519724403,0.7261724659606656,0.9805501056451075,1.0,4/5,35.19%,BNA2;PDC1;BNA5;THI3
prerank,phosphatidylcholine biosynthetic process (GO:0006656),-0.5183908101671062,-0.8594554171847902,0.7022058823529411,0.9797784558862882,1.0,4/11,16.32%,KAP95;PSD2;SAH1;PSD1
prerank,proteasomal protein catabolic process (GO:0010498),-0.4352811687438949,-0.858967018725032,0.7427083333333333,0.9793091583368573,1.0,6/43,15.02%,FYV10;RPN8;SSA2;RAD23;SSA1;UBX2
prerank,'de novo' IMP biosynthetic process (GO:0006189),-0.5466276656868152,-0.8584323789358168,0.7161981258366801,0.9789328737518749,1.0,3/7,17.50%,ADE16;ADE8;ADE6
prerank,cellular response to misfolded protein (GO:0071218),-0.4796162971512702,-0.8581182343887404,0.7051744885679904,0.9782418700581019,1.0,2/16,9.75%,TMC1;PMT2
prerank,protein maturation by iron-sulfur cluster transfer (GO:0097428),-0.5829772125045583,-0.8579913418076004,0.7136563876651982,0.9772556258936426,1.0,2/5,21.22%,MET18;ISA1
prerank,fatty acid oxidation (GO:0019395),-0.509918726221259,-0.8576555657201392,0.7208706786171575,0.9765927523636834,1.0,4/11,24.54%,PEX11;POT1;POX1;FOX2
prerank,regulation of glucan biosynthetic process (GO:0010962),0.5186907873877139,0.8568605364219429,0.6752136752136753,0.9708921402890986,1.0,2/5,11.81%,PCL6;PCL7
prerank,regulation of glycogen metabolic process (GO:0070873),0.5186907873877139,0.8568605364219429,0.6752136752136753,0.9708921402890986,1.0,2/5,11.81%,PCL6;PCL7
prerank,endosome organization (GO:0007032),-0.5175680602947875,-0.8565154374848533,0.6932114882506527,0.9771784645176101,1.0,2/9,13.25%,DOA4;SNF7
prerank,negative regulation of cellular biosynthetic process (GO:0031327),-0.48909472367439244,-0.8556872328434502,0.7268292682926829,0.9772465520358793,1.0,6/15,25.57%,FYV10;MOT3;VID30;RMD5;ORM1;OPI1
prerank,protein localization to pre-autophagosomal structure (GO:0034497),-0.48940152734780856,-0.8548180455899036,0.7270531400966184,0.9774008093721678,1.0,3/14,19.81%,ATG29;ATG11;ATG8
prerank,regulation of meiotic DNA double-strand break formation (GO:1903341),0.48835911009561817,0.854357485902992,0.6206896551724138,0.9704461616524773,1.0,2/6,9.75%,SMC2;SPP1
prerank,DNA damage checkpoint (GO:0000077),-0.48315752893962005,-0.8531365022420482,0.7171837708830548,0.9787206247919511,1.0,2/16,4.28%,GCN2;TSA1
prerank,adenylate cyclase-modulating G-protein coupled receptor signaling pathway (GO:0007188),-0.5678273643913128,-0.8525455573526597,0.7298507462686568,0.9784869788101813,1.0,4/6,22.14%,IRA1;CYR1;RAS1;RGS2
prerank,monocarboxylic acid biosynthetic process (GO:0072330),-0.47137645201345013,-0.8521263630035784,0.7414965986394558,0.9778819426013984,1.0,2/22,5.47%,SPE1;TDA9
prerank,isopentenyl diphosphate biosynthetic process (GO:0009240),-0.5675978803380564,-0.8507869513592147,0.723823975720789,0.9786772612904038,1.0,3/5,22.52%,HMG1;ERG12;MVD1
prerank,lipid particle organization (GO:0034389),-0.5721976070954787,-0.8507775079911125,0.7312312312312312,0.9775114273089396,1.0,1/5,15.02%,UBX2
prerank,carbohydrate derivative transport (GO:1901264),-0.5786987578447602,-0.8501844564089122,0.7528735632183908,0.9771608478390046,1.0,2/5,14.43%,THI72;THI7
prerank,Rab protein signal transduction (GO:0032482),-0.5091145391289974,-0.8497967931693432,0.7235984354628422,0.9765494625834333,1.0,1/10,4.64%,YPT32
prerank,dolichol-linked oligosaccharide biosynthetic process (GO:0006488),0.453692518764773,0.848348042770668,0.6804511278195489,0.9766632025486822,1.0,2/7,6.97%,DPM1;ALG14
prerank,proteolysis involved in cellular protein catabolic process (GO:0051603),-0.44542026336911034,-0.8466790385166465,0.7567276641550054,0.979857152940599,1.0,4/30,14.32%,STE23;PNG1;SSA3;YME1
prerank,positive regulation of transcription elongation from RNA polymerase II promoter (GO:0032968),-0.44506538291969255,-0.8455717972885894,0.7758985200845666,0.9803698797590781,1.0,8/32,22.25%,NOT5;XRN1;SUB1;POP2;NOT3;VPS34;ELC1;JHD1
prerank,"RNA splicing, via transesterification reactions with bulged adenosine as nucleophile (GO:0000377)",-0.42266592878554304,-0.8455077613205185,0.8291457286432161,0.9792943006594593,1.0,9/81,11.65%,MUD1;SPP381;NAM8;SNU66;NRD1;CBC2;NTC20;IST3;PRP46
prerank,phospholipid biosynthetic process (GO:0008654),0.31914258237964144,0.8454381800679891,0.7572815533980582,0.9770191293717684,1.0,2/24,4.46%,CSH1;ERG20
prerank,error-prone translesion synthesis (GO:0042276),-0.5152040414252359,-0.8453745444017471,0.7431906614785992,0.978330493297294,1.0,2/9,12.68%,POL2;RAD5
prerank,protein methylation (GO:0006479),-0.5065279586890583,-0.8437062104569011,0.7327365728900256,0.979569528100582,1.0,4/10,32.50%,SET2;STE14;RMT2;CTM1
prerank,regulation of ATPase activity (GO:0043462),0.41128725174671243,0.840926299066099,0.642570281124498,0.9801351844874161,1.0,4/9,20.95%,VFA1;SPP2;HSP30;SQS1
prerank,lipid transport (GO:0006869),-0.44563412448860823,-0.8407939227390594,0.7739504843918191,0.982682690708251,1.0,5/26,15.40%,OSH6;FAA4;PRY2;DAN1;PRY1
prerank,plasma membrane organization (GO:0007009),0.4452531702997379,0.8403300184590277,0.6245733788395904,0.9763128671590773,1.0,2/7,7.10%,NCE102;RVS161
prerank,C-terminal protein lipidation (GO:0006501),-0.5777032456491564,-0.8397257647236279,0.7769230769230769,0.983078990383533,1.0,1/5,14.16%,ATG16
prerank,negative regulation of protein kinase activity (GO:0006469),-0.5520867543710081,-0.8396937740297542,0.7340116279069767,0.981942097817806,1.0,2/6,11.88%,GCN2;LRE1
prerank,glyceraldehyde-3-phosphate metabolic process (GO:0019682),-0.5461468839974887,-0.8381526903819543,0.7369165487977369,0.9830576242906219,1.0,3/6,21.56%,TKL1;RPE1;RKI1
prerank,protein processing involved in protein targeting to mitochondrion (GO:0006627),-0.5632386678253334,-0.8379958310574077,0.7363770250368189,0.9821236183784117,1.0,2/5,15.28%,OCT1;MAS2
prerank,ncRNA transcription (GO:0098781),-0.5369157628892258,-0.8379579763731846,0.7475728155339806,0.9810109453159227,1.0,2/7,15.78%,RSC9;HHT2
prerank,protein O-linked mannosylation (GO:0035269),-0.536894194340023,-0.8378546300199089,0.7241379310344828,0.9788314903405655,1.0,1/6,9.75%,PMT2
prerank,protein mannosylation (GO:0035268),-0.536894194340023,-0.8378546300199089,0.7241379310344828,0.9788314903405655,1.0,1/6,9.75%,PMT2
prerank,cilium organization (GO:0044782),0.45976598045506445,0.8377859992343826,0.6543624161073825,0.9760594032739297,1.0,4/7,26.96%,CDC10;CDC11;CDC12;SPR28
prerank,phosphatidylethanolamine biosynthetic process (GO:0006646),-0.5377104540544491,-0.8366988081777849,0.7428958051420839,0.9792160193846012,1.0,2/7,16.32%,PSD2;PSD1
prerank,amide transport (GO:0042886),-0.5402696683488711,-0.8366160325934333,0.748,0.9782044170127138,1.0,2/7,14.43%,THI72;THI7
prerank,cellular monovalent inorganic cation homeostasis (GO:0030004),-0.5542213138084906,-0.833933012743057,0.7402799377916018,0.9808282042528771,1.0,2/5,25.15%,VHS3;PPZ2
prerank,negative regulation of mitotic nuclear division (GO:0045839),0.47470493809231434,0.8332338010644703,0.6942675159235668,0.9741638842264136,1.0,2/6,5.15%,CDC7;AMN1
prerank,negative regulation of mitotic cell cycle phase transition (GO:1901991),0.47470493809231434,0.8332338010644703,0.6942675159235668,0.9741638842264136,1.0,2/6,5.15%,CDC7;AMN1
prerank,peptidyl-lysine dimethylation (GO:0018027),-0.5522429269618274,-0.8330154256016259,0.7647058823529411,0.9808545396665459,1.0,1/6,12.48%,EFM1
prerank,maintenance of translational fidelity (GO:1990145),-0.5508990199440063,-0.8329600620958861,0.7283582089552239,0.9797655052473794,1.0,2/5,8.14%,EFT2;EFT1
prerank,polyadenylation-dependent snoRNA 3'-end processing (GO:0071051),-0.4854424304695748,-0.8324942690663739,0.75,0.9792413336410765,1.0,2/13,7.19%,MTR4;RRP6
prerank,cAMP-mediated signaling (GO:0019933),0.43815827700688126,0.8321847663087504,0.6746575342465754,0.9712294908724907,1.0,3/7,3.05%,GPA2;YVH1;SOK1
prerank,RNA splicing (GO:0008380),-0.5260804392503073,-0.8318881345056086,0.7353361945636624,0.9788844128634672,1.0,1/7,24.00%,SLU7
prerank,response to reactive oxygen species (GO:0000302),0.4462382749076502,0.8303041463196242,0.6983050847457627,0.969784291725788,1.0,3/7,12.53%,CCP1;GSH1;AIF1
prerank,mitochondrial translation (GO:0032543),-0.41683092993955595,-0.8296706172618291,0.8696969696969697,0.9808051987873366,1.0,11/88,15.71%,MRPL16;AEP3;MRF1;MRPL44;MSE1;PTH1;MRP7;MRPS28;MRP20;MRPL4;AEP2
prerank,cardiolipin metabolic process (GO:0032048),0.3963602464260684,0.8293854259615439,0.6908212560386473,0.96667247916936,1.0,4/10,10.31%,PGS1;AFT1;GEP4;UPS2
prerank,negative regulation of meiotic cell cycle (GO:0051447),-0.5436141183335188,-0.8290352176649561,0.7457865168539326,0.9805083666500936,1.0,2/6,16.88%,SET3;SNF3
prerank,maintenance of rDNA (GO:0043007),0.4218945322547309,0.828448030980236,0.6523297491039427,0.963441601910099,1.0,2/8,15.42%,CSM2;NUR1
prerank,tRNA transcription (GO:0009304),-0.46874363885859704,-0.8283536111320955,0.7653890824622532,0.9791597049572757,1.0,5/17,16.83%,RPC82;RPB10;RPB5;RPC53;RPC40
prerank,tRNA transcription from RNA polymerase III promoter (GO:0042797),-0.46874363885859704,-0.8283536111320955,0.7653890824622532,0.9791597049572757,1.0,5/17,16.83%,RPC82;RPB10;RPB5;RPC53;RPC40
prerank,nuclear polyadenylation-dependent snRNA catabolic process (GO:0071037),-0.5489656515652614,-0.8280410468995022,0.7556904400606981,0.9749927506018835,1.0,1/5,7.19%,RRP6
prerank,snoRNA catabolic process (GO:0016077),-0.5489656515652614,-0.8280410468995022,0.7556904400606981,0.9749927506018835,1.0,1/5,7.19%,RRP6
prerank,nuclear polyadenylation-dependent snoRNA catabolic process (GO:0071036),-0.5489656515652614,-0.8280410468995022,0.7556904400606981,0.9749927506018835,1.0,1/5,7.19%,RRP6
prerank,snRNA catabolic process (GO:0016076),-0.5489656515652614,-0.8280410468995022,0.7556904400606981,0.9749927506018835,1.0,1/5,7.19%,RRP6
prerank,phosphatidylinositol biosynthetic process (GO:0006661),0.3063426523340203,0.8278005047684348,0.8181818181818182,0.9598055903685722,1.0,5/24,11.97%,CMD1;DPM1;GPI19;PIS1;GPI12
prerank,tRNA wobble position uridine thiolation (GO:0002143),0.4974627376195493,0.8267326157516449,0.6758241758241759,0.9569302894196915,1.0,1/5,2.04%,URM1
prerank,protein modification by small protein conjugation (GO:0032446),-0.4205426207443515,-0.8267305540031158,0.8358662613981763,0.9756232141741257,1.0,14/62,20.44%,NOT5;PEX10;APC9;APC1;ELP2;MET30;SIZ1;APJ1;HRT1;HUL4;NOT3;RFA3;GMC2;DEF1
prerank,protein exit from endoplasmic reticulum (GO:0032527),-0.488765353085561,-0.8252293040508257,0.749379652605459,0.9764628609418532,1.0,2/11,9.75%,HRD3;PMT2
prerank,cellular response to osmotic stress (GO:0071470),-0.44474590867079533,-0.825081934226419,0.7575083426028921,0.975552249891384,1.0,6/22,20.87%,FLC2;PSR2;CTT1;MOT3;SSK2;HSP12
prerank,histone H3-K4 methylation (GO:0051568),-0.5111295662538544,-0.8236369765130613,0.7615894039735099,0.9763668132463085,1.0,4/9,27.75%,BRE2;SHG1;SDC1;ORC2
prerank,phosphorylated carbohydrate dephosphorylation (GO:0046838),0.46758684740078593,0.8235944953726347,0.6689419795221843,0.9579971326014565,1.0,2/6,6.86%,INP51;GEP4
prerank,nucleus localization (GO:0051647),-0.5548533297108775,-0.8221231112721122,0.7579425113464447,0.9772270431203993,1.0,2/5,22.77%,SLK19;TOP1
prerank,positive regulation of protein complex assembly (GO:0031334),-0.5344870290776262,-0.8212449943596294,0.7547445255474453,0.9772245843353699,1.0,1/6,5.63%,SLY1
prerank,establishment of protein localization to endoplasmic reticulum (GO:0072599),-0.49360593271907915,-0.8185359459213171,0.7388362652232747,0.9796994360708938,1.0,2/10,13.31%,YDJ1;SRP14
prerank,ncRNA metabolic process (GO:0034660),-0.4889852999411121,-0.8161276830450521,0.7686375321336761,0.9816542786989009,1.0,1/10,6.03%,MTR4
prerank,nucleic acid metabolic process (GO:0090304),-0.5390598347823722,-0.8161014592332099,0.7724637681159421,0.9805650465530633,1.0,2/6,34.81%,MRH4;LSM12
prerank,DNA strand elongation involved in DNA replication (GO:0006271),-0.4445418634196456,-0.8160057625918432,0.7564245810055866,0.979571718555385,1.0,2/22,6.21%,RFC1;POL2
prerank,nuclear polyadenylation-dependent rRNA catabolic process (GO:0071035),-0.4605621726644118,-0.8153797481565728,0.7758620689655172,0.9792659713882669,1.0,2/17,7.19%,MTR4;RRP6
prerank,base-excision repair (GO:0006284),-0.45975896443695663,-0.8153550851484572,0.7657550535077289,0.9781613670535639,1.0,5/16,26.45%,POL2;APN1;XRS2;PAP2;RAD27
prerank,histone modification (GO:0016570),-0.41067841082417744,-0.8150341668897529,0.8340122199592668,0.9774936629290586,1.0,16/57,22.50%,HAT1;TAF6;GIS1;SET3;HOS3;AHC1;TAF9;SWC4;EAF3;SET2;HEL2;SDS3;SAS3;ACS2;JHD1;TAF5
prerank,vesicle organization (GO:0016050),-0.41768580995847704,-0.8143954506310076,0.8207253886010363,0.9772372553225191,1.0,5/45,14.90%,SAR1;VAC8;PEP7;VAM3;SPO20
prerank,regulation of chromatin silencing (GO:0031935),-0.45254536862542616,-0.8143617654196741,0.767962308598351,0.9761628332226157,1.0,1/16,0.76%,HIR2
prerank,mitochondrial proton-transporting ATP synthase complex assembly (GO:0033615),0.3878044648478271,0.8121487091848766,0.6491228070175439,0.9683723594213057,1.0,2/10,2.11%,ATP25;ATP14
prerank,proton-transporting ATP synthase complex assembly (GO:0043461),0.3878044648478271,0.8121487091848766,0.6491228070175439,0.9683723594213057,1.0,2/10,2.11%,ATP25;ATP14
prerank,cellular response to oxygen-containing compound (GO:1901701),-0.49781948956293726,-0.8117425100493983,0.76775956284153,0.9783466410327702,1.0,1/9,6.59%,KOG1
prerank,chitin biosynthetic process (GO:0006031),0.49544368983879683,0.8109357718855854,0.668769716088328,0.965801315406691,1.0,2/5,7.46%,SHC1;CHS2
prerank,chaperone-mediated protein complex assembly (GO:0051131),-0.49712530011764144,-0.810496867118305,0.768324607329843,0.9787650299567736,1.0,2/9,20.55%,HSP60;BCS1
prerank,regulation of transcription from RNA polymerase II promoter in response to osmotic stress (GO:0061392),-0.5288741002939131,-0.8104471299375468,0.7623906705539358,0.9776811131210624,1.0,4/6,27.50%,USV1;MOT3;SKO1;HOT1
prerank,proteasome assembly (GO:0043248),-0.42587255181440176,-0.8091086753318751,0.7949836423118866,0.9782328372277818,1.0,3/29,8.96%,PMA1;RPN9;ECM29
prerank,"protein localization to chromosome, centromeric region (GO:0071459)",-0.46226986918028623,-0.8064489777724884,0.7766871165644171,0.9805046850585664,1.0,1/13,1.05%,MPS1
prerank,response to ethanol (GO:0045471),0.46180020147521816,0.8061939309258224,0.7010309278350515,0.9694163277284912,1.0,3/6,20.75%,ATH1;HSP30;MIG3
prerank,zinc II ion transport (GO:0006829),0.42954465077082904,0.8057315851456455,0.6630824372759857,0.9656212484885975,1.0,1/7,9.35%,ATX2
prerank,alpha-amino acid catabolic process (GO:1901606),0.44304714939836004,0.8045565811577997,0.6442307692307693,0.9631683639358728,1.0,1/6,1.66%,LPD1
prerank,mitotic cytokinesis (GO:0000281),-0.41518209960501984,-0.8036879532253904,0.8073298429319372,0.982813507034919,1.0,4/38,10.94%,PKC1;BCH1;CDC15;RTS1
prerank,mitotic DNA integrity checkpoint (GO:0044774),-0.4575604587191171,-0.8036739288289926,0.781664656212304,0.9817196792100135,1.0,4/15,18.71%,POL2;SIR3;MAD3;TOP2
prerank,nucleobase transport (GO:0015851),-0.557250348203216,-0.8035533602806638,0.8002936857562408,0.9807669345856126,1.0,2/5,14.43%,THI72;THI7
prerank,heterochromatin assembly (GO:0031507),-0.5446228750713012,-0.8034861430251191,0.7848297213622291,0.9797323683022016,1.0,2/5,7.87%,SIR3;NUP170
prerank,protein retention in Golgi apparatus (GO:0045053),-0.5189257126206195,-0.8027315604295847,0.7770083102493075,0.9795707022740201,1.0,1/7,8.52%,VPS35
prerank,regulation of DNA-dependent DNA replication initiation (GO:0030174),-0.4568688579640526,-0.8026909920644052,0.7640845070422535,0.9785047212827019,1.0,5/16,21.52%,SUM1;MET30;EAF3;SET2;RIX1
prerank,nitrogen catabolite regulation of transcription from RNA polymerase II promoter (GO:0001079),0.4281369185788766,0.8021969628157092,0.6877192982456141,0.9625353064674672,1.0,3/7,22.14%,GLN3;RTG2;GCN4
prerank,"cleavage in ITS2 between 5.8S rRNA and LSU-rRNA of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000448)",0.43752637714936476,0.8003780216210591,0.7022058823529411,0.9608788132903505,1.0,1/7,9.93%,RPL37B
prerank,rRNA processing (GO:0006364),-0.400404786755634,-0.7998357121480345,0.8755020080321285,0.9808623846517184,1.0,15/90,18.18%,RPL7B;PRP43;DSS1;NOC3;RRP5;MTR4;SNU66;HCA4;XRN1;SSZ1;TOS4;BUD22;DBP2;RIO2;UTP30
prerank,chromatin disassembly (GO:0031498),-0.45717942837393616,-0.7995236486919066,0.7951105937136205,0.979037134288064,1.0,5/16,24.72%,RSC2;RSC9;RSC1;NAP1;NPL6
prerank,nucleosome disassembly (GO:0006337),-0.45717942837393616,-0.7995236486919066,0.7951105937136205,0.979037134288064,1.0,5/16,24.72%,RSC2;RSC9;RSC1;NAP1;NPL6
prerank,"DNA-templated transcription, termination (GO:0006353)",-0.4366220175124894,-0.7985490903045614,0.8006756756756757,0.979144298457808,1.0,4/22,12.12%,CHD1;ISW2;REB1;SUB1
prerank,lysine biosynthetic process (GO:0009085),-0.5119894228305477,-0.7980277488243482,0.7860082304526749,0.9786680000248171,1.0,1/7,8.90%,LYS1
prerank,chromatin silencing at rDNA (GO:0000183),-0.440998736821413,-0.7979650733517817,0.802013422818792,0.9776416914812232,1.0,4/21,15.58%,DOT6;ISW2;IRS4;NET1
prerank,mitotic chromosome condensation (GO:0007076),-0.48506676656016073,-0.7977182539732749,0.7595772787318362,0.9768693207858593,1.0,4/9,24.61%,SMC4;PDS5;TOP1;YCG1
prerank,dicarboxylic acid transport (GO:0006835),-0.5209295388448482,-0.7950986408131849,0.7815750371471025,0.9789343082736468,1.0,1/6,9.03%,YPR003C
prerank,"mRNA cis splicing, via spliceosome (GO:0045292)",0.40836471872428076,0.7945675740025165,0.6653386454183267,0.9659723225949339,1.0,3/9,9.88%,PRP42;PRP9;PRP28
prerank,inorganic anion transport (GO:0015698),-0.4600116832644765,-0.7941767279238952,0.7992957746478874,0.9789098457725776,1.0,2/14,13.22%,SUL2;PHO90
prerank,peroxisome fission (GO:0016559),-0.5118787562659299,-0.7940868668670141,0.7958041958041958,0.9779460697188163,1.0,1/7,11.39%,PEX11
prerank,endoplasmic reticulum to cytosol transport (GO:1903513),0.39900327753118364,0.7925479441980969,0.7,0.9607602482620482,1.0,1/8,0.45%,YOS9
prerank,"retrograde protein transport, ER to cytosol (GO:0030970)",0.39900327753118364,0.7925479441980969,0.7,0.9607602482620482,1.0,1/8,0.45%,YOS9
prerank,mRNA 3'-end processing (GO:0031124),-0.42000964162825793,-0.7924610703935776,0.8175895765472313,0.9787872713110812,1.0,3/29,9.17%,THO2;RTT103;NRD1
prerank,attachment of mitotic spindle microtubules to kinetochore (GO:0051315),0.4044031068980124,0.7911273613543082,0.6856060606060606,0.9587511828852954,1.0,3/9,13.22%,DAM1;NUF2;NDC80
prerank,modification-dependent protein catabolic process (GO:0019941),-0.397504218089229,-0.7910899253382142,0.8761421319796955,0.9793327929741534,1.0,15/64,22.70%,BSD2;ELA1;RPN9;RPN8;DOA4;RTT101;YDJ1;HRT1;CUE5;ELC1;DEF1;RMD5;MDM30;UFD2;RAD7
prerank,pentose metabolic process (GO:0019321),-0.530622958536003,-0.7905125580512415,0.772795216741405,0.9789475629245257,1.0,2/5,21.56%,RPE1;RKI1
prerank,ncRNA catabolic process (GO:0034661),-0.47908697069456635,-0.7870748118602148,0.7883870967741935,0.9817990242474954,1.0,2/10,9.17%,MTR4;NRD1
prerank,'de novo' cotranslational protein folding (GO:0051083),-0.5047041040825965,-0.7866023050676996,0.7943661971830986,0.9812593742354628,1.0,4/7,28.87%,SSZ1;BTT1;EGD2;ZUO1
prerank,cellular modified amino acid catabolic process (GO:0042219),0.3914999349549726,0.7850410014960393,0.7440944881889764,0.9643344372206155,1.0,2/9,12.60%,DUG2;ECM38
prerank,transcription elongation from RNA polymerase I promoter (GO:0006362),-0.533508361882187,-0.7849541814621781,0.7942942942942943,0.981981021493444,1.0,1/5,12.66%,RPA49
prerank,L-phenylalanine metabolic process (GO:0006558),-0.5100641565872142,-0.7848610015095426,0.7855072463768116,0.9810024293579086,1.0,2/6,15.80%,ARO9;ARO7
prerank,serine family amino acid biosynthetic process (GO:0009070),-0.4591624401451655,-0.7846095629392517,0.7940119760479042,0.9802135449461323,1.0,1/12,1.73%,SER3
prerank,anaphase-promoting complex-dependent catabolic process (GO:0031145),0.4271945662154019,0.7821793733832187,0.7322834645669292,0.9644638590581314,1.0,2/8,4.84%,APC11;CDC16
prerank,organonitrogen compound catabolic process (GO:1901565),0.30408741498848113,0.7811315448374037,0.8468468468468469,0.9619113313634489,1.0,4/21,7.84%,RPT2;APA1;SUE1;DAL3
prerank,response to endoplasmic reticulum stress (GO:0034976),-0.4734110808872695,-0.7787230053927313,0.8005181347150259,0.9859099846879809,1.0,2/10,5.06%,RTN1;EUG1
prerank,Golgi to plasma membrane protein transport (GO:0043001),0.3909162158372156,0.7785738891760976,0.7521008403361344,0.961569586179873,1.0,2/10,9.52%,SFH5;ARL1
prerank,manganese ion transport (GO:0006828),-0.5258998751297184,-0.77820657626807,0.8143712574850299,0.98548282424281,1.0,3/5,28.60%,PMR1;PHO84;SMF2
prerank,dicarboxylic acid metabolic process (GO:0043648),-0.44907570286031107,-0.7756890493474232,0.8014705882352942,0.9872310991943427,1.0,4/12,20.51%,BNA1;FUM1;YMR31;NIT3
prerank,nucleotide metabolic process (GO:0009117),-0.4557684745343457,-0.7753890287614397,0.8118214716525934,0.9864697655567775,1.0,2/13,14.68%,PHM8;AMD1
prerank,DNA replication checkpoint (GO:0000076),-0.44620856282383814,-0.7747166931440665,0.8062575210589651,0.9861780402170659,1.0,3/14,7.93%,POL2;SIR3;DPB11
prerank,negative regulation of chromatin silencing (GO:0031936),0.3218457491043704,0.7712023427941997,0.8296296296296296,0.9691227073880362,1.0,4/18,12.68%,RAP1;WTM2;SIF2;RPD3
prerank,negative regulation of transcription from RNA polymerase II promoter by pheromones (GO:0046020),-0.4606867613324811,-0.7699435515496544,0.7891963109354414,0.9904012973990066,1.0,2/10,10.85%,PRR2;ISW2
prerank,positive regulation of kinase activity (GO:0033674),-0.51760331627312,-0.7695978685731176,0.7960725075528701,0.9896500029188645,1.0,1/5,13.78%,RPP2B
prerank,snoRNA 3'-end processing (GO:0031126),-0.41999190508586326,-0.7683555305947095,0.8194130925507901,0.9899024429990814,1.0,3/22,9.17%,MTR4;RRP6;NRD1
prerank,vesicle docking (GO:0048278),-0.46325657292024525,-0.7665577647537498,0.821917808219178,0.9907839315501761,1.0,2/11,18.98%,VAM3;VAM7
prerank,protein targeting to membrane (GO:0006612),-0.40768602559404676,-0.7660367190036954,0.8520130576713819,0.9902552977159327,1.0,4/29,16.70%,STP22;KAP95;GET4;BTT1
prerank,cytoskeleton organization (GO:0007010),0.40948928179105065,0.7659448247795658,0.7453183520599251,0.9729887749611361,1.0,1/8,1.52%,CMD1
prerank,arginine metabolic process (GO:0006525),-0.4922430720867861,-0.7637496740186547,0.8076923076923077,0.9916771815878554,1.0,3/7,23.11%,ARG3;ARG7;CAR2
prerank,organic hydroxy compound transport (GO:0015850),-0.4319541607532088,-0.7628958791062374,0.8208092485549133,0.9915714671730742,1.0,4/16,15.40%,OSH6;PRY2;DAN1;PRY1
prerank,cell wall glycoprotein biosynthetic process (GO:0031506),0.29980822369497956,0.7627843298326128,0.8032786885245902,0.9650835803708975,1.0,8/18,18.53%,KTR1;VAN1;VMA9;KTR5;KTR6;HOC1;GON7;KTR3
prerank,mannoprotein biosynthetic process (GO:0006057),0.29980822369497956,0.7627843298326128,0.8032786885245902,0.9650835803708975,1.0,8/18,18.53%,KTR1;VAN1;VMA9;KTR5;KTR6;HOC1;GON7;KTR3
prerank,cell wall mannoprotein biosynthetic process (GO:0000032),0.29980822369497956,0.7627843298326128,0.8032786885245902,0.9650835803708975,1.0,8/18,18.53%,KTR1;VAN1;VMA9;KTR5;KTR6;HOC1;GON7;KTR3
prerank,positive regulation of transcription from RNA polymerase II promoter by pheromones (GO:0007329),-0.5000314276529173,-0.7626180568226553,0.828696925329429,0.9896865654107748,1.0,2/6,12.15%,SUB1;CRZ1
prerank,positive regulation of transcription by pheromones (GO:0009371),-0.5000314276529173,-0.7626180568226553,0.828696925329429,0.9896865654107748,1.0,2/6,12.15%,SUB1;CRZ1
prerank,positive regulation of ATPase activity (GO:0032781),0.4257529752229988,0.7624990250324356,0.7619047619047619,0.9613386655565686,1.0,3/7,20.95%,VFA1;SPP2;SQS1
prerank,dephosphorylation (GO:0016311),-0.39409716738115846,-0.7621409360077906,0.864693446088795,0.989141261264096,1.0,12/37,22.86%,PPH22;PSY2;PTC5;RTS1;PSR2;PPQ1;REF2;PHO8;TFC7;SIW14;LTP1;THR4
prerank,posttranslational protein targeting to endoplasmic reticulum membrane (GO:0006620),-0.4400812905920955,-0.7596776364173503,0.8152173913043478,0.990666760898093,1.0,3/14,16.94%,GET4;BTT1;SBH2
prerank,positive regulation of protein modification process (GO:0031401),0.4385318062699055,0.7592743670342215,0.7658862876254181,0.9619208840293393,1.0,1/6,0.04%,GLC7
prerank,nuclear polyadenylation-dependent ncRNA catabolic process (GO:0071046),-0.4242483985607448,-0.7589518695709703,0.8335220838052095,0.9904232951918299,1.0,2/18,7.19%,MTR4;RRP6
prerank,glucose import (GO:0046323),-0.44387922253367157,-0.7588084009632818,0.8104325699745547,0.9895166438884228,1.0,3/11,17.32%,HXT14;SNF3;STL1
prerank,protein import into mitochondrial matrix (GO:0030150),-0.42353128947277696,-0.7583626646305109,0.8373983739837398,0.9889032400505514,1.0,6/19,20.15%,ZIM17;TOM40;YME1;TOM70;MDJ2;TOM6
prerank,ncRNA processing (GO:0034470),-0.38240001483201935,-0.7581063476267372,0.9032258064516129,0.9880924807928553,1.0,7/70,12.82%,REX3;PRP43;DSS1;NOC3;HCA4;XRN1;SSZ1
prerank,protein transmembrane import into intracellular organelle (GO:0044743),-0.38712829552289185,-0.7576277790942672,0.8972250770811921,0.9875014643455131,1.0,10/55,15.60%,CAJ1;PEX10;ZIM17;TOM40;GPD1;PEX5;OXA1;HSP60;YME1;TOM70
prerank,regulation of protein kinase activity (GO:0045859),0.3905886173446039,0.757092642514087,0.7796610169491526,0.9610286726749236,1.0,1/9,0.07%,PIL1
prerank,establishment of mitochondrion localization (GO:0051654),-0.512167025540373,-0.755806241390776,0.8242811501597445,0.9883547535974628,1.0,1/5,18.15%,ARC18
prerank,regulation of pheromone-dependent signal transduction involved in conjugation with cellular fusion (GO:0010969),-0.5067539310377525,-0.7553374534187404,0.8259629101283881,0.9877885374450939,1.0,3/5,25.30%,PPQ1;DSE1;AKR1
prerank,nuclear polyadenylation-dependent mRNA catabolic process (GO:0071042),-0.44030390829118016,-0.7552887568173922,0.8127250900360145,0.9857192068041295,1.0,2/13,7.19%,MTR4;RRP6
prerank,polyadenylation-dependent mRNA catabolic process (GO:0071047),-0.44030390829118016,-0.7552887568173922,0.8127250900360145,0.9857192068041295,1.0,2/13,7.19%,MTR4;RRP6
prerank,positive regulation of endocytosis (GO:0045807),-0.48119132557020555,-0.7545475970618949,0.8185654008438819,0.9854596858635655,1.0,2/7,18.47%,ROM2;ALY2
prerank,U4 snRNA 3'-end processing (GO:0034475),-0.43452123669711057,-0.7530914059817799,0.8243727598566308,0.9858580200184475,1.0,2/13,7.19%,MTR4;RRP6
prerank,"protein import into peroxisome matrix, docking (GO:0016560)",-0.5110212734035307,-0.7525929626895527,0.8266871165644172,0.9853556449720287,1.0,2/5,14.28%,PEX5;PEX14
prerank,aromatic compound biosynthetic process (GO:0019438),-0.41187786276858124,-0.7512973230822572,0.8533333333333334,0.9855984040452772,1.0,3/21,15.80%,SNO3;PHO2;ARO7
prerank,nucleolus organization (GO:0007000),-0.5035194721431676,-0.7509868805474165,0.8177710843373494,0.9848857897407062,1.0,2/5,23.94%,NET1;LRS4
prerank,regulation of translational initiation (GO:0006446),-0.4344485318598663,-0.7494041948601737,0.8543689320388349,0.9853946180179743,1.0,3/14,15.87%,GCN2;GCN3;PAT1
prerank,negative regulation of hydrolase activity (GO:0051346),-0.494886184699943,-0.7485100492726376,0.8344827586206897,0.9853021617225813,1.0,2/6,21.81%,ROY1;INH1
prerank,replication fork processing (GO:0031297),-0.4745774844441674,-0.7479725883231464,0.8171589310829818,0.9847591645499502,1.0,3/7,15.11%,SGS1;RTT101;PIF1
prerank,negative regulation of pseudohyphal growth (GO:2000221),-0.4892783077202468,-0.7463826315670138,0.8297872340425532,0.9853050022848894,1.0,1/6,8.29%,SFL1
prerank,"positive regulation of cytokinesis, actomyosin contractile ring assembly (GO:2000433)",-0.503352944403474,-0.7431506118266108,0.8216939078751857,0.9853204343918717,1.0,1/5,1.66%,ROM1
prerank,regulation of mitotic actomyosin contractile ring assembly (GO:1903499),-0.503352944403474,-0.7431506118266108,0.8216939078751857,0.9853204343918717,1.0,1/5,1.66%,ROM1
prerank,positive regulation of mitotic actomyosin contractile ring assembly (GO:1903501),-0.503352944403474,-0.7431506118266108,0.8216939078751857,0.9853204343918717,1.0,1/5,1.66%,ROM1
prerank,regulation of intracellular transport (GO:0032386),-0.4768345672280593,-0.7416623448189118,0.8202247191011236,0.9856706017845237,1.0,3/7,18.47%,NUP145;NUP192;ALY2
prerank,global genome nucleotide-excision repair (GO:0070911),-0.4886775797542035,-0.740634386112391,0.8371040723981901,0.9856232197871798,1.0,2/6,20.08%,HHT2;ELC1
prerank,U1 snRNA 3'-end processing (GO:0034473),0.4352788078841545,0.7395612649471429,0.7463126843657817,0.9830321588259952,1.0,3/5,7.80%,RRP45;RRP43;SKI6
prerank,nuclear polyadenylation-dependent tRNA catabolic process (GO:0071038),-0.42581062542424997,-0.7386798896645731,0.8462455303933254,0.9855107098808373,1.0,2/14,7.19%,MTR4;RRP6
prerank,tRNA catabolic process (GO:0016078),-0.42581062542424997,-0.7386798896645731,0.8462455303933254,0.9855107098808373,1.0,2/14,7.19%,MTR4;RRP6
prerank,"nuclear-transcribed mRNA catabolic process, non-stop decay (GO:0070481)",-0.4251508873455848,-0.7381567455891844,0.8345410628019324,0.9850023508282575,1.0,2/15,7.35%,YGR122W;SIR3
prerank,macromolecule biosynthetic process (GO:0009059),-0.4790816185090297,-0.7378635174454462,0.8071942446043165,0.9842387071624298,1.0,2/6,8.14%,EFT2;EFT1
prerank,regulation of establishment or maintenance of cell polarity (GO:0032878),-0.48474106834634995,-0.7368624300230104,0.8284839203675345,0.9841962601498118,1.0,1/5,7.69%,PCL1
prerank,sphingolipid metabolic process (GO:0006665),-0.39173398862682424,-0.7367615638236217,0.8760775862068966,0.9832511400299805,1.0,3/30,5.45%,FLC2;SKN1;FLC1
prerank,rRNA metabolic process (GO:0016072),-0.37223382387352044,-0.7351293774758918,0.9186991869918699,0.9838740372969157,1.0,10/68,16.76%,PRP43;DSS1;NOC3;MTR4;HCA4;RSC9;XRN1;SSZ1;HHT2;DBP2
prerank,positive regulation of hydrolase activity (GO:0051345),-0.4064008498286654,-0.7350049285627025,0.8503401360544217,0.9829586704098126,1.0,3/20,14.39%,IRA1;MSH2;SED4
prerank,barrier septum assembly (GO:0000917),-0.4578358244054913,-0.7338255992544779,0.8407557354925776,0.9830937255493685,1.0,3/8,18.67%,CHS1;HOF1;MNN10
prerank,protein deubiquitination (GO:0016579),0.29699542514624655,0.7332149899883653,0.8543046357615894,0.9879143199415105,1.0,3/18,10.87%,UBP3;SGF73;SGF11
prerank,trehalose metabolic process (GO:0005991),-0.4624476390668961,-0.7331732361354147,0.8396094839609484,0.9826400591498217,1.0,3/8,19.72%,PGM1;TPS3;TPS2
prerank,mRNA metabolic process (GO:0016071),-0.41574401496785873,-0.7329684622993206,0.8503480278422274,0.9818224529746462,1.0,2/16,11.34%,AEP3;QRI5
prerank,receptor-mediated endocytosis (GO:0006898),-0.4927233090966879,-0.7328140344236075,0.8361669242658424,0.98094248115251,1.0,1/5,4.82%,UBX3
prerank,"nuclear-transcribed mRNA catabolic process, nonsense-mediated decay (GO:0000184)",0.2895326584418176,0.7311966015398117,0.9,0.9865486619164633,1.0,6/20,14.23%,RRP45;RRP43;SKI6;SKI8;UPF3;NMD4
prerank,mitochondrial gene expression (GO:0140053),-0.3663821048253301,-0.7299339925795912,0.9524772497472194,0.9826373779446064,1.0,10/90,15.64%,MRPL16;MRF1;MRPL44;MSE1;PTH1;RSF1;MRP7;MRPS28;MRP20;MRPL4
prerank,establishment of protein localization to mitochondrion (GO:0072655),-0.3801064596684608,-0.7297803542758503,0.8825396825396825,0.9817531522915632,1.0,10/36,20.93%,ZIM17;TOM40;SSA1;YDJ1;HSP60;YME1;TOM70;MDJ2;TOM6;HOT13
prerank,cytochrome complex assembly (GO:0017004),0.4341485304016153,0.7296696558773962,0.7732919254658385,0.9844409222542774,1.0,5/5,56.63%,CYC3;COX15;CYC2;CBT1;CYT2
prerank,hydrogen peroxide metabolic process (GO:0042743),-0.4817732902332532,-0.729268297262836,0.8441176470588235,0.9811953947096556,1.0,2/6,14.79%,TSA1;CTT1
prerank,drug transmembrane transport (GO:0006855),-0.4235189326761575,-0.7287992600528325,0.8489208633093526,0.9795744571405056,1.0,4/13,23.33%,QDR2;TPO4;YHK8;DTR1
prerank,drug transport (GO:0015893),-0.4235189326761575,-0.7287992600528325,0.8489208633093526,0.9795744571405056,1.0,4/13,23.33%,QDR2;TPO4;YHK8;DTR1
prerank,SCF-dependent proteasomal ubiquitin-dependent protein catabolic process (GO:0031146),-0.4187326565599467,-0.7280637058430653,0.8467933491686461,0.9792827265070702,1.0,7/15,23.44%,YDR131C;MET30;HRT1;UFO1;MDM30;RAD7;YDR306C
prerank,regulation of gene expression (GO:0010468),-0.37091618744144383,-0.7279942192408075,0.9087221095334685,0.9783325439983099,1.0,10/52,21.25%,CLA4;SPN1;CRZ1;SET3;TOS4;LEU3;MLP2;SET2;NUP133;MDM30
prerank,establishment or maintenance of actin cytoskeleton polarity (GO:0030950),-0.43822551694045386,-0.7266213863637832,0.8396349413298566,0.9785802420784416,1.0,2/10,18.33%,MLF3;TSC11
prerank,chemical homeostasis (GO:0048878),-0.4237060992424997,-0.7260955548118874,0.8608374384236454,0.9780698327823768,1.0,4/13,25.24%,MCP1;CRZ1;POX1;APQ12
prerank,endoplasmic reticulum inheritance (GO:0048309),-0.4258934088364238,-0.7257472797135464,0.8497474747474747,0.9773588043633309,1.0,1/12,4.66%,RTN1
prerank,protein retention in ER lumen (GO:0006621),-0.44860997993535123,-0.7256298790664939,0.8262599469496021,0.976464395795317,1.0,1/8,6.57%,EPS1
prerank,protein urmylation (GO:0032447),0.42565470528369254,0.7242328275927477,0.8144654088050315,0.9880462410509986,1.0,2/6,4.95%,URM1;ELP6
prerank,actin nucleation (GO:0045010),-0.4709067754042436,-0.7229777682212007,0.8467153284671532,0.9779008492395194,1.0,3/6,18.15%,BZZ1;ARP3;ARC18
prerank,membrane fusion (GO:0061025),-0.37632672258852096,-0.7218658083077801,0.8945686900958466,0.9779166077638103,1.0,11/34,25.44%,VPS41;VAC8;VPS16;VAM3;FZO1;VAM7;ATG8;MDM30;VTC4;VAM10;TRX2
prerank,glyoxylate metabolic process (GO:0046487),-0.4863511553853547,-0.7208342434512934,0.8280060882800608,0.97779567671416,1.0,2/5,19.57%,DAL7;CIT2
prerank,mRNA splice site selection (GO:0006376),-0.43369122713217,-0.7173236114295694,0.8560411311053985,0.97994199071744,1.0,1/10,3.90%,NAM8
prerank,fatty acid beta-oxidation (GO:0006635),-0.42706754858569873,-0.7173020824722836,0.8653113087674714,0.9789555109261245,1.0,4/11,24.54%,POT1;POX1;AIM45;FOX2
prerank,organelle membrane fusion (GO:0090174),-0.3893876071139956,-0.7125686004536382,0.8838495575221239,0.9821117873951575,1.0,4/22,18.98%,PEP7;VAM3;SPO20;VAM7
prerank,biotin biosynthetic process (GO:0009102),0.42091039320858065,0.7112840268047865,0.7951070336391437,0.9974899104207461,1.0,2/5,11.59%,BIO3;ISA2
prerank,biotin metabolic process (GO:0006768),0.42091039320858065,0.7112840268047865,0.7951070336391437,0.9974899104207461,1.0,2/5,11.59%,BIO3;ISA2
prerank,negative regulation of protein modification process (GO:0031400),-0.453832051768809,-0.7094784706166705,0.8493353028064993,0.9838068003819151,1.0,1/6,10.65%,CLB2
prerank,autophagy of mitochondrion (GO:0000422),-0.37930372179090815,-0.7091852818408322,0.876265466816648,0.9820480203981116,1.0,5/23,19.81%,ATG29;ATG16;SCM4;ATG11;ATG8
prerank,mitochondrion disassembly (GO:0061726),-0.37930372179090815,-0.7091852818408322,0.876265466816648,0.9820480203981116,1.0,5/23,19.81%,ATG29;ATG16;SCM4;ATG11;ATG8
prerank,mitochondrial transport (GO:0006839),-0.361191360454276,-0.7085040354858245,0.9287925696594427,0.9816194784483157,1.0,9/51,15.60%,ZIM17;TOM40;YMC2;CYT1;SSA1;YDJ1;HSP60;YME1;TOM70
prerank,histone exchange (GO:0043486),-0.4448016902364945,-0.7071464435998871,0.8644536652835408,0.9818428071465951,1.0,4/8,25.93%,SWC5;SWC4;SWC3;VPS71
prerank,establishment of mitotic sister chromatid cohesion (GO:0034087),-0.4139853286990892,-0.7057271223767374,0.871536523929471,0.982079013936101,1.0,1/12,2.89%,MCM16
prerank,nuclear polyadenylation-dependent CUT catabolic process (GO:0071039),-0.42696241288777437,-0.7050410382839191,0.8729351969504447,0.9816609758831849,1.0,1/10,7.19%,RRP6
prerank,invasive growth in response to glucose limitation (GO:0001403),-0.37125729298463883,-0.7029673650673471,0.8878306878306879,0.9823739118011782,1.0,5/33,16.63%,RIM8;FLO10;STE4;DSE1;EMP70
prerank,establishment of protein localization to membrane (GO:0090150),-0.36846964233131874,-0.7023967876752997,0.9017278617710583,0.9818388244889739,1.0,2/28,6.50%,STP22;KAP95
prerank,tRNA aminoacylation for protein translation (GO:0006418),-0.37429116955646713,-0.7000433278572255,0.8972677595628415,0.9829199375585596,1.0,3/26,12.28%,MSE1;THS1;GUS1
prerank,mRNA destabilization (GO:0061157),0.4256644638430417,0.6986603937210399,0.8108108108108109,1.0,1.0,2/5,11.72%,TIS11;CTH1
prerank,peptide metabolic process (GO:0006518),0.2790432671565535,0.6980870783932275,0.9107142857142857,1.0,1.0,6/22,14.05%,RPT2;AFG3;SPC3;GRX2;YFH1;YTA12
prerank,glycolytic process (GO:0006096),-0.39928554034868147,-0.6957753354905802,0.8864734299516909,0.9844822231538045,1.0,2/15,8.11%,TDH1;FBA1
prerank,ATP generation from ADP (GO:0006757),-0.39928554034868147,-0.6957753354905802,0.8864734299516909,0.9844822231538045,1.0,2/15,8.11%,TDH1;FBA1
prerank,invasive filamentous growth (GO:0036267),-0.36596314280352005,-0.6944672742313523,0.9060190073917634,0.9845490805496577,1.0,10/35,26.04%,RIM8;FLO10;STE4;DSE1;EMP70;ASC1;UBA4;POF1;DIA3;SPH1
prerank,oxoacid metabolic process (GO:0043436),-0.4332342528292354,-0.6936430106335565,0.86468200270636,0.9842149345163504,1.0,6/8,29.27%,VPH1;PHO90;VTC4;PHO84;VTC1;PHO87
prerank,cellular glucan metabolic process (GO:0006073),-0.401073726978184,-0.6923919291922175,0.881851400730816,0.9842178940345006,1.0,1/14,1.10%,SPR1
prerank,protein sumoylation (GO:0016925),-0.41306005157006714,-0.6922439822719819,0.8919254658385093,0.9833527049911346,1.0,3/12,20.28%,SIZ1;APJ1;GMC2
prerank,mitotic metaphase plate congression (GO:0007080),-0.44958148959976085,-0.6903179842957139,0.8604992657856094,0.9839732519597669,1.0,2/6,18.20%,ASK1;MIF2
prerank,sulfur compound catabolic process (GO:0044273),0.3626657654942146,0.6902809522509987,0.8214285714285714,1.0,1.0,2/8,12.60%,DUG2;ECM38
prerank,macromolecule catabolic process (GO:0009057),-0.4392905938236582,-0.6901804529974971,0.8774647887323944,0.9831070179257447,1.0,3/7,26.22%,NMA111;YSP3;SKI7
prerank,maintenance of DNA trinucleotide repeats (GO:0035753),0.3388601353199515,0.690008258148252,0.8508771929824561,1.0,1.0,2/11,6.14%,POL30;CDC9
prerank,error-free translesion synthesis (GO:0070987),0.3502234840832531,0.6893309353396101,0.8410852713178295,1.0,1.0,5/9,22.95%,POL30;RAD30;CSM2;RAD6;REV7
prerank,protein deacetylation (GO:0006476),-0.4044885074670583,-0.6891606579305296,0.8884711779448622,0.9829511404481184,1.0,5/13,20.22%,SET3;HOS3;EAF3;SET2;SDS3
prerank,isoprenoid biosynthetic process (GO:0008299),0.367531391504498,0.6866137305393388,0.8067796610169492,1.0,1.0,2/7,5.18%,ERG20;RER2
prerank,eisosome assembly (GO:0070941),-0.4074359627492997,-0.684186835905383,0.8873591989987485,0.9860559348935876,1.0,2/11,11.97%,YKL050C;EIS1
prerank,ion homeostasis (GO:0050801),-0.426199321073114,-0.6816135655415676,0.8834688346883469,0.9871511328120591,1.0,3/8,16.67%,PTK2;CRZ1;CMP2
prerank,cellular ion homeostasis (GO:0006873),-0.4074859732703508,-0.6794284708338332,0.9013732833957553,0.9879040124157611,1.0,2/11,8.54%,SNQ2;PTK2
prerank,negative regulation of DNA recombination (GO:0045910),-0.40870778262677854,-0.6772477761599842,0.8886010362694301,0.9885444736014148,1.0,3/11,18.38%,MSH2;SRS2;SET2
prerank,maintenance of protein localization in endoplasmic reticulum (GO:0035437),-0.41074394755265586,-0.6764474980466464,0.87146529562982,0.9881814689658072,1.0,1/9,6.57%,EPS1
prerank,positive regulation of translational fidelity (GO:0045903),-0.4112992452054969,-0.6756504962335094,0.876117496807152,0.987828248374337,1.0,2/10,17.37%,RPS9B;CTK3
prerank,regulation of actin filament bundle assembly (GO:0032231),-0.43521818444103094,-0.6745863751819826,0.8713286713286713,0.9876275204419072,1.0,2/6,18.35%,KEL1;KEL2
prerank,translesion synthesis (GO:0019985),-0.38445253231384907,-0.6734010903396878,0.9084423305588585,0.9874954793661898,1.0,2/15,12.68%,POL2;RAD5
prerank,second-messenger-mediated signaling (GO:0019932),0.3616024866890789,0.6725685672660137,0.8442028985507246,1.0,1.0,2/7,10.44%,CMD1;RCN1
prerank,inositol lipid-mediated signaling (GO:0048017),-0.4324573683164774,-0.6714574297502302,0.8748180494905385,0.9880037356597761,1.0,2/6,18.58%,IRS4;VPS34
prerank,rRNA modification (GO:0000154),0.3464268486388562,0.6688645903746482,0.8625592417061612,1.0,1.0,1/9,8.20%,NOP10
prerank,regulation of cellular component organization (GO:0051128),-0.351009852378247,-0.6687890644637362,0.9032258064516129,0.9890531584253207,1.0,6/29,18.33%,PKC1;KOG1;ROM2;RAV2;MKK2;TSC11
prerank,arginine biosynthetic process (GO:0006526),-0.42533792181467434,-0.6679655520742428,0.8780821917808219,0.9886918198006807,1.0,2/7,19.61%,ARG3;ARG7
prerank,rRNA pseudouridine synthesis (GO:0031118),0.3873020671832254,0.6668552728781958,0.8333333333333334,1.0,1.0,1/6,8.20%,NOP10
prerank,carbohydrate catabolic process (GO:0016052),-0.37120387702066326,-0.665625793724635,0.9120370370370371,0.9895224237075106,1.0,2/18,8.11%,TDH1;FBA1
prerank,peptidyl-lysine monomethylation (GO:0018026),-0.43916548605337874,-0.6643662144900497,0.8913043478260869,0.9894940678250314,1.0,1/6,12.48%,EFM1
prerank,regulation of mRNA stability (GO:0043488),0.3185092737241486,0.6636517937569373,0.8904109589041096,1.0,1.0,4/10,14.25%,ATP25;RMD9;HEK2;IGO1
prerank,ubiquitin-dependent ERAD pathway (GO:0030433),-0.3362335621502894,-0.6597619580607997,0.9430051813471503,0.9920041807760237,1.0,7/44,15.02%,PNG1;EPS1;HRD3;RAD23;YDJ1;JEM1;UBX2
prerank,regulation of organelle assembly (GO:1902115),-0.43206946618317976,-0.6578980216718079,0.8879432624113475,0.9924750077969607,1.0,2/6,33.75%,BCY1;RAS2
prerank,snRNA pseudouridine synthesis (GO:0031120),0.38730281151710516,0.6567096033626727,0.8328358208955224,1.0,1.0,1/5,8.20%,NOP10
prerank,snRNA modification (GO:0040031),0.38730281151710516,0.6567096033626727,0.8328358208955224,1.0,1.0,1/5,8.20%,NOP10
prerank,cellular protein complex assembly (GO:0043623),-0.3302335227617125,-0.656011299877898,0.9676767676767677,0.99291501330533,1.0,7/75,12.55%,RPN9;RTN1;KAP95;NUP170;ECM29;HSP60;RCF1
prerank,cellular amide catabolic process (GO:0043605),0.3799941994112711,0.6544231706355322,0.8243626062322946,1.0,1.0,1/5,7.84%,DAL3
prerank,inositol phosphate catabolic process (GO:0071545),-0.44677818296594274,-0.6520472163639499,0.9010494752623688,0.9937078975375899,1.0,1/5,10.98%,INM2
prerank,inositol phosphate dephosphorylation (GO:0046855),-0.44677818296594274,-0.6520472163639499,0.9010494752623688,0.9937078975375899,1.0,1/5,10.98%,INM2
prerank,"mitochondrial electron transport, cytochrome c to oxygen (GO:0006123)",-0.3924921325635141,-0.651969807534131,0.9092071611253197,0.9927776640711217,1.0,1/10,8.94%,COX6
prerank,mitotic cytokinetic process (GO:1902410),-0.39820782654227294,-0.6519432610253243,0.9127604166666666,0.9918075954060123,1.0,3/9,18.67%,CHS1;HOF1;MNN10
prerank,glutamine family amino acid biosynthetic process (GO:0009084),0.2568968882690958,0.6518742053936828,0.9181818181818182,1.0,1.0,5/19,17.21%,YHR033W;ORT1;PRO3;IDP1;PUT1
prerank,glucose transport (GO:0015758),-0.3776990910510367,-0.6513147266773417,0.8932160804020101,0.9912597514571126,1.0,3/12,17.32%,HXT14;SNF3;STL1
prerank,pre-replicative complex assembly involved in nuclear cell cycle DNA replication (GO:0006267),-0.3621432137820706,-0.6510269958321268,0.9190751445086706,0.9905188878060295,1.0,3/18,21.52%,NOC3;MCM3;RIX1
prerank,protein import into mitochondrial intermembrane space (GO:0045041),0.3430014344377078,0.6507056208929043,0.8695652173913043,1.0,1.0,1/8,0.25%,MIC60
prerank,amide biosynthetic process (GO:0043604),-0.35969426878878014,-0.6506127743348589,0.9308807134894092,0.9898428029452928,1.0,1/21,3.47%,SPE1
prerank,nicotinamide nucleotide metabolic process (GO:0046496),-0.3708838763798976,-0.6495345951679219,0.9234449760765551,0.9896256616678503,1.0,2/16,8.11%,TDH1;FBA1
prerank,protein modification by small protein removal (GO:0070646),-0.35655615559742526,-0.6484595579368265,0.9258836944127709,0.9894049982788653,1.0,4/18,17.30%,RRI1;UBP1;UBP9;UBP6
prerank,regulation of protein export from nucleus (GO:0046825),-0.4225386334450574,-0.6471286627256764,0.914616497829233,0.9893130031621886,1.0,1/6,8.31%,SPN1
prerank,nuclear DNA replication (GO:0033260),-0.35778101788005673,-0.6462194126384223,0.9230769230769231,0.9890240990043939,1.0,1/19,5.09%,NOC3
prerank,regulation of actin cytoskeleton organization (GO:0032956),0.332951350734906,0.6458636996265712,0.888,1.0,1.0,2/9,10.29%,RHO4;RHO1
prerank,regulation of actin filament-based process (GO:0032970),0.332951350734906,0.6458636996265712,0.888,1.0,1.0,2/9,10.29%,RHO4;RHO1
prerank,regulation of cytoskeleton organization (GO:0051493),0.332951350734906,0.6458636996265712,0.888,1.0,1.0,2/9,10.29%,RHO4;RHO1
prerank,branched-chain amino acid metabolic process (GO:0009081),0.3816211767510284,0.6450333894982367,0.855072463768116,0.9987229118982218,1.0,3/5,32.05%,ILV5;ILV2;THR1
prerank,mitochondrial protein processing (GO:0034982),0.3337060936462479,0.6445260865204301,0.8866396761133604,0.9953551788739277,1.0,4/8,19.16%,AFG3;MAS1;YTA12;IMP2
prerank,cell septum assembly (GO:0090529),-0.41546663194677935,-0.6391206449144393,0.9014492753623189,0.9928843682536886,1.0,2/6,18.67%,HOF1;MNN10
prerank,cellular response to ethanol (GO:0071361),0.37762626237769503,0.6384699260557023,0.8548895899053628,0.9973644308908463,1.0,2/5,18.60%,ATH1;HSP30
prerank,proteasome-mediated ubiquitin-dependent protein catabolic process (GO:0043161),-0.3154568077430566,-0.6384556743283234,0.9869739478957916,0.9923309138106806,1.0,24/107,22.70%,FYV10;RPN8;EPS1;APC1;HRD3;YDR131C;MET30;SSA2;RAD23;SSA1;YDJ1;JEM1;HRT1;UBX2;UBP6;VID30;UFO1;RMD5;MDM30;USA1;PUP1;DOC1;UFD2;RAD7
prerank,methionine metabolic process (GO:0006555),-0.39318708206753666,-0.6381288751678849,0.9154929577464789,0.9915810502862071,1.0,2/9,15.84%,SAM1;SAH1
prerank,regulation of cell wall organization or biogenesis (GO:1903338),-0.3609081348128827,-0.6361788156815785,0.9227053140096618,0.9919045526118206,1.0,3/15,15.76%,PKC1;ROM2;MKK2
prerank,histone deacetylation (GO:0016575),-0.36974483973394934,-0.6358729573963243,0.9173859432799013,0.9911349979582151,1.0,5/14,20.22%,SET3;HOS3;EAF3;SET2;SDS3
prerank,negative regulation of cellular catabolic process (GO:0031330),-0.4238726841862725,-0.6356890151997728,0.8969230769230769,0.9902934707328547,1.0,3/5,38.14%,SPT10;IGD1;PHO23
prerank,translational frameshifting (GO:0006452),-0.4263603572689778,-0.6314479223129978,0.8979907264296755,0.9922507644011709,1.0,1/5,12.82%,SSZ1
prerank,regulation of fungal-type cell wall organization (GO:0060237),-0.3627918073516344,-0.6308573659951873,0.9352078239608802,0.9916757421894286,1.0,3/14,15.76%,PKC1;ROM2;MKK2
prerank,negative regulation of cell cycle process (GO:0010948),-0.398251738150354,-0.6294623278708583,0.9260752688172043,0.9915990376138949,1.0,2/8,16.88%,SET3;SNF3
prerank,negative regulation of DNA metabolic process (GO:0051053),0.3386837181482064,0.6293353808518541,0.8832116788321168,1.0,1.0,2/7,10.06%,SIR2;PAF1
prerank,mitochondrial fusion (GO:0008053),0.3632685939171145,0.6292911468606813,0.900990099009901,0.9980783703915059,1.0,1/6,1.93%,AFG3
prerank,protein lipidation (GO:0006497),0.2183324030874845,0.6280944330649996,1.0,0.995305335236169,1.0,12/33,24.72%,DPM1;GPI19;PFA4;PFA5;GPI12;ERI1;PER1;ATG21;SPT14;HSV2;PBN1;ATG12
prerank,fatty acid biosynthetic process (GO:0006633),0.2958190444521235,0.6259010701861375,0.9130434782608695,0.9933804887039294,1.0,6/11,22.50%,LIP5;EHT1;ACP1;CEM1;ELO1;ETR1
prerank,allantoin catabolic process (GO:0000256),-0.4245844694350771,-0.6240541008108829,0.9144634525660964,0.9941192532110645,1.0,2/5,19.54%,DAL1;DAL7
prerank,regulation of Arp2/3 complex-mediated actin nucleation (GO:0034315),-0.3942402534202733,-0.6219864135161338,0.9182561307901907,0.994402991250827,1.0,3/8,21.54%,VRP1;AIM7;CRN1
prerank,cyclic-nucleotide-mediated signaling (GO:0019935),-0.4099303276034495,-0.6218370125299902,0.908955223880597,0.9935368961826095,1.0,2/6,16.56%,PDE2;PDE1
prerank,cellular response to nitrogen starvation (GO:0006995),-0.37599354071157703,-0.6210017514613272,0.9269882659713168,0.9931054765673406,1.0,6/10,34.24%,ATG8;GAT1;ATG7;MSN2;BCY1;VPS30
prerank,Arp2/3 complex-mediated actin nucleation (GO:0034314),0.3613073974350436,0.620647988113611,0.8739255014326648,0.9942331918220242,1.0,2/5,8.61%,ARC40;ARC35
prerank,peptide catabolic process (GO:0043171),-0.38500770634682385,-0.6198780724762556,0.9186991869918699,0.9927604361115976,1.0,1/8,4.68%,STE23
prerank,negative regulation of meiosis I (GO:0110029),-0.39532069142407145,-0.6176294983336225,0.9282639885222381,0.9932094845578637,1.0,4/7,28.64%,MSH2;SET2;YCG1;YCS4
prerank,cellular response to oxidative stress (GO:0034599),-0.30918043526132644,-0.6168623982152263,0.9899699097291875,0.9926593284688364,1.0,8/80,14.93%,SOD2;TSA1;EOS1;ASK10;HYR1;ALO1;GRX1;FRM2
prerank,spliceosomal snRNP assembly (GO:0000387),-0.3619635591141718,-0.6167705046147246,0.9264705882352942,0.9917661471988096,1.0,3/12,22.12%,PRP24;MRN1;CWC2
prerank,double-strand break repair via break-induced replication (GO:0000727),-0.34001540278428,-0.6165587813603994,0.9483516483516483,0.990947314756316,1.0,5/22,21.67%,DPB11;PIF1;MCM3;PSF3;SLX4
prerank,vesicle fusion (GO:0006906),-0.3276072102264302,-0.616051550570664,0.9365079365079365,0.9902848444933385,1.0,5/29,18.98%,SLY1;PEP7;VAM3;SPO20;VAM7
prerank,response to cadmium ion (GO:0046686),-0.4173593597418149,-0.6148165780162199,0.9247311827956989,0.9901078478457033,1.0,1/5,10.13%,MET30
prerank,protein localization to Golgi apparatus (GO:0034067),-0.36257842618952074,-0.6114764027653604,0.9485294117647058,0.9911467957496575,1.0,3/12,23.82%,VPS35;IRE1;ARL3
prerank,positive regulation of mitotic cell cycle phase transition (GO:1901992),-0.3583345686039491,-0.6078874656094078,0.9351620947630923,0.992330365311017,1.0,2/12,14.88%,ESP1;SLK19
prerank,generation of catalytic spliceosome for second transesterification step (GO:0000350),0.32703761134244425,0.6078056257163467,0.9382239382239382,1.0,1.0,2/8,15.60%,CDC40;ISY1
prerank,positive regulation of mitotic cytokinetic process (GO:1903438),-0.38780772313188133,-0.607252620083773,0.9346049046321526,0.9917327146162889,1.0,1/8,1.66%,ROM1
prerank,GPI anchor metabolic process (GO:0006505),0.23640668869696282,0.6065152283466527,1.0,0.9985137281228252,1.0,8/21,23.62%,DPM1;GPI19;GPI12;ERI1;PER1;SPT14;IPT1;PBN1
prerank,vesicle fusion with Golgi apparatus (GO:0048280),-0.38928470338655763,-0.6060830709400182,0.918918918918919,0.9914635465236191,1.0,1/7,5.63%,SLY1
prerank,replication-born double-strand break repair via sister chromatid exchange (GO:1990414),-0.3606078941263477,-0.6011153641272604,0.9236842105263158,0.9933051459758866,1.0,2/11,14.55%,SMC3;AHC1
prerank,double-strand break repair via single-strand annealing (GO:0045002),-0.3915206307538427,-0.6004134119311976,0.9293948126801153,0.9927351843679325,1.0,2/6,27.07%,SLX4;RAD1
prerank,regulation of exocytosis (GO:0017157),0.3588195629591702,0.5989905671359402,0.9069069069069069,1.0,1.0,1/5,5.47%,SFH5
prerank,response to hydrogen peroxide (GO:0042542),-0.3691505769804154,-0.5988042695042609,0.9398692810457516,0.9926885468127484,1.0,3/9,20.82%,RSC9;CTT1;ZWF1
prerank,cellular response to reactive oxygen species (GO:0034614),-0.4052600535218246,-0.5985293582162653,0.9278033794162827,0.9919015965748847,1.0,1/5,10.42%,RSC9
prerank,calcium-mediated signaling (GO:0019722),-0.37865283922089843,-0.5979792257867326,0.9328767123287671,0.9912330443416739,1.0,2/7,16.67%,RSF1;CMP2
prerank,peptidyl-diphthamide biosynthetic process from peptidyl-histidine (GO:0017183),-0.38707792892964454,-0.596770464913516,0.9306518723994452,0.9890955374792908,1.0,2/7,19.43%,DPH1;DPH6
prerank,regulation of cytoplasmic translational elongation (GO:1900247),-0.38707792892964454,-0.596770464913516,0.9306518723994452,0.9890955374792908,1.0,2/7,19.43%,DPH1;DPH6
prerank,peptidyl-diphthamide metabolic process (GO:0017182),-0.38707792892964454,-0.596770464913516,0.9306518723994452,0.9890955374792908,1.0,2/7,19.43%,DPH1;DPH6
prerank,cellular response to hydrogen peroxide (GO:0070301),-0.3821777160054859,-0.5953321409969629,0.9291666666666667,0.9889142256724449,1.0,1/7,10.42%,RSC9
prerank,regulation of chromatin silencing at rDNA (GO:0061187),0.3333571649444993,0.592283323533676,0.8952095808383234,1.0,1.0,2/6,19.45%,RPD3;NAT4
prerank,RNA polymerase III transcriptional preinitiation complex assembly (GO:0070898),-0.4034489928185526,-0.5904552571453328,0.9420731707317073,0.9906728805210407,1.0,2/5,19.90%,SUB1;BRF1
prerank,cytoskeleton-dependent cytokinesis (GO:0061640),-0.3470189863293689,-0.5898121837569978,0.9417721518987342,0.9900521758121639,1.0,2/12,18.09%,CDC15;HOF1
prerank,regulation of nucleic acid-templated transcription (GO:1903506),-0.30899313759936153,-0.587865659777352,0.9680851063829787,0.9901103236008046,1.0,8/33,24.72%,CRZ1;SET3;LEU3;MLP2;SET2;NUP133;NUP53;NPL6
prerank,"posttranslational protein targeting to membrane, translocation (GO:0031204)",-0.38493483087215563,-0.5860998315979955,0.9351585014409222,0.9900846830017891,1.0,1/6,16.94%,SBH2
prerank,box C/D snoRNP assembly (GO:0000492),-0.37804259136662854,-0.5854377971626358,0.9523121387283237,0.9894748485527419,1.0,1/7,13.40%,TAH1
prerank,aspartate family amino acid biosynthetic process (GO:0009067),-0.3427271949104783,-0.5853653302873442,0.9589867310012062,0.988579543151774,1.0,4/13,27.19%,LYS1;THR4;HOM3;ASN1
prerank,mitochondrial DNA metabolic process (GO:0032042),0.33940462944057886,0.5836482214153403,0.9047619047619048,1.0,1.0,3/5,21.07%,HMI1;RIM1;MSH1
prerank,mRNA catabolic process (GO:0006402),-0.3324995240800694,-0.5829472040094658,0.9616766467065868,0.9888360869057844,1.0,2/14,13.29%,XRN1;VTS1
prerank,DNA replication-dependent nucleosome organization (GO:0034723),-0.40056763010009305,-0.5825692442594951,0.9344773790951638,0.9871350325275279,1.0,2/5,20.89%,CAC2;RTT106
prerank,DNA replication-dependent nucleosome assembly (GO:0006335),-0.40056763010009305,-0.5825692442594951,0.9344773790951638,0.9871350325275279,1.0,2/5,20.89%,CAC2;RTT106
prerank,negative regulation of ATPase activity (GO:0032780),-0.38926042667721916,-0.5775872410749888,0.93033381712627,0.9886469052062881,1.0,3/5,33.39%,INH1;MCM2;YRA1
prerank,N-terminal protein amino acid acetylation (GO:0006474),-0.3407835255395944,-0.5730705690981218,0.9483870967741935,0.9899065508553323,1.0,4/11,29.05%,MDM20;YIR042C;NAT2;MAK10
prerank,regulation of meiotic cell cycle (GO:0051445),0.3039581913737734,0.5706489948236287,0.9345454545454546,1.0,1.0,2/7,15.26%,RCK1;SWE1
prerank,maintenance of DNA repeat elements (GO:0043570),-0.3093532519606594,-0.5705876913336208,0.9579646017699115,0.990131383863757,1.0,7/22,28.64%,MSH2;DCC1;CSM3;XRS2;SRC1;RAD27;YCS4
prerank,MAPK cascade (GO:0000165),-0.3713549253192852,-0.5694595441216495,0.9460992907801419,0.9897372880012819,1.0,1/6,18.60%,SSK2
prerank,regulation of endocytosis (GO:0030100),-0.3547662837104688,-0.5648909635049313,0.9393939393939394,0.9908199829129216,1.0,1/9,10.74%,ROM2
prerank,cellular manganese ion homeostasis (GO:0030026),0.28683410391567205,0.5624736952328695,0.9512195121951219,1.0,1.0,3/8,18.56%,ATX2;SMF1;PER1
prerank,manganese ion homeostasis (GO:0055071),0.28683410391567205,0.5624736952328695,0.9512195121951219,1.0,1.0,3/8,18.56%,ATX2;SMF1;PER1
prerank,tRNA wobble base modification (GO:0002097),-0.31159201668900643,-0.5606372231165307,0.9766407119021134,0.9918310068811869,1.0,4/20,16.97%,ELP2;SAP185;ELP3;TUM1
prerank,nitrogen catabolite activation of transcription from RNA polymerase II promoter (GO:0001080),0.3127320525980982,0.5586209246230833,0.9506578947368421,1.0,1.0,2/6,22.14%,GLN3;GCN4
prerank,nitrogen catabolite activation of transcription (GO:0090294),0.3127320525980982,0.5586209246230833,0.9506578947368421,1.0,1.0,2/6,22.14%,GLN3;GCN4
prerank,peptidyl-lysine methylation (GO:0018022),-0.3407058999584885,-0.5555551164465324,0.9607843137254902,0.9930450980580963,1.0,1/9,12.48%,EFM1
prerank,threonine biosynthetic process (GO:0009088),-0.37466785185292006,-0.5535664111587866,0.9429892141756548,0.9929090005786754,1.0,3/5,32.99%,THR4;HOM3;HOM2
prerank,ribose phosphate biosynthetic process (GO:0046390),0.31956912028725315,0.5504026136059306,0.9545454545454546,1.0,1.0,6/6,68.09%,PRS4;PRS3;SHB17;PRS5;PRS1;PRS2
prerank,terpenoid biosynthetic process (GO:0016114),0.30064210226622945,0.5405352407284587,0.9561128526645768,1.0,1.0,1/6,4.46%,ERG20
prerank,tRNA wobble uridine modification (GO:0002098),-0.29661984733857055,-0.5388614026664469,0.9790979097909791,0.9976173589799481,1.0,4/22,16.97%,ELP2;SAP185;ELP3;TUM1
prerank,lipid biosynthetic process (GO:0008610),-0.2902609221042519,-0.5370401427226806,0.9887640449438202,0.9973609855656678,1.0,5/24,25.57%,URA8;HMG2;HMG1;SCS22;OPI1
prerank,pyrimidine deoxyribonucleotide biosynthetic process (GO:0009221),-0.35784203790558855,-0.5360399834836239,0.9567099567099567,0.9967969223601156,1.0,1/5,19.74%,CDC21
prerank,folic acid metabolic process (GO:0046655),0.32151671527933606,0.5348730480073195,0.9447674418604651,1.0,1.0,5/5,67.88%,MIS1;FSH3;FSH2;FSH1;ABZ2
prerank,positive regulation of pseudohyphal growth (GO:2000222),0.28154467894027857,0.5308171169758474,0.9644268774703557,1.0,1.0,8/8,71.90%,PHD1;CDC42;TEC1;SIP1;MSN1;RAS2;ASH1;SIP2
prerank,5-phosphoribose 1-diphosphate metabolic process (GO:0046391),0.31949741978909585,0.529763634026247,0.9376947040498442,0.9962062845579417,1.0,5/5,68.09%,PRS4;PRS3;PRS5;PRS1;PRS2
prerank,5-phosphoribose 1-diphosphate biosynthetic process (GO:0006015),0.31949741978909585,0.529763634026247,0.9376947040498442,0.9962062845579417,1.0,5/5,68.09%,PRS4;PRS3;PRS5;PRS1;PRS2
prerank,vacuolar transmembrane transport (GO:0034486),0.30475763016157986,0.5287705247657022,0.9605263157894737,0.9931501809328036,1.0,6/6,69.57%,AVT4;YPQ2;AVT3;RTC2;YPQ1;ATG22
prerank,farnesyl diphosphate biosynthetic process (GO:0045337),0.3024695485668744,0.5122490255589766,0.9725274725274725,0.9974585297639534,1.0,1/5,4.46%,ERG20
prerank,sulfur compound biosynthetic process (GO:0044272),-0.2931847896936917,-0.5122255084381145,0.9815668202764977,1.0,1.0,4/16,22.10%,SAM1;MET5;ISA1;BIO4
prerank,mitotic actomyosin contractile ring assembly (GO:1903475),-0.3410586643618105,-0.5083186059038801,0.9799072642967542,1.0,1.0,2/5,25.35%,HOF1;PFY1
prerank,histone H3 acetylation (GO:0043966),-0.32575548915413866,-0.5032301546061289,0.9703389830508474,1.0,1.0,3/7,27.52%,TAF9;ELP4;SPT10
prerank,regulation of dephosphorylation (GO:0035303),-0.3216095221390923,-0.4949197503305983,0.9715994020926756,1.0,1.0,2/6,29.72%,SCS22;IST2
prerank,regulation of pseudohyphal growth (GO:2000220),-0.28255809012974853,-0.4948884811123473,0.9929660023446659,1.0,1.0,4/16,28.15%,KSP1;KAP123;UBA4;SIP2
prerank,pentose catabolic process (GO:0019323),-0.31907654488775017,-0.4917641567284373,0.9703264094955489,1.0,1.0,1/6,21.09%,RPE1
prerank,ceramide metabolic process (GO:0006672),-0.3110917745577163,-0.4915120818360691,0.988031914893617,1.0,1.0,3/8,27.90%,LRO1;ORM1;DGA1
prerank,RNA modification (GO:0009451),-0.26345974018234797,-0.4905048569431923,0.9944994499449945,1.0,1.0,6/24,26.02%,MOD5;PUS7;PUS5;TRM2;PAP2;KAE1
prerank,peptidyl-lysine modification (GO:0018205),-0.2644067551524598,-0.48662617242328404,0.9912376779846659,1.0,1.0,3/23,20.28%,SIZ1;APJ1;GMC2
prerank,positive regulation of protein ubiquitination (GO:0031398),-0.3189439647865705,-0.4851189219787054,0.985734664764622,1.0,1.0,3/6,31.71%,UFD2;RUP1;DCN1
prerank,DNA biosynthetic process (GO:0071897),-0.31230749339325686,-0.48267225473646297,0.9833333333333333,1.0,1.0,2/6,36.75%,RAD1;POL31
prerank,sulfur amino acid biosynthetic process (GO:0000097),0.27081424662332587,0.4821286599030105,0.9845559845559846,1.0,1.0,3/7,19.34%,MET2;HOM6;MET6
prerank,response to hexose (GO:0009746),-0.3251495052284174,-0.4810228959926726,0.983433734939759,1.0,1.0,2/5,30.64%,YCK1;GSY1
prerank,positive regulation of growth of unicellular organism as a thread of attached cells (GO:0070786),-0.2853131029151643,-0.4760710068557756,0.9925373134328358,1.0,1.0,4/11,33.75%,YTA7;GAL11;SIP2;RAS2
prerank,dicarboxylic acid catabolic process (GO:0043649),-0.31723947179383977,-0.47273025157614806,0.9795021961932651,1.0,1.0,1/5,18.94%,AAT1
prerank,glutamate metabolic process (GO:0006536),-0.2771234176344436,-0.4671661773957727,0.9902794653705954,1.0,1.0,4/12,29.61%,CIT2;CIT1;CAR2;GDH1
prerank,positive regulation of transcription from RNA polymerase II promoter in response to osmotic stress (GO:0061393),-0.2926657465826498,-0.4636105802232245,0.9945280437756497,1.0,1.0,4/7,31.85%,MOT3;SKO1;HOT1;MSN2
prerank,fatty acid catabolic process (GO:0009062),-0.2670400349290142,-0.461199519528929,0.9878787878787879,0.9998473167747504,1.0,3/13,24.54%,POT1;POX1;FOX2
prerank,negative regulation of chromatin silencing at rDNA (GO:0061188),-0.30944598606593215,-0.4595794960711452,0.9890282131661442,0.9991825133772307,1.0,1/5,20.22%,SDS3
prerank,actomyosin contractile ring assembly (GO:0000915),0.24221594341278013,0.4536828292681622,0.99644128113879,1.0,1.0,3/8,20.82%,NOP15;CDC11;TPM2
prerank,response to glucose (GO:0009749),-0.28683834204145464,-0.44991817652977845,0.9902097902097902,0.999695143516445,1.0,2/7,20.04%,SNF3;YCK1
prerank,positive regulation of transcription from RNA polymerase II promoter in response to nitrogen starvation (GO:0036278),0.24798025134649918,0.4308004277621297,0.9968051118210862,1.0,1.0,6/6,75.24%,GLN3;GCN4;MSN4;BCY1;MSN2;GAT1
prerank,negative regulation of lipid biosynthetic process (GO:0051055),0.23246885354753946,0.42969507805830076,1.0,1.0,1.0,2/7,21.74%,YPK1;SPO7
prerank,"endonucleolytic cleavage to generate mature 3'-end of SSU-rRNA from (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000461)",-0.29012422330456944,-0.42712079239458145,0.9970501474926253,1.0,1.0,2/5,25.59%,RPS21A;TSR1
prerank,glutamate biosynthetic process (GO:0006537),-0.25798258901202004,-0.42113554092050737,0.9974391805377721,1.0,1.0,3/10,29.61%,CIT2;CIT1;GDH1
prerank,regulation of phosphorylation (GO:0042325),-0.26341577336841626,-0.4092096216963209,0.9916317991631799,1.0,1.0,1/7,18.33%,TSC11
prerank,mitochondrial respiratory chain complex III assembly (GO:0034551),0.20543331836551418,0.393320742958726,1.0,0.9995468252210504,1.0,8/8,79.49%,FMP25;CBP4;MZM1;QCR9;CBP6;QCR7;CBP3;BCS1
prerank,mitochondrial respiratory chain complex III biogenesis (GO:0097033),0.20543331836551418,0.393320742958726,1.0,0.9995468252210504,1.0,8/8,79.49%,FMP25;CBP4;MZM1;QCR9;CBP6;QCR7;CBP3;BCS1
prerank,respiratory chain complex III assembly (GO:0017062),0.20543331836551418,0.393320742958726,1.0,0.9995468252210504,1.0,8/8,79.49%,FMP25;CBP4;MZM1;QCR9;CBP6;QCR7;CBP3;BCS1
prerank,7-methylguanosine mRNA capping (GO:0006370),-0.2600403859098048,-0.3828797785447913,0.9956204379562044,1.0,1.0,5/5,74.05%,ABD1;CDC28;CTL1;CEG1;SPT4
prerank,7-methylguanosine RNA capping (GO:0009452),-0.2600403859098048,-0.3828797785447913,0.9956204379562044,1.0,1.0,5/5,74.05%,ABD1;CDC28;CTL1;CEG1;SPT4
prerank,threonine metabolic process (GO:0006566),-0.23739271583540547,-0.378025942807093,1.0,1.0,1.0,2/8,24.32%,THR4;HOM3
prerank,dicarboxylic acid biosynthetic process (GO:0043650),-0.2143312175236476,-0.3723337817149527,1.0,0.9993854679634024,1.0,4/16,32.16%,CIT2;CIT1;GDH1;ABZ2
